Comparing methods for modeling longitudinal and survival data, with consideration of mediation analysis by Ngwa, Julius S.
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2013
Comparing methods for modeling
longitudinal and survival data, with
consideration of mediation analysis
https://hdl.handle.net/2144/15210
Boston University
BOSTON UNIVERSITY 
 
GRADUATE SCHOOL OF ARTS AND SCIENCES 
 
 
 
 
 
Dissertation 
 
 
 
 
 
COMPARING METHODS FOR MODELING LONGITUDINAL AND  
 
SURVIVAL DATA, WITH CONSIDERATION OF MEDIATION ANALYSIS 
 
 
 
 
by 
 
 
 
 
JULIUS S. NGWA 
 
B.Sc., University of Buea, Cameroon, 2001  
M.S., Youngstown State University, 2006 
 
 
 
 
 
 
 
 
Submitted in partial fulfillment of the  
 
requirements for the degree of  
 
Doctor of Philosophy  
 
2013 
 
 
Approved by 
 
 
 
 
 
 
First Reader   
   L. Adrienne Cupples, Ph.D. 
   Professor of Epidemiology and Biostatistics 
 
 
 
 
 
 
Second Reader   
   Howard J. Cabral, Ph.D. 
   Professor of Biostatistics 
 
 
 
 
 
 
Third Reader   
   Debbie M. Cheng, Ph.D. 
   Professor of Biostatistics 
 
iii 
ACKNOWLEDGEMENTS 
 
“Coming together is a beginning; keeping together is progress; working together is success.” 
Henry Ford 
 
I would like to begin by saying that this dissertation would not have been possible 
without the guidance and help of several individuals who contributed and provided their 
valuable assistance in the completion of the thesis. First and foremost I would like to deeply 
thank my thesis advisor Dr. L. Adrienne Cupples. It has been a great honor and delight for 
me to work with her. I could not have completed this thesis work without her help. Her 
patience, enthusiasm and motivation have helped me throughout the research and writing 
phase of the thesis. I would like to sincerely thank my thesis committee readers: Dr. Howard 
Cabral and Dr. Debbie Cheng. Their immense knowledge and feedback during the thesis 
committee meetings provided me with the guidance during the project. I also like to thank 
Dr. Mike Lavalley and Dr. David Gagnon for being part of the full committee and providing 
their valuable advice during the thesis defense and submission phase. 
I would like to thank Dr. Michael Pencina for his great input in the second project of 
the thesis. His insightful comments and hard questions transformed the direction of the 
research. I would like to thank Dr. Timothy Heeren for his input and direction in the 
statistical analysis of the thesis. I would like to also thank Dr. Mayetri Gupta and Dr. 
Gheorghe Doros for the opportunity they provided me to work with them during my time 
in the program. I am grateful for their valuable insight and motivational discussions both in 
my work and in this thesis. 
iv 
I would like to thank all the faculty and staff at the Boston University Biostatistics 
Department for assisting me through the Ph.D. program. The department provided a great 
support system for me to achieve my goals and aspirations. The program has prepared and 
trained me in a variety of statistical research areas. Special thanks to Cynthia Korhonen, 
Ginger Quinn, and Amparo Ortiz for being accommodating to all my administrative 
inquiries and to the curriculum coordinators for their work in assisting students.  
 I would like to thank my mates in the Biostatistics Program and my colleagues in all 
the projects I have participated in as a research assistant. I would like to thank Dr. Clint 
Baldwin for allowing me to complete the statistical genetics rotation in his Lab. I also want 
to thank the BUSPH Data Coordinating Center for providing me with interdisciplinary 
training experience in clinical trials.  
 Finally I would like to thank my friends in the U.S. and around the world for all their 
help and source of laughter and joy during this period. I would like to extend my sincere 
gratitude to my wife and entire family for all their prayers and moral support. Their love and 
encouragement have always been my inspiration and a driving force in my academic 
achievements. I would like to dedicate this work to my entire family for all the support I 
have received throughout my academic career and my entire life. 
 
  
v 
COMPARING METHODS FOR MODELING LONGITUDINAL AND 
SURVIVAL DATA, WITH CONSIDERATION OF MEDIATION ANALYSIS 
JULIUS S. NGWA 
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Major Professor: L. Adrienne Cupples, Professor of Epidemiology and Biostatistics 
ABSTRACT 
Joint modeling of longitudinal and survival data has received much attention and is 
becoming increasingly useful. In clinical studies, longitudinal biomarkers are used to monitor 
disease progression and to predict survival. These longitudinal measures are often missing at 
failure times and may be prone to measurement errors. In previous studies these two types 
of data are frequently analyzed separately where a mixed effects model is used for 
longitudinal data and a survival model is applied to event outcomes. The argument in favor 
of a joint model has been the efficient use of the data as the survival information goes into 
modeling the longitudinal process and vice versa. 
In this thesis, we present joint maximum likelihood methods, a two stage approach 
and time dependent covariate methods that link longitudinal data to survival data. First, we 
use simulation studies to explore and assess the performance of these methods with bias, 
accuracy and coverage probabilities. Then, we focus on four time dependent methods 
considering models that are unadjusted and adjusted for time. Finally, we consider mediation 
analysis for longitudinal and survival data. Mediation analysis is introduced and applied in a 
research framework based on genetic variants, longitudinal measures and disease risk. We 
implement accelerated failure time regression using the joint maximum likelihood approach 
vi 
(AFT–joint) and an accelerated failure time regression model using the observed longitudinal 
measures as time dependent covariates (AFT–observed) to assess the mediated effect.  
We found that the two stage approach (TSA) performed best at estimating the link 
parameter. The joint maximum likelihood methods that used the predicted values of the 
longitudinal measures, similar to the TSA, provided larger estimates. The time dependent 
covariate methods that used the observed longitudinal measures in the survival analysis 
underestimated the true estimates. The mediation results showed that the AFT–joint and the 
AFT–observed underestimated the mediated effect. Comparison of the methods in 
Framingham Heart Study data revealed similar patterns. We recommend adjusting for time 
when estimating the association parameter in time dependent Cox and logistic models. 
Additional work is needed for estimating the mediated effect with longitudinal and survival 
data. 
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CHAPTER 1: MODELING LONGITUDINAL AND SURVIVAL DATA 
 
1.1 BACKGROUND 
Joint modeling of longitudinal and survival data has received much attention in 
statistical research. There is extensive literature and a wide range of statistical packages for 
jointly modeling longitudinal and survival data. Some recent papers include those of Brown 
and Ibrahim 2003; Zeng and Cai 2005; Tseng, Hsieh, and Wang 2005; Ye, Lin, and Taylor 
2008; Ibrahim, Chu, and Chen 2010; Rizopoulos 2010, among others. Tsiatis and Davidian 
2004 provide a comprehensive overview of earlier articles addressing a number of methods 
for jointly modeling longitudinal and survival data. These articles include work on joint 
models by Robins and Tsiatis 1992; DeGruttola and Tu 1994; Tsiatis, DeGruttola, and 
Wulfsohn 1995; Lavalley and DeGruttola 1996; Faucett and Thomas 1996; Wulfsohn and 
Tsiatis 1997; Wang and Taylor 2001; Xu and Zeger 2001. 
In clinical trials and medical research studies in which the primary end-point is the 
time to event, repeated measures are often generated concurrently. In these studies, 
participants are followed over a period of time and outcomes are collected; for example, 
longitudinal response measurements; a survival response (such as relapse or death); and 
additional covariate information on each participant. Typical settings where these may occur 
include AIDS clinical studies and cancer vaccine trials. In HIV studies baseline 
characteristics are recorded and immunological measures such as CD4+ lymphocyte counts 
or viral load are measured to assess patients’ health. Similarly, in cancer studies, patients are 
administered vaccines to raise antibody levels against tumor cells. The event outcome is 
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disease recurrence or death and patients also provide repeated measures of antibody levels or 
other carcinogenic markers such as prostate specific antigen (PSA) measurements. A 
common objective in these longitudinal studies is to characterize the relationship between 
the longitudinal response and the time-to-event (Tsiatis and Davidian, 2004). 
In joint modeling of longitudinal and survival data, the main focus may be on the 
longitudinal model, the survival model, or both models, depending on the objectives of the 
study. When the focus is on one model, the other model is then secondary, so its parameters 
may be viewed as nuisance parameters (Wu, 2010). When interest is on the longitudinal 
measurements one may be interested in modeling the longitudinal patterns and its 
association with covariates or any relationship that may exist between the missing 
longitudinal measurements and the occurrence of events. When interest is in the survival 
model one may wish to characterize the association between the longitudinal measurements 
and the time-to-event process adjusting for covariates.  A typical situation where this may 
arise is survival analysis with measurement error or missing data in longitudinal time 
dependent covariates. If the covariates are measured with error, the analysis becomes more 
complex. In this case modeling the longitudinal processes may be used to address these 
issues. In some instances a shared parameter model may be implemented in which the 
random effects of each subject from the longitudinal model may be linked to the survival 
process. In this case the shared parameters provide an obvious link between the longitudinal 
and survival processes. The link is described as the association parameter between the 
longitudinal trajectories and the survival outcome.  
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Sometimes we may need to model the longitudinal and survival processes 
simultaneously.  Both models are treated as responses and are modeled jointly. This 
approach was implemented by DeGruttola and Tu (2004) in which the survival times and 
the longitudinal measures are jointly modeled using normally distributed random effects.  In 
their paper the CD4 cell counts and the survival times were modeled in a joint distribution as 
a multivariate normal. The parameter estimates in the model were obtained using the EM 
algorithm. Xu and Zeger (2004) explored the relationship between a longitudinal process and 
a survival outcome in which a latent process was used to describe the longitudinal measures. 
They present a general model for jointly modeling longitudinal and survival data and they 
applied the model to identify whether the information from the longitudinal measures can be 
used to predict survival and act as a surrogate variable for survival. Wulfsohn and Tsiatis 
(1997) proposed a likelihood model for jointly modeling survival and longitudinal data 
measured with error. They assumed a repeated measures random effect approach to model 
the longitudinal data and the measurement error. The parameter estimates were obtained 
using the EM algorithm and Newton-Raphson approximation. 
Faucett and Thomas (1996) applied a similar approach as Wulfsohn and Tsiatis 
(1997) in a Bayesian framework to solve the problem. They assumed the random 
components model (Intercept and Slope) with normal errors for the longitudinal measures 
and a proportional hazards model for the survival time. They used Gibbs sampling to obtain 
the parameter estimates for the model. With simulation studies they compared the analysis 
of joint covariate modeling using Gibbs sampling to separate analysis using standard 
methods. 
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In all these methods the link between the longitudinal measures and the survival 
times may not be obvious or easily interpreted. There may not be a clear parameter which 
links the two processes. In this thesis we evaluate methods that link the longitudinal 
measures to the survival times in a proportional hazards model, through a scalar parameter 
that links the longitudinal process to the hazard function. We consider the scalar as a link 
parameter which describes the strength of the relationship between the longitudinal 
measures and the survival times. We conduct a series of simulations to explore and assess 
the performance of these methods with bias, accuracy and coverage probabilities in a 
number of scenarios. The bias is defined as the difference between the true value and the 
observed mean value; Mean square error (MSE), a measure of accuracy, is the sum of 
squares of the bias and the standard errors of the estimates; Coverage probability (CP) is the 
proportion of times, among all the replicates, the 100(1 –  α)% confidence intervals include 
the estimate. 
 
1.2 INTRODUCTION 
A common objective in longitudinal and survival studies is to characterize the 
relationship between the longitudinal response and the time-to-event (Tsiatis and Davidian 
2004). Typical settings where these may occur include HIV studies in which baseline 
characteristics are recorded and immunological measures such as CD4+ lymphocyte counts 
or viral load are measured to assess patients’ health. In these studies the primary endpoint 
may be the time to conversion to AIDs or death. The CD4 counts may be important 
predictors of survival for subjects in the study.  
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We apply these joint modeling methods to the Framingham Heart Study (FHS) data. 
The FHS (http://www.framinghamheartstudy.org/) is a widely known longitudinal study 
which identifies potential risk factors for the development of cardiovascular disease. Since 
1948 three generations of participants have been recruited and followed: Original cohort, 
Offspring and third generation. We consider data from the Framingham Heart Study (FHS) 
in which lipid measurements and myocardial infarction (MI) data were collected in the 
offspring cohort over a period of 26 years. Among the offspring participants, high-density 
lipoprotein (HDL), low density lipoprotein (LDL) and triglycerides (TG) were measured at 
fairly similar time intervals over a period of 26 years. The time to myocardial infarction was 
also recorded for each participant, although some subjects were censored by the end of the 
study period. These lipid longitudinal measures may be predictive of survival, thus we 
evaluate the effect of the TG measures on the myocardial infarction. A total of 2262 subjects 
with complete data were followed from 1979 to 2005 and data was collected at the start of 
each exam. Using the methods described below in section 1.3 we characterize the association 
between the longitudinal measures and time-to-event response. 
In the first part of the thesis, we present several methods which link the longitudinal 
data to the survival data. We explore methods that provide a clear link between the 
longitudinal measures to the survival times. We assess the performance of these methods 
with bias, accuracy and coverage probabilities. In the second part of the thesis, we focus on 
three of the time dependent models (TDCM, PLR and CSP), consider models that are 
unadjusted and adjusted for time. We simulate a number of scenarios and evaluate the effect 
of accounting for the time intervals at which the longitudinal measures are collected in these 
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models. In the third part of the thesis, we apply the concept of jointly modeling longitudinal 
and survival data in the context of mediation analysis. Mediation analysis is introduced and 
applied in a research framework based on genetic variants, longitudinal measures and disease 
risk. We assess the links between biological and environmental factors and disease risks. The 
direct, indirect and mediated effects of longitudinal measures on time-to-event outcome are 
assessed using a series of regression equations.  
In the mediation analysis setting a genetic variant (coded as the number of minor 
alleles for a Single Nucleotide Polymorphism) is the exposure variable, the longitudinal 
measure is the mediator and the time to myocardial infarction is the survival outcome. The 
genetic variant is a Single Nucleotide Polymorphism (SNP), which represents a difference in 
a single DNA building block, called a nucleotide. SNPs are known as DNA sequence 
variations that occur when a single nucleotide (A, T, C or G) in the genome sequence is 
altered. An example of a SNP is the alteration of the DNA segment AAGGTTA to 
ATGGTTA, where the second "A" in the first snippet is replaced with a "T" in the second. 
SNPs are usually considered to be point mutations that have been evolutionarily successful 
enough to recur in a population. SNPs occur normally throughout a person’s DNA. They 
can occur in coding (gene) and noncoding regions of the genome. Most commonly, they can 
be found in the DNA between genes. They can act as biological markers and may help 
scientists locate genes that are associated with disease. When SNPs occur within a gene or in 
a regulatory region near a gene, they may play a more direct role in disease by affecting the 
gene’s function. SNPs found within a coding sequence are of particular interest to 
researchers because they are more likely to alter the biological function of a protein. Recent 
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advances in technology, coupled with the unique ability of these genetic variations to 
facilitate gene identification, have resulted in a flurry of SNP discovery and detection. In this 
thesis we examine the extent to which the effect of a SNP on myocardial infarction is 
mediated by longitudinal lipid measures and whether there also is a direct effect of the SNP 
on myocardial infarction. We conclude by providing some recommendations for modeling 
longitudinal and survival data with consideration of mediation analysis and further areas of 
research. 
 
1.3. JOINT MODELING OF LONGITUDINAL AND SURVIVAL DATA 
In this section, we consider a number of methods for modeling longitudinal data and 
survival data. In modeling longitudinal and survival data, the main focus may be on the 
longitudinal model, the survival model, or both models, depending on the objectives of the 
study. When the focus is on one model, the other model is then secondary, so its parameters 
may be viewed as nuisance parameters (Wu, 2010). Our goal is to characterize the 
relationship between time-to-event (primary) and the longitudinal responses (secondary) 
adjusting for covariates in the model. In this thesis we explore the methods that link the 
longitudinal measures to the survival times in a proportional hazards model. We focus on the 
scalar parameter which links the longitudinal process to the hazard function. 
1.3.1 Joint Likelihood Models  
We consider a joint likelihood model similar to that of Brown and Ibrahim (2003), 
which links the longitudinal trajectories of each patient to the survival data. The longitudinal 
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responses are linked to the time-to-event model using a Cox proportional hazard model 
(Cox, 1972).  We consider a joint likelihood which is a product of the longitudinal model and 
survival model conditional on the longitudinal measures.  
 𝑓 𝑌! , 𝑡! , 𝛿! = 𝑓(𝑌!) ∗ 𝑓 𝑡! , 𝛿!|𝑌!   
We begin by constructing a likelihood model for the longitudinal measures. These 
measures are often missing at failure times and may be prone to measurement errors. 
Including the raw longitudinal measurements in analysis may lead to bias if the measures are 
related to the censoring process (Prentice, 1982). We implement a model for the longitudinal 
measurements by constructing trajectories for each patient. For the longitudinal measures we 
consider a time dependent covariate with possible measurement errors in the observed data.  
We implement a random effects approach which models the longitudinal measures 
with possible measurement errors. Each subject has 𝑚!  measures denoted by  𝑌!"  , 𝑗 =1, 2,… ,𝑚!  ,  where 𝑌!" represents the observed outcome for the 𝑖!! subject at the 𝑗!!  time 
point. We denote  𝑌!"∗ as the true unobserved value such that: 
  𝑌!" =  𝑌!"∗ + 𝜖!"  , 𝜖!"  ~ 𝑁(0,𝜎!) (1.1) 𝑌!"∗  is also known as the trajectory function.  The trajectory can be modeled in a linear form 
(Brown and Ibrahim, 2003) or Quadratic form (Tsiatis, DeGruttola, and Wulfsohn, 1995). 
Splines and other time series forms can be implemented to capture the trajectory of the 
longitudinal measures but the trade-off is the complexity and interpretation of the model, if 
the longitudinal process is primary. 
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We focus on a simple linear mixed effects model (LME), which allows individual or 
subject-specific inference (Laird and Ware, 1982), to fit data from longitudinal process. 
 𝐸  𝑌!" = 𝑌!∗(𝑡!") = 𝑈!! +  𝑈!! ∗ 𝑡!" (1.2) 
Here 𝑈!! and 𝑈!! represent the subject specific intercepts and slopes and are usually 
assumed to be normally distributed. The variable 𝑡!" represent the different times in which 
the longitudinal measures were recorded during the follow-up period. 
For the survival model we consider the Cox model which links the time-to-event 
data and the longitudinal trajectories through the hazard function. For each individual 𝑖, 𝑖 =1, 2,… , 𝑛, we let 𝑆! denote the survival or event time and 𝐶! denote the censoring time 
respectively. We assume that the censoring process is random and non-informative. Due to 
censoring we observe 𝑇𝑖 = 𝑚𝑖𝑛 𝑆𝑖 , 𝐶𝑖 . Let 𝛿𝑖 = 𝐼 𝑆𝑖 ≤ 𝐶𝑖 , denote the censoring indicator: 
𝛿! = 1  𝑖𝑓  𝑆! ≤ 𝐶!0  𝑖𝑓  𝑆! > 𝐶!   
The Cox model which links the time-to-event data and the longitudinal trajectories through 
the hazard function can be written as: 
 ℎ 𝑡 𝑌 =  𝜆! 𝑡 𝑒𝑥𝑝 𝑌!∗ 𝑡 𝜸 +  𝑋!!𝛼  (1.3) 
The parameter 𝜸 is a scalar (link) parameter which links the longitudinal trajectories 
to the hazard function; 𝛼 is a vector with unknown parameter estimates for the covariate 
measures  𝑋!!;   𝜆! 𝑡  is the baseline hazard function. From (1.3) a Cox partial likelihood 
(Cox, 1972) can be generated from which statistical inferences can be based if 𝑌!∗ were 
observed. 
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 𝐿!∗ = 𝑒𝑥𝑝 𝑌!∗(𝑡!)𝜸 + 𝑋!!𝛼𝑒𝑥𝑝 𝑌!∗(𝑡!)𝜸 + 𝑋!!𝛼 𝐼 𝑡! ≥ 𝑡!!!!!!!!!
!!
 
(1.4) 
In (1.4) a number of assumptions are made: (i) survival times are independent and without 
ties; (ii) the longitudinal measures must be available at each event time for all individuals. 
This is usually not the case as covariate measurement times may not coincide with event 
times, leading to missing data in time dependent covariates in the survival model. Such 
missingness may be assumed to be ignorable or MAR where the missingness may not be 
related to the missing values that would be observed (Little and Rubin, 2002). The last-value-
carried-forward (LVCF) method for missing longitudinal measures has been widely used to 
impute the missing covariates, but may lead to bias in the estimates (Prentice 1982). 
The hazard function for the survival component (1.3) given the longitudinal 
trajectory function yields: 
𝑓 𝑡! , 𝛿! ∝ 𝑓 𝑡! !!𝑆 𝑡! !!!! =  ℎ 𝑡! !!𝑆 𝑡! , 𝑤ℎ𝑒𝑟𝑒  𝑆 𝑡 = 𝑒𝑥𝑝 − ℎ 𝑢 𝑑𝑢!!  
𝑓 𝑡! , 𝛿! 𝑌!∗,𝑋! = 𝜆!(𝑡!)!! 𝑒𝑥𝑝 𝛿! 𝑌!∗ 𝑡! 𝜸 + 𝑋!!𝛼 ∗ 𝑒𝑥𝑝 − 𝜆!(𝑢) 𝑒𝑥𝑝 𝑌!∗ 𝑢 𝜸 + 𝑋!!𝛼!!! 𝑑𝑢  (1.5) 
Statistical inference based on the above likelihood function can be computationally intensive. 
A non-adaptive Gauss-Kronrod integration can be employed to numerically calculate the 
integral. The maximum likelihood parameter estimates can be obtained using the EM 
algorithm and Newton-Raphson approximation (Rizopoulos, 2010). A Monte Carlo Markov 
Chain (MCMC) approach can also be implemented in a Bayesian framework. Tsiatis and 
Davidian 2004 applied a different approach to the issue by proposing a conditional score 
which is also efficient and yields consistent and asymptotically normal estimators. 
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1.3.1.1 Bayesian Semi-Parametric Joint Model (BSJM) 
In this section we review Bayesian methods for jointly modeling longitudinal and 
survival data. Faucett and Thomas 1996 applied a Bayesian approach to estimate the 
parameters of the longitudinal process (𝜎!, mean and covariance of 𝑈!! and 𝑈𝑖2 ) and 
proportional hazard (𝜆!, 𝛾 and 𝛼) in the joint likelihood framework via Markov Chain 
Monte Carlo (MCMC). They specified non-informative priors to the parameters, in equation 
(1.1), in order to achieve results similar to the maximum likelihood estimates. Wang and 
Taylor 2001 applied a similar approach to model the survival component and used a more 
flexible approach to the longitudinal part by incorporating a stochastic process into the 
longitudinal trajectory. Brown and Ibrahim (2003) considered a semi-parametric Bayesian 
joint model in which they relax the distributional assumptions for the longitudinal model 
using Dirichlet process priors on the random effect parameters. 
In this thesis we apply a Bayesian approach for joint modeling of longitudinal and 
survival data similar to that of Brown and Ibrahim (2003). For the survival model, we specify 
normal priors for the parameters 𝛾 and 𝛼. We use MCMC methods to obtain posterior 
distributions of the parameters given the data. For the longitudinal model, we consider the 
LME model in which we assume prior distributions for the mean parameters, with variance 
components.  
 
From (1.1) and (1.2) we have that:  𝑌!" =  𝑌!"∗ + 𝜖!";    𝑌!"∗ = 𝑈!! +  𝑈!! ∗ 𝑡!";    𝑖 = 1, 2,… , 𝑛;    𝑗 = 1, 2,… ,𝑚! 𝜖!"  ~ 𝑁 0,𝑅!  𝑎𝑛𝑑 𝑅! =  𝜎!𝐼!! 
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 𝑌!"|𝑈!  ~ 𝑁 𝑌!"∗ ,𝑉 , 𝑉 = 𝑍!𝐺𝑍!! + 𝑅! 
G denotes the covariance matrix of the random effects and 𝑍! is a diagonal matrix of the 
longitudinal time points.  
A subject 𝑖′𝑠 contribution to the joint likelihood function can be written as:  
𝑓 𝑌! , 𝑡! , 𝛿! =  𝜆! 𝑡! !! 𝑒𝑥𝑝 𝛿! 𝑌!∗ 𝑡! 𝜸 + 𝑋!!𝛼 ∗ 𝑒𝑥𝑝 − 𝜆! 𝑢 𝑒𝑥𝑝 𝑌!∗ 𝑢 𝜸 + 𝑋!!𝛼!!! 𝑑𝑢 ∗ 12𝜋𝜎! !!! 𝑒𝑥𝑝 − 12𝜎! 𝑌!" − 𝑌!"∗ !
!!
!!!  
(1.6) 
A typical approach assumes a constant hazard ratio for the baseline hazard and 
normal prior distributions for the random effects and the unknown regression 
parameter (𝛼). The variance-covariance matrix (V) is assigned a Wishart distribution 
through a precision matrix P: 
𝑃 = 𝑉!! ~ 𝑊𝑖𝑠ℎ𝑎𝑟𝑡 𝑆!!, 𝑣  𝜎! ~ 𝐼𝐺 𝑎, 𝑏  
In the Wishart distribution, S denotes the scale matrix and 𝑣 denotes the degrees of 
freedom. IG represents the inverse gamma distribution with shape a and scale parameter b. 
We employed R and WinBUGS to obtain parameter estimates and credible intervals 
from the posterior distribution of the Bayesian modeling using standard MCMC methods as 
Gibbs sampling. Once the model, data and initial values are specified in WinBUGS, the 
parameters can be monitored until convergence is attained. At the end of the MCMC 
process we obtain plots and diagnostic statistics to access convergence in the parameters.  
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We implemented the Bayesian Output Analysis (Boa) package in R to obtain 
convergence diagnostics in R. The Boa package, written by Brian Smith, is based on the 
Convergence Diagnosis and Output Analysis Software for Gibbs sampling output (CODA) 
developed by Best, Cowles, and Vines. This package provides a variety of diagnostic 
functions useful for MCMC output. The Boa package provides various summary statistics 
such as means, standard deviations, quantiles, highest probability density intervals, and 
simulation standard errors for correlated output based on batch means. It allows one to 
compare autocorrelations and cross-correlations of simulated samples from different 
parameters. It computes various convergence diagnostics, such as those proposed by 
Geweke, Gelman and Rubin, and Raftery and Lewis. It also provides a variety of different 
plots, such as lag correlations, density estimates and running means. These convergence 
diagnostics are implemented to determine if there is convergence in the parameter estimates 
of the model. 
1.3.1.2 Maximum Likelihood Approach (MLA) 
In this section, we review the maximum likelihood approach for jointly modeling 
longitudinal and survival data by Rizopoulos (2010). This method, employing the same 
general approach as Wulfsohn and Tsiatis (1997), implements shared parameter model for 
the joint modeling of longitudinal responses and time-to-event data. The joint distribution 
for the longitudinal and survival model can be written as: 
 𝑓 𝑌! ,𝑇! , 𝛿! = 𝑓(𝑌! 𝑈! ∗ ℎ! 𝑇! 𝑈! !!𝑆 𝑇! 𝑈! ∗ 𝑓 𝑈! 𝑑𝑈! (1.7) 
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where 𝑆 𝑇! 𝑈!  represents the survival function conditional on the random effects, ℎ! 𝑇! 𝑈!  
is the hazard function and 𝑓 𝑌! ,𝑇! , 𝛿!  is the density function. Equation (1.7) assumes that 
given the random effects, the longitudinal measures are independent of the time-to-event 
outcome and are independent of each other. The true unobserved (expected) values of the 
longitudinal measures 𝑌!∗ 𝑡  are associated with the event outcome (𝑇𝑖): 
ℎ! 𝑡 𝑌!∗ = ℎ! 𝑡 𝑒𝑥𝑝 𝑌!∗ 𝑡 𝜸 + 𝑋!!𝛼  
𝑤ℎ𝑒𝑟𝑒 𝑌!∗ 𝑡 =  𝑌!∗ 𝑠 , 0 ≤ 𝑠 ≤ 𝑡   
The parameter estimates, using Equation 1.6, are obtained using the Rizopoulos 
(2010) JM package in R. The package fits a shared parameter model for the joint modeling of 
normal longitudinal responses and event time under the likelihood approach. The maximum 
likelihood estimation for joint models is based on the maximization of the log-likelihood 
corresponding to the joint distribution of the time-to-event and longitudinal outcomes. The 
maximization may be challenging as the integral of the survival function has no analytic 
solution. Following Rizopoulos, we implemented a Weibull model using Gauss-Hermite 
integration rule to approximate the integral. In the estimation process a hybrid optimization 
approach is employed that starts with EM and then continues with direct maximization. The 
procedure for the EM algorithm uses a fixed number of iterations, and if convergence is not 
achieved it switches to a quasi-Newton algorithm until convergence is attained. 
1.3.2  Two Step Approach (TSA)  
In the TSA the longitudinal process is estimated separately and the random effect 
estimates are substituted directly to the survival model. This approach was first implemented 
15 
 
 
 
by Tsiatis (1995) in which a linear mixed effect (LME) is fit to the longitudinal measures and 
the fitted values are inserted to the Cox Proportional Hazard model in the second stage as 
time dependent covariate measures. Ye, Lin, and Taylor (2008) proposed two approaches for 
modeling the TSA called risk set regression calibration (RRC) and ordinary regression 
calibration (ORC). In the first approach the LME model is fit using the observed 
longitudinal data among subjects with event. This approach may be implemented in 
instances where the longitudinal trajectories of subjects who experienced the event may be 
different from those who did not.  
In the second approach the LME model is fit using all observed longitudinal data. 
We apply the LME model fit using all observed covariate data. In the first step the 
longitudinal process is estimated using the LME model in (1.1) and (1.2) and estimates of the 
random effects are used to obtain predicted values of the longitudinal measures at event 
times, which may not be the time of measurement. In the second step the predicted 
longitudinal measures are used in the Cox Model to estimate the association parameters for 
the hazard function. At each event time, a new evaluation of the partial likelihood is added 
to the analysis. The variance estimates are obtained from the observed information of the 
partial likelihood function. 
 ℎ 𝑡 𝑌∗ =  𝜆! 𝑡 𝑒𝑥𝑝 𝑌!∗ 𝑡 𝛾 +  𝑋!!𝛼  (1.8) 
The 𝑋!! represents the additional covariate measures to the model and the 𝑌!∗ 𝑡  represents 
the predicted values of the longitudinal measures at the time-to-event. The link parameter (𝛾) 
in this approach can be interpreted as the association between the longitudinal measures at 
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the event time and the survival. The estimation and inference for the hazard model (1.8) can 
be performed using the partial likelihood theory proposed by Cox (1975).  
The main advantage of this approach is that it is simple and can be implemented 
using existing statistical packages. Tsiatis (1997) argued that using estimated values from a 
repeated measures random effects model for the covariate process is superior to naive 
methods where one maximizes the partial likelihood of the Cox using the observed 
covariates values. Ye, Lin, and Taylor (2008) and Albert and Shih (2009) have argued that 
there are two main disadvantages of a simple TSA; 1) it may provide biased estimates 
especially when the longitudinal process and the survival process are strongly associated; and 
2) it does not incorporate the uncertainty of estimation in the first stage into the second 
stage, possibly leading to under-estimation of the standard errors. We evaluate a number of 
scenarios to access the validity of these assumptions in simulation studies.  
 
1.4 OTHER LONGITUDINAL AND SURVIVAL ANALYSES METHODS 
In this section we review four other methods which are typically used to assess the 
relationship between time dependent covariate measures and time-to-event data. In these 
methods the observed longitudinal measures are employed to predict an event.  
1.4.1 Time Dependent Covariate Modeling (TDCM) 
A time dependent explanatory variable is one whose value for any given subject may 
change over the period of time that the subject is observed (Cox and Oakes, 1984). The 
most common type of time dependent covariate is a repeated measurement on a subject or a 
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change in the subject’s treatment assignment. Therneau and Grambsch, (2000) considered a 
well-known example of TDCM using the Stanford Heart Transplant Program. Data for 
subjects are presented as multiple observations, each of which applies to an interval of 
observation. A proportional hazard model is often used to analyze covariate information that 
changes over time. The hazard may be thought of as being proportional to the instantaneous 
probability of an event at a particular time (Cox, 1972). This approach is more complicated 
than a naïve baseline approach as the covariate information changes over time.  
We consider a sample of size n, consisting of 𝑇𝑖, 𝛿𝑖, 𝑌𝑖 𝑡 , 0 ≤ 𝑡 ≤ 𝑇𝑖 , 𝑖 =1, 2,… , 𝑛 , where 𝑇! is the time-to-event for the 𝑖!! subject, 𝛿! is the event indicator. 
𝛿! = 1  𝑖𝑓  𝑇! ≤ 𝐶!0  𝑖𝑓  𝑇! > 𝐶!   
The hazard for this model at time t can be written as: 
ℎ 𝑡 = ℎ! 𝑡 ∗ exp 𝛽𝑌! 𝑡 +  𝑋!!𝛼  = ℎ! 𝑡 ∗ exp 𝛽!!!!!! 𝑌!" 𝑡 +  𝑋!!𝛼   (1.9) 
The vector 𝑌! 𝑡 = 𝑌!! 𝑡 ,… ,𝑌!!! 𝑡  is a set of covariates and 𝑚! is the number of time 
intervals for the 𝑖!! subject. We define 𝑡! < 𝑡! < 𝑡! < ⋯ < 𝑡! as a set of ordered event times 
and 𝑍! 𝑡!  as the covariate associated with the individual whose failure time is 𝑡𝑖. The risk 
set 𝑅(𝑡𝑖) at time 𝑡! is the set of all individuals who are still under study at a time just prior 
to 𝑡! . The partial likelihood based on the hazard function in (1.9) can be written as: 
  𝐿(𝛼,𝛽) = 𝑒𝑥𝑝 𝛽!!!!!! 𝑌!"(𝑡) +  𝑋!!𝛼𝑒𝑥𝑝 𝛽!!!!!! 𝑌!" 𝑡! +  𝑋!!𝛼!"!(!!)!!!!  (1.10) 
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In most applications, 𝛽𝑘 = 0, for other intervals which are not under consideration. The 
estimates can be obtained by maximizing the likelihood specified in (1.10). This can be 
implemented in SAS using the PHREG procedure. Programming statements can be written 
in the PHREG procedure to capture the appropriate covariate values of the subjects in each 
risk set. 
1.4.2 Andersen and Gill Approach 
Andersen and Gill (1982) reformulated the proportional hazard model as a counting 
process in which events for subjects are observed as time marches onwards. In this approach 
multiple records are created for each subject, one record for each distinct pattern of the time 
dependent measurements. Each record contains a start value and a stop value representing 
the time interval during which the values of the explanatory variables remain unchanged. 
Each record also contains the censoring status at the stop time. The event is the time 
dependent version of the event indicator variable which equals 1 only in the time period 
during which the event occurs.  
We consider a time dependent covariate process 𝑁! ≡ 𝑁! 𝑡 , 𝑡 ≥ 0  to represent the 
number of observed events experienced over time for subject 𝑖. The model is discussed at 
great length by Fleming and Harrington (2011) and Per Kragh Andersen, (1993). This 
approach quantifies the link parameter 𝛾  as the effect of the time dependent covariate on 
the hazard at the same time point as the time-to-event. 
 ℎ! 𝑡 = 𝑊! 𝑡 𝜆! 𝑡 𝑒𝑥𝑝 𝑌! 𝑡! 𝛾 + 𝑋!!𝛼  (1.11) 𝑊! 𝑡 = 1, 𝑢𝑛𝑖𝑡 𝑖 𝑖𝑠 𝑢𝑛𝑑𝑒𝑟 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛 𝑎𝑛𝑑 𝑎𝑡 𝑟𝑖𝑠𝑘 𝑎𝑡 𝑡𝑖𝑚𝑒 𝑡0, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒  
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This multivariate hazard model (1.11) is similar to the Cox model in (1.3). The 
difference lies in the definition of 𝑊! 𝑡 . In (1.11), when an event occurs an individual is no 
longer at risk and 𝑊! goes to zero. In the AG model for recurrent events, 𝑊! 𝑡  remains one 
even after events occur. The partial likelihood for (1.11) has the form: 
 𝐿 𝛾 =  𝑊! 𝑡 𝑒𝑥𝑝 𝑌! 𝑡 𝛾 + 𝑥!!𝛼𝑊! 𝑡 𝑒𝑥𝑝 𝑌! 𝑡 𝛾 + 𝑥!!𝛼!!!!!!! ∆!! !  
!
!!!  (1.12) 
Both SAS and R (R Development Core Team, 2011) can be used to solve the partial 
likelihood with the Newton-Raphson algorithm. 
1.4.3  Pooled Repeated Observation (PRO) 
The PRO described by (Cupples et al., 1988) has been conventionally employed in 
the Framingham Heart Study. In this method each observation interval is considered a mini-
follow up study in which the current risk factors are updated to predict events in the interval. 
The intervals represent the time periods in which longitudinal measures are recorded. The 
data setup is similar to the AG approach in which follow-up intervals are created for each 
subject. This approach pools observations over the intervals into a single sample in order to 
predict the short term risk of the event.  
In the PRO implementation once an individual has an event or is censored in a 
particular interval all subsequent intervals are excluded from the analysis. The proportional 
hazard model (Cross sectional pooling – CSP) and the logistic regression (Pooled logistic 
regression – PLR) can both be implemented in the context of the PRO. In the PLR the 
outcome is an event indicator that records whether an event occurs in the interval or not; it 
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does not account for the length of time within an interval when an event occurs. The CSP 
addresses this issue by utilizing information on the length of time to event in the interval as 
well as whether or not the event occurs. In both models the time intervals at the exam visits 
can be accounted for in the models. 
1.4.3.1 Pooled Logistic Regression (PLR) 
In the PLR the outcome is an event indicator which records whether an event occurs 
or not and does not account for the time to event or censoring during the interval. This 
model relates the probability of an event occurring in an interval of observation to a logistic 
function of the risk factors (Cupples et al., 1988).  
 𝐿𝑛 ! !;!!!!! !;!! = 𝛽! + 𝑌! 𝑡 𝜸+ 𝑋!!𝛼 + 𝜃 ∗𝑊! (1.13) 
The parameter 𝛽! is the intercept for the logistic model. The 𝑌! 𝑡  represent the observed 
longitudinal measures for the interval; the parameter 𝜃 is a coefficient for the time intervals 
at which the longitudinal measurements were recorded (𝑊!). In the unadjusted model we 
set  𝜃 = 0. This method pools subjects at risk and the events that are developed at each 
interval. This model assumes that the risk of an event (𝜸) is constant across the different 
time intervals in which the longitudinal measures are recorded. One drawback of the PLR is 
that the model does not utilize information on the point in time during the interval at which 
a response occurs or the exact time in an interval that an individual is lost to follow-up. A 
response occurring near beginning of the follow-up period is given the same weight in the 
analysis as one occurring at the end of that period. Thus the contribution of the risk factor 
to disease is dependent on the length of follow-up period (Green and Symons, 1978). 
21 
 
 
 
1.4.3.2 Cross Sectional Pooling (CSP) 
The CSP approach utilizes information on the length of time to event or censoring 
in an interval as well as whether or not the event occurs. The model relates the instantaneous 
risk of an event to the longitudinal measures at the beginning of the interval. 
  ℎ! 𝑡;𝑌 = ℎ!! 𝑡 ∗ exp 𝑌! 𝑡 𝜸+ 𝑋!!𝛼  (1.14) 
The parameters 𝛼 and 𝛾 represent the proportional hazard coefficients to be estimated; 𝑡 is 
the time-to-event. In the adjusted analysis a stratified Cox model is implemented and the 
strata are considered to be the time intervals (𝑗) defined by time intervals when the 
longitudinal measurements were recorded. In the unadjusted model, the hazard is assumed 
to be the same across all the time intervals and analysis is performed without stratification. 
In this stratified model, the regression coefficients are assumed to be the same in each 
stratum; the baseline hazard function may be different. 
Prentice and Gloeckler (1979) show in their paper that the CSP and the PLR provide 
similar estimates as the grouping intervals become small. Green and Symonds (1983) argued 
that if the follow-up period is short and the outcome is generally rare, the regression 
coefficients of the logistic model approximate to those of the proportional hazard model 
with a constant underlying hazard rate. D’Agostino et al. (1990) showed that the PLR and 
the CSP provide similar results. In their paper they clearly document the theoretical 
relationship that exists between the two models. Using a number of simulation scenarios we 
explore the two models and determine the circumstances under which the CSP and the PLR 
yield different results. 
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1.5 INTRODUCTION TO MEDIATION ANALYSIS 
 In this section, we present an overview of mediation analysis and describe the 
methods for estimating the mediated effect in the context of longitudinal and survival data. 
The standard approach to mediation analysis consists of series of regression analysis. 
Mediation occurs when the relationship between the independent variable (exposure) and 
the dependent variable (outcome) can be partially or totally accounted for by an intermediate 
variable (mediator). In many instances the outcome and the mediator are considered to be 
continuous with normally distributed random error terms. Sobel (1982) and Mackinnon 
(1995) have published methods for obtaining the estimates and standard errors of the 
mediated effect. The mediated effect can be calculated from a series of regression equations 
using the product or the difference in coefficients. For a continuous outcome these 
estimates are equivalent. These methods use information from the following three regression 
equations using notation from MacKinnon, Warsi and Dwyer (1995): 
 𝑌 = 𝑖! + 𝜏𝑋!  +  𝜖! (1.15) 
 𝑌 = 𝑖! + 𝜏!𝑋!  + 𝛽𝑋! +  𝜖! (1.16) 
 𝑋! = 𝑖! + 𝛼𝑋! + 𝜖! (1.17) 
Where 𝑖!, 𝑖!, 𝑖! are the intercepts, Y is the outcome, 𝑋! is the exposure variable and 𝑋! is 
the mediator. The coefficient 𝜏 represents the unadjusted effect (without the mediator in 
model) of the exposure on the outcome. This unadjusted effect is known as the total effect 
of the exposure on the outcome. The coefficient 𝜏! is the adjusted effect of the exposure on 
the outcome. This adjusted effect is known as the direct effect of the exposure on the 
outcome. The coefficient 𝛼 is the effect of the exposure on the mediator. The coefficient 𝛽 
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is the effect of the mediator on the outcome adjusting for the exposure in the model. The 
terms 𝜖!, 𝜖! and 𝜖! are residual error terms in the three regression equations.  This model is 
referred to as a single-mediator model since there is only one mediator and no interaction 
terms in the model.  
 Two methods for calculating the mediated effect can be performed using the 
coefficients in the three regression equations. In the difference method by Judd and Kenny 
(1981), the mediated effect (indirect effect) is computed by taking the difference between the 
total effect and the direct effect (τ – τ!). In order to test for significance, the difference is 
divided by its standard error and the ratio is compared to a standard normal distribution. In 
the second method by Alwin & Hauser (1975), the mediated effect is computed by 
calculating the product of the effect of the exposure (𝛼) on the mediator and the effect of 
the mediator on the outcome (𝛽). The rationale behind this approach is that mediation 
depends on the extent to which the exposure affects the mediator and the extent to which 
the mediator affects the outcome. There are a number of methods for computing the 
standard errors of the mediated effect for the product and difference methods. For the 
product method this can be obtained using the following methods: (1) a first order Taylor 
series or the multivariate delta formula (Sobel, 1982), (2) a second order Taylor series 
formula (Mood et al. 1974), or (3) an unbiased standard error formula (Goodman 1960). 
MacKinnon et al. (1995) showed that there are no substantial differences among the three 
analytical methods with ordinary least squares regression. These methods have been applied 
to computing confidence intervals and testing the statistical significance of mediated effects.  
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 MacKinnon et al. (1995) showed the algebraic equivalence of the product (𝛼𝛽) and 
the difference (𝜏 – 𝜏!) measures of mediation under the assumption that the dependent 
variable is continuous with normally distributed residual variance. In ordinary least squares 
regression (OLS) the two methods yield identical estimates of the mediated effect. For 
Multilevel models (Krull and Mackinnon, 1999), Logistic or Probit regression models 
(MacKinnon and Dwyer, 1993) and survival analysis (Tein and MacKinnon, 2003), the 
product and the difference estimators of the mediated effect are not always equivalent and a 
transformation may be required for the two to yield similar results. This non-equivalence is 
due to the fact that the residual variance and the coefficients in the regression equations may 
come from equations on different scales. Tein and Mackinnon showed that in survival 
analysis under the condition of no censored data and no time dependent mediators, the 
difference between the product and the difference methods were negligible using the a 
Weibull model with LogT as the outcome (LifeReg in SAS). In this thesis, we evaluate bias 
of both estimators of the mediated effects in the longitudinal and survival data setting with 
censored data and a time dependent mediator.  
 
1.6 SUMMARY 
In Chapter 1, we consider a number of methods for modeling longitudinal data and 
survival data. We characterize the relationship between time-to-event (primary) and the 
longitudinal responses (secondary) adjusting for covariates in the model. We describe the 
methods that link the longitudinal measures to the survival times in a proportional hazards 
model.  
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In Chapter 2, we perform a series of simulations to access the performance of these 
methods (BSJM, MLA, TSA, TDCM, AG, PLR and CSP). We use real data from the 
Framingham Heart Study (FHS) and apply these methods to analyze the data. We use 
parameter estimates from the FHS for the simulation studies. We conclude with some 
discussion on the results from the simulation and real data from FHS.  
In Chapter 3, we focus on four time dependent models (TDCM, AG, PLR and CSP), 
considering models that are unadjusted and adjusted for time interval. We explored time 
dependent covariate methods that link longitudinal and survival data for intervals of 
observation. We conducted a series of simulations to assess the performance of these 
methods through bias, coverage probabilities and Type I error rates. We simulate a number 
of scenarios and evaluate the effect of accounting for the time intervals at which the 
longitudinal measures are taken on these models.  
In Chapter 4, we apply the concept of jointly modeling longitudinal and survival data 
in the context of mediation analysis. We implement an accelerated failure time regression 
model using the joint maximum likelihood approach (AFT–joint) and an accelerated failure 
time regression model using the observed longitudinal measures (AFT–observed). We focus 
estimation of the mediator effect, assessing both the point and variance estimates. We 
employed the accelerated failure time model as there is nonequivalence in the product and 
difference of the mediated effect when the Cox model is applied. We conduct a series of 
simulations to compare the joint maximum likelihood approach (AFT–joint) for modeling 
longitudinal and survival data to the accelerated failure time regression model using the 
observed longitudinal measures (AFT–observed) in estimating the point and variance 
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estimators of the mediated effect measures. The AFT–joint model is implemented in a joint 
framework in modeling the longitudinal measures, genetic variants and the time to event 
occurrence. A linear mixed effect model is used to estimate random effects from the 
longitudinal measures which are then used to obtain predicted values of the potential 
mediator. A Weibull model under the accelerated failure time formulation is then 
implemented to obtain parameter estimates for the exposure and the mediator. In the AFT–
observed model a parametric baseline hazard survival regression in performed in which the 
longitudinal measures are considered as time dependent covariate measures.  
In Chapter 5, we provide an overview of the three research questions addressed in 
this thesis: 1) comparing methods for jointly modeling longitudinal and survival data; 2) 
evaluating time dependent covariate methods for modeling longitudinal and survival data; 3) 
application of longitudinal and survival data in the context of mediation analyses. We 
provide a summary of the different methods explored in the analysis of longitudinal and 
survival data. We conclude with some discussion on results from the simulation studies and 
real data from FHS. We provide an overview of the methods and recommendations on the 
use of these methods in modeling longitudinal and survival data. 
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CHAPTER 2: COMPARING METHODS FOR MODELING LONGITUDINAL 
AND SURVIVAL DATA 
 
2.1 INTRODUCTION 
In Chapter 1, we described several methods for modeling longitudinal and survival 
data. These methods estimated the association between time dependent longitudinal 
measures and survival times for subjects. A mixed effects model was used to model the 
longitudinal measures and a Cox proportional hazard model for the survival times. The 
longitudinal and survival models were linked by an association parameter which measured 
the strength of the relationship between the longitudinal measure and survival. The methods 
were categorized as joint models (MLA and BSJM), two stage models (TSA) and time 
dependent covariate models (TDCM, AG, CSP and PLR). The main difference among these 
models was the use of predicted longitudinal measures in the joint models and the two stage 
model, as oppose to the observed longitudinal measures in the time dependent covariate 
methods. A number of authors have argued in favor of the use of joint models. Tsiatis 
(1997) argued that using repeated measures random effects models for the longitudinal 
process is superior to methods where one maximizes the partial likelihood of the Cox using 
observed covariates values; Sweeting (2011) indicated that using observed longitudinal 
measures as time dependent covariate measures in the survival analysis resulted in 
underestimation of the true estimates. In this Chapter, we explore the methods described in 
section 1.3 and 1.4 using simulation studies and real data (Framingham Heart Study). We 
assess the performance of these methods with Type I error, bias, accuracy and coverage 
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probabilities. We provide some recommendation on the use of these methods in estimating 
the association between longitudinal and survival data. 
 
2.2 INTRODUCTION TO SIMULATION STUDY 
In this section, we perform a series of simulations to explore and assess the 
performance of the joint modeling, TSA, and time-dependent methods described in Chapter 
1 with varying scenarios. We assess the performance of the methods with Type I error, bias, 
accuracy and coverage probabilities. We simulate longitudinal and survival data to resemble 
data from the Framingham Heart Study. In Table 2.1, we highlight the simulation model and 
the required parameters (Residual error, Random means, Age, Sex and Covariance of 
Random Effects) for simulating the longitudinal and survival data. The longitudinal 
trajectories were generated from a linear model adjusting for the age at baseline of the 
participants. The survival time was generated to depend on the longitudinal measures and a 
set of covariates (Age at baseline and Sex).  
For the survival data two distributions were simulated: (i) the survival times that 
would be observed if the follow-up had been sufficiently long to reach the event and (ii) the 
censoring times. The survival data depend on the longitudinal measures and a set of 
covariates. We derive the survival times using Lambert’s W function. The survival function 
for Cox proportional hazard model can be written as: 
 𝑆 𝑡 𝑥 = 𝑒𝑥𝑝 −𝐻! 𝑡 ∗ 𝑒𝑥𝑝 (𝑋!𝛽)  (2.1) 
29 
 
 
 
The variable 𝑡 represents the survival time, X the vector of covariates, 𝛽 the vector of 
regression coefficients and ℎ! 𝑡  the baseline hazard function. The cumulative baseline 
hazard function can be written as:  
 𝐻! 𝑡 =  ℎ!(𝑢)𝑑𝑢!!  (2.2) 
The cumulative distribution function of the Cox model can be written as: 
  𝐹 𝑡|𝑥 =  1− 𝑒𝑥𝑝 −𝐻! 𝑡 ∗ 𝑒𝑥𝑝 (𝑋!𝛽)  (2.3) 
Let Y be a random variable with distribution function F; M = F(Y) will follow a uniform 
distribution on the interval 0 to 1 (Bender, Augustin, and Blettner, 2005). Moreover, (1 – M) 
will also follow a Uniform [0, 1]. Thus let 𝑀 be defined as: 
 𝑀 = 𝑒𝑥𝑝 −𝐻! 𝑡 ∗ 𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!  +  𝑈!!  ∗ 𝑡)  (2.4) 
For an exponential distribution 𝐻! 𝑡 = 𝜆𝑡, thus if  ℎ! 𝑡 > 0 for all t, then  𝐻! can be 
inverted and we have that: 
 − 𝑙𝑜𝑔 𝑀 = 𝜆𝑡 ∗ 𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!  +  𝑈!!  ∗ 𝑡)   
 
− 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!) = 𝑡 ∗ 𝑒𝑥𝑝 𝛾(𝑈!!  ∗ 𝑡)   
 
−𝛾(𝑈!!) 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!) = 𝛾(𝑈!! ∗ 𝑡) ∗ 𝑒𝑥𝑝  𝛾(𝑈!! ∗ 𝑡)  (2.5) 
The variables 𝑈!! and 𝑈!! are the random effects for the intercept and slope from the 
longitudinal model. We apply Lambert’s W function for solve for 𝑡 from Equation 2.5. Many 
equations involving exponentials can be solved using the W function. The general strategy is 
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to move all instances of the unknown to one side of the equation and to make the equation 
be of the form 𝑌 = 𝑋𝑒𝑥𝑝 𝑋  at which point the W function provides a solution for the 
variable X. If 𝑓 𝑤 = 𝑤 ∗ 𝑒𝑥𝑝 𝑤  then the inverse of this function is known as the 
Lambert W Function (L). Applying Lambert’s W function to (2.5) we have that: 
 𝛾(𝑈!! ∗ 𝑡) = 𝐿 −𝛾 𝑈!! 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾 𝑈!!  (2.6) 
Thus, from equation (2.6) we obtain a function of the survival time as: 
  𝑇 =  1( 𝛾 ∗ 𝑈!!) 𝐿 −𝛾(𝑈!!) 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!)  (2.7) 
For a Weibull distribution 𝐻! 𝑡 = 𝜆𝑡!, thus if  ℎ! 𝑡 > 0 for all t, then  𝐻! can be inverted 
and from (2.4) we have that: 
 − 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!) = 𝑡! ∗ 𝑒𝑥𝑝 𝛾(𝑈!!  ∗ 𝑡)  (2.8) 
An equivalent form of (2.8) can be written as: 
𝛾 𝑈!! ∗ 1𝜈 ∗ − 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!) !! = 𝛾 𝑈!! ∗ 𝑡 ∗ 1𝜈 ∗ 𝑒𝑥𝑝  𝛾(𝑈!!  ∗ 𝑡) !! (2.9) 
Applying Lambert W function to (2.9) we obtain:  
𝛾 𝑈!! ∗ 𝑡 ∗ 1𝜈 = 𝐿 𝛾 𝑈!! ∗ 1𝜈 ∗ − 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾 𝑈!! !!  (2.10) 
By solving (2.10) a function of the survival time can be written as: 
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𝑇 =  1𝛾 𝑈!! ∗ 1𝜈 𝐿 𝛾 𝑈!! ∗ 1𝜈 ∗ − 𝑙𝑜𝑔 𝑀𝜆𝑒𝑥𝑝 𝑋!𝛽 +  𝛾(𝑈!!)
!!
 (2.11) 
If the survival time is less than or equal to the censored time, then the event is considered to 
be observed and the time-to-event time equals the survival time; otherwise the event is 
censored and the time-to-event equals the censored time (Burton et al., 2006). We assume 
random non-informative right censoring and employ a uniform distribution for censoring 
that allows a maximum follow-up time of 30 years. We use a Weibull and exponential 
distributions to generate the survival data. We simulated 1000 independent multivariate 
datasets consisting of longitudinal measures, time-to-event outcomes and additional 
covariates.  
2.2.1 Simulating Longitudinal Data 
The simulation requires the specification of the longitudinal measures and the 
distribution of the survival data. The longitudinal measures can be obtained from a mixed 
effects model by introducing the random effects as shown in Equation 1.1 and 1.2. We focus 
on a simple linear mixed effects model (LME), which allows individual or subject-specific 
inference (Laird and Ware, 1982), to fit data from longitudinal response processes. Below we 
describe the algorithm used to generate the longitudinal data. We generated the longitudinal 
data using Steps 1 to 6.  
1. Parameter estimates of the mean and variance-covariance matrix 𝐺  of the random 
effects intercept and slope are obtained by fitting a linear mixed effects (LME) model to the 
FHS data. The residual variance 𝜎! is also obtained from the LME model. 
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2. Generate random effects (𝑈!! ,𝑈!!) from a bivariate normal distribution with mean and 
variance-covariance 𝐺  obtained in step 1. The random effects (𝑈𝑖1 ,𝑈𝑖2) represent the 
subject specific intercept and slope. 
3. Generate baseline covariates similar to FHS. Covariates are simulated independently. 
Age at baseline ~ 𝑁(35, 5)  and Sex ~ 𝑟𝑏𝑒𝑟𝑛(0.54) 
4. Generate the expected longitudinal trajectories 𝜑𝛽 𝑡𝑖𝑗  for each subject (𝑖 = 1, 2,… , 𝑛) 
and for each time point (𝑗 = 1, 2,… ,𝑚𝑖) using the linear mode for 𝑡!"  = 0, 5, 10, 15, 20, 25. 𝜑! 𝑡!"  =  𝑈!! +  𝑈!! ∗ 𝑡!" + 𝛼𝐴𝑔𝑒!  
5. Generate the observed longitudinal measures 𝑌𝑖𝑗 𝑡𝑖𝑗  from a multivariate normal 
distribution with mean 𝜑! 𝑡!"  and variance 𝑉 : 
𝑉 = 𝑍!𝐺𝑍!! + 𝑅! ,   𝑤ℎ𝑒𝑟𝑒 𝑍! =  
1 01 51111
10152025
 𝑎𝑛𝑑 𝑅!  ~ 𝑑𝑖𝑎𝑔𝑚𝑎𝑡𝑟𝑖𝑥 𝜎!  
6. Fit a random effects model to the observed longitudinal measures in step 5 to 
obtain (𝑈!! ,𝑈!!). These random effects are used to generate the survival data. 
2.2.2 Simulating Survival Data 
In the final steps of the algorithm (Steps 7 – 9) we generate the uncensored survival 
times that would be observed if the follow-up had been sufficiently long to reach the event 
for each person and the censoring times. We use parameter estimates from the FHS data to 
generate the survival distributions.  
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7. Specify values for the parameter estimates for Age, Sex and the link parameter, which 
measures the strength of the association between the longitudinal measures 𝑌 𝑡  and the 
time-to-event. 
8. Generate the time-to-event (𝑇) from the inverse of the cumulative hazard distribution 
for an Exponential model using Equation 2.7 and for a Weibull model using Equation 2.11.  ℎ(𝑡) =  𝜆 𝑡 𝑒𝑥𝑝 𝛼!𝐴𝑔𝑒 +  𝛼!𝑆𝑒𝑥 +  𝛾𝜑! 𝑡  
The baseline hazard is specified depending on the survival distribution function. In Table 2.2 
we provide an overview of the hazard, cumulative hazard, survival times and density 
functions for the Exponential and the Weibull distributions.  
9. Generate the censoring variable 𝐶 ~ 𝑈𝑛𝑖𝑓 25, 30  for censoring to occur later in study. 
We implemented three censoring scenarios (10%, 50% and 90%). These scenarios were 
obtained by varying the scale parameter for the Weibull and Exponential distributions. From 
the survival and censoring times we obtain the censoring indicator δ! such that: 
𝛿! = 1  𝑖𝑓  𝑇! ≤ 𝐶!0  𝑖𝑓  𝑇! > 𝐶!   
We derive a general formula from Equation 2.7 (Exponential) and 2.11 (Weibull) which links 
the survival time of the Cox model and the random effects of the longitudinal model.  
2.2.3 Analysis of Methods  
 We fit the methods described in Chapter 1 to a set of 1000 replicates. These methods 
include: (1) Bayesian semi-parametric joint model (BSJM); (2) Maximum likelihood approach 
(MLA); (3) Two-step approach (TSA); (4) Time dependent covariate model (TDCM); (5) 
Andersen and Gill (AG); (6) Pooled logistic regression (PLR); (7) Cross-sectional pooling 
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(CSP). In all these methods a multiplicative hazard model is implemented.  
 The variable Sex is considered to be a fixed covariate at each exam in all the 
methods. In the AG, CSP and PLR methods the Age variable is included in the model as a 
time varying covariate; the data structure in these methods is multiple rows per subject 
where each row is considered a mini-follow up study in which the current risk factors are 
updated to predict events in the interval. In the BSJM, MLA, TSA and TDCM methods the 
baseline Age variable is included in the model; the data structure is a single row per subject 
where the overall survival/censoring time is specified for each subject. The Age at each 
exam is calculated by adding the difference in time from the current exam and the first exam 
to the Age at baseline. 
 In the BSJM method a number of criteria were considered in the MCMC runs. These 
include 1) the number of chains for each run, 2) correlation between successive draws and 3) 
the length of burn-in time. A total of 101,000 iterations were run with a thinning of 50 and a 
burn-in of 1000 for 4 chains each, thus providing a sample of 500 iterations per chain. The 
empirical means and standard deviations for each variable were estimated. The quantiles for 
each variable are estimated in WinBUGS and can be used to compute credible intervals. As 
mentioned earlier, one shortcoming of the BSJM is the computing time involved in 
estimating the parameters and lack of convergence in some of the MCMC runs. 
 In the PLR we adjust for the time interval in which the longitudinal measures were 
recorded by including a time variable (coded as 0, 5, 10, 15, 20 and 25) in the model. In the 
CSP we use a stratified Cox to adjust for the different time intervals in which the 
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longitudinal measures were recorded. We conduct a series of simulations to explore and 
assess the performance of these methods with Type I error, bias, accuracy and coverage. 
 
2.3 SIMULATION SCENARIOS 
We consider a number of scenarios to assess the performance of the methods 
described in Chapter 1: 
• The effect of the longitudinal measure on survival (link parameter): 
o Link (γ) = 0.00 – Type I Error (No longitudinal measure effect on survival) 
o Link (γ) = 0.50 
o Link (γ) = 1.00 
• Weibull and Exponential distributions 
• The total number of subjects in the study (N = 100 and 1000) 
• The proportion of subjects that had an event in the study (10%, 50%, 90%). This 
was implemented by taking the minimum of the survival and censoring times. We 
obtain the censoring indicator (δ!). 
  
2.4 SIMULATION COMPARISONS AND RESULTS 
In this section we present results from the simulation studies for the methods 
described in Chapter 1. In Figure 2.1, we show the distribution of the longitudinal measures 
by exam periods. The spread of the distributions is similar across the 6 different exams with 
a mean intercept of 4.250 and a slope of 0.250. The residual variance for the longitudinal 
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measures was 0.1161 (Table 2.1). We also display the distribution of the survival times in 
Figure 2.2 using two different simulation schemes. In the first scheme we use a Weibull 
distribution for the censoring mechanism while in the second scheme we use a uniform 
distribution from 25 through 30 with censoring occurring at the tail end. 
We compute Type I errors for the link parameter to assess all six methods (Table 
2.3) using a sample size of 100 and 10,000 replicates. The methods seem to provide Type I 
error rates close to the nominal level (0.050) for both the Exponential and Weibull models 
with two exceptions. The BSJM showed deflated type I error with high censoring rates and 
elevated Type I error for Weibull with low censoring. The MLA shows elevated Type I 
errors with high censoring. The MLA and BSJM provide lower standard errors and shorter 
confidence intervals for the link estimate (see Figure 2.3) compared to the other methods. 
The simulation scenarios with higher censoring rates show higher standard errors and larger 
confidence intervals, as expected. 
In Table 2.4, we present the estimates, standard errors, coverage probability (CP), 
bias and mean square error (MSE) for the association of the longitudinal effect on survival 
using the Weibull distribution (Table 2.4a with N = 100 and Table 2.4b with N = 1000). We 
varied the censoring rates (10%, 50% and 90%) and the link parameter (γ = 0.00, 0.50, and 
1.00) in the simulation models. The results suggest the TSA performs best at estimating the 
link parameter, with low bias and high coverage probability (CP) compared to the other 
methods. For example with, n = 100, 10% censoring and γ = 0.00, the TSA has a low bias of 
0.000 with a CP value of 95.2% (Table 2.4a). Across the scenarios the TSA consistently 
provides larger standard errors for the link estimate with larger confidence intervals and CP 
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values close to the nominal level of 95% (Figure 2.4). The PLR, CSP and TDCM provide a 
negative bias with low CP values when there is a strong effect of the longitudinal measure on 
the outcome. The MLA and the BSJM both show a positive bias in the link parameter 
estimates with low CP values when the censoring rate is low and when there is a strong 
longitudinal effect. For example when n = 1000, γ = 1.00 and Censoring = 10% the MLA 
has a CP of 0.258 and the BSJM of 0.016 (Table 2.4b). Both methods give smaller standard 
errors and smaller confidence interval for all the simulations considered (Figure 2.4). In 
Table 2.4b we show the results for the comparison of the longitudinal effect on survival 
using a Weibull distribution (N = 1000). As seen with the Exponential distribution 
(Appendix Figure A.1) the TSA gives higher standard errors and larger confidence intervals 
for the link parameter. In general for all methods the standard errors, CP and confidence 
intervals are smaller when N = 1000. 
The performance of the methods in estimating the simulated effects of Age (𝛼! = 0.050) and Sex (𝛼! = −0.500) was assessed. Figure 2.5 shows the estimates and 
confidence intervals for Age effect using the Weibull distribution (N = 100). For the null 
case (γ = 0.00) the estimates are on target for all the methods. When the effect of the 
longitudinal measure on survival is stronger the effect of Age becomes weaker for all the 
other methods except the TSA. For example with γ = 1.00 and the censoring = 90%, the 
Age effect is diminished for all the other methods.  We see similar patterns in the estimation 
of the Age effect when N = 1000. The standard errors, CP and confidence intervals tend to 
be smaller when N = 1000. The results for the sex effect show that all methods provide 
precise estimates for all the scenarios considered (Figure 2.6). The standard errors and 
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confidence intervals become larger with higher censoring rates. The PLR method shows a 
slight positive bias with low censoring rates. The sex effect is fairly consistent among the 
different methods for all simulation scenarios considered. The CSP, TDCM and the AG 
approach show identical results in all simulations considered.  
Next we varied the effect of the residual error to assess the performance of the 
different methods. Since the BSJM are generally similar to those of MLA, we do not present 
them here. We considered γ = 0.500 and a censoring rate of 90%. The results indicate that 
with lower residual errors in the longitudinal measures the TSA provides results similar to 
the time dependent covariate methods that use the observed longitudinal measures (Table 
2.5a, 2.5b and 2.5c). From Table 2.5b we see that with low residual error the TSA provides 
similar results as the time dependent covariate methods. We interpreted this to mean that a 
small residual error results in low measurement error and the observed values become 
similar to the predicted values. When we applied larger residual errors (Table 2.5c) we found 
that the time dependent covariate methods (PLR, CSP and TDCM) provided lower 
estimates for the link parameter and the MLA provided larger estimates compared to the 
TSA approach.  
 
2.5 APPLICATION TO FRAMINGHAM HEART STUDY (FHS) 
We consider FHS data in which lipid measurements and myocardial infarction (MI) 
data were collected over a period of 26 years. The FHS is a widely known longitudinal study 
that seeks to identify common factors contributing to cardiovascular disease (CVD). Since 
1948 three generations of participants have been recruited and followed over the years: 
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Original cohort (recruited in 1948), Offspring (recruited in 1971) and third generation 
(recruited in 2002). Among the offspring participants, high-density lipoprotein (HDL), low 
density lipoprotein (LDL) and triglycerides (TG) were measured at fairly similar time 
intervals over a period of 26 years. The time to myocardial infarction was recorded for each 
participant, although some subjects were censored at the end of the study period. We log 
transformed the TG measures in our analysis to reduce skewness in TG measures. A total of 
2262 subjects with complete data until event or death were followed from 1979 to 2005 and 
data was collected at the start of each exam (Table 2.6). The mean age at baseline was 43.3 
years. Six exams were considered in the analysis from Exam 2 to Exam 7 as shown in Table 
2.6. The mean triglyceride measures at each exam were calculated with values ranging from 
100.49 to 158.70, showing an increasing trend from Exam 2 to Exam 7. The cumulative 
event rate for the 30 year period was 3.71%. The proportion of female participants was 
51.19% in the sample (n = 2262).  
We performed a linear regression using the mean Log TG with time values over the 
follow up time period. The results indicate a trend in the mean Log TG values. The slope of 
the linear trend was 0.0251, thus for a unit change in time (in years) the Log TG increased by 
0.0251. An R-square value of 0.9516 was obtained confirming a linear trend in the Log TG 
values. We also performed a mixed effects longitudinal analysis (Equation 1.2) in SAS using 
the PROC MIXED procedure. In this model the variable time is coded as the time in years, 
from baseline, when the longitudinal measures were recorded. The parameter estimation is 
based on a restricted maximum likelihood approach (REML). An unstructured covariance 
matrix was implemented for the random effects of the slope and the intercept. The 
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covariance matrix was estimated for the random effects. A total of 2262 subjects with up to 
6 observations per subject and consisting of 16142 observations was used in the analysis. 
The parameter estimates of the covariance matrix for the random effects of longitudinal 
analysis are displayed in Table 2.7. The estimates of the fixed effects for the Intercept and 
Slope were also obtained from the PROC MIXED procedure. The estimate of the slope was 
0.025, thus for a unit increase in time (one year) the Log TG increases by 0.025 (Table 2.8). 
This estimate was highly significant (P < 0.001) and similar to the regression estimates based 
on the mean Log TG. 
Longitudinal analysis was also performed in WINBUGS by estimating the 
trajectories of the longitudinal data using an exchangeable model. A total of 11000 iterations 
were run with a thinning of 20 and a burn-in of 1000 for 4 chains each, thus providing a 
sample size of 500 per chain. The empirical means and standard deviation for each variable 
were estimated from the likelihood of the longitudinal model. These results are presented in 
Table 2.9. The quantiles for each variable can also be estimated using WINBUGS (Table 
2.10). These quantiles can be used to compute credible intervals for the parameters of 
interest. The Bayesian approach indicated that individual trajectories increased over time 
(slope for log TG = 0.025 per year, 95% credible interval = (0.023, 0.028)). These estimates 
are similar to the results obtained from SAS. 
Using the methods described in Chapter 1, we characterize the association between 
the longitudinal measures and time-to-event response. We used log TG at each exam for the 
longitudinal part of the model assuming a linear trend and survival time measured from 
exam 1 to MI or loss to follow up. We adjusted for Sex and Age in all the models. In Figure 
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2.7, we show the distribution of time-to-event data by event status. The survival distribution 
among subjects with events was fairly uniform and the distribution of survival times for 
censored subjects was skewed to the left with event times occurring at the tail end of the 
distribution (20 – 26 years). 
In Table 2.11 we present the estimates for Age, Sex and the link parameters for each 
method. The results suggest a higher estimate in the link parameter, which describes the 
strength of the relationship between triglycerides and survival, for the MLA and BSJM (γ = 
0.9764 and 1.0263) compared to the TSA and the time dependent covariate methods. These 
results are similar to the findings by Wulfsohn and Tsiatis (1997) with higher estimates in the 
joint maximization compared to the two-stage approach. The PLR, TDCM, AG and CSP 
methods show a lower link estimate compared to the TSA and the joint likelihood methods. 
The TSA and the MLA provided higher standard errors for the link parameter compared to 
the other methods. Tsiatis (1997) argued that the standard error for the link parameter is 
greater when using the joint estimation procedure compared to the TSA because the random 
effects are assumed to be influenced by the uncertainty in the estimated growth curve 
parameters; thus, more variability is incorporated. The Age effects and standard errors were 
similar among the methods with estimates ranging from 0.050 to 0.065. The Sex effect was 
fairly consistent among the different methods ranging from -1.025 to -0.999. Using a 0.050 
level of significance the Age, Sex and Log of the triglyceride measures were significantly 
associated with time-to-myocardial infarction. These results suggest that repeated measures 
of triglyceride levels are significantly associated with the time-to-event myocardial infarction 
in the Framingham Heart Study Cohort.  
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2.6 SUMMARY AND DISCUSSION 
We explored longitudinal and survival data methods which link longitudinal 
trajectories to survival. These methods quantify the link parameter as the association 
between longitudinal measure and survival outcome on the hazard at the same time point as 
the time-to-event. We analyzed data from FHS in which lipid measurements and myocardial 
infarction (MI) data were collected over a period of 26 years. We used a simulation study to 
assess the performance of these methods with respect to Type I error, bias, accuracy and 
coverage probabilities. To our knowledge this is the first paper that compares the BSJM to 
the TSA, MLA, TDCM, PRO methods and provides a derivation of the survival time 
function for modeling time dependent covariate data.  
Based on the results from the simulation studies we conclude that the TSA 
performed best at estimating the link parameter. The BSJM and the MLA provided larger 
estimates in the link parameter, similar to the findings by Wulfsohn and Tsiatis. The TDCM, 
CSP and the PLR that use the observed longitudinal measures as time dependent covariate 
measures in the survival analysis resulted in underestimation of the true estimates. These 
results are similar to the findings by Sweeting and Thompson (2011); where they 
recommended the use of a shared random effects model. The TDCM, stratified CSP and the 
AG provided identical results in all scenarios considered, as expected.  
In most models the age effect was attenuated depending on the association of the 
longitudinal measures on survival. This result was expected as age at baseline was associated 
with the longitudinal measures in the data generation model. In the data generation of the 
time varying longitudinal measures the sex variable was not associated with the longitudinal 
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measures. The time independent covariates (Age at baseline and Sex) were unbiased when 
there was no association between the time varying longitudinal measures and survival (γ = 
0.00). Comparison of the methods in Framingham Heart Study revealed similar patterns. We 
explored a number of other scenarios where we varied the residual error in the longitudinal 
measures. The results show that with low residual errors in the longitudinal measures the 
TSA provides similar results as time dependent covariate methods that use the observed 
longitudinal measures. Higher residual error resulted in severe underestimation of the true 
association parameter by the time dependent covariate methods. 
One limitation of our study is the linearity assumption in the longitudinal measures. 
The trajectory can be modeled in a linear form or quadratic form or more complicated 
trajectories. Splines and other time series forms can also be implemented to capture the 
trajectory of the longitudinal measures but the trade-off is the complexity of the model and 
interpretability, if the longitudinal process is primary. The simulation data generation scheme 
was based on the Two-stage approach, an approach that may provide more precise estimates 
when analyzing the data using the two stage model. We also implemented two other 
simulation schemes to assess whether the results were dependent on the simulation. In one 
of the schemes we implemented a CSP data generation approach in which the observed 
longitudinal measures, as oppose to the predicted measure, were used in generating the 
survival time.  In another scheme we applied a Copula approach in which the survival times, 
longitudinal measures and the covariates were linked through a correlation matrix. The 
pattern in the results was similar in the different simulation schemes. 
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2.7 TABLES AND FIGURES 
Table 2.1: Simulation Model and Parameters 
Exams (𝑼𝒊𝟏 ,𝑼𝒊𝟐) Residual Age Sex Link Censoring 
6 (4.250, 0.250) σ2 = 0.1161 0.050 -0.500 Varying Uniform(25, 30) 
𝐑𝐚𝐧𝐝𝐨𝐦 𝐄𝐟𝐟𝐞𝐜𝐭𝐬 𝐂𝐨𝐯𝐚𝐫𝐢𝐚𝐧𝐜𝐞 𝐌𝐚𝐭𝐫𝐢𝐱:   𝑮 = 𝟎.𝟐𝟗 −𝟎.𝟎𝟎𝟒𝟔𝟓−𝟎.𝟎𝟎𝟒𝟔𝟓 𝟎.𝟎𝟎𝟎𝟑𝟐𝟎  𝐋𝐨𝐧𝐠𝐢𝐭𝐮𝐝𝐢𝐧𝐚𝐥 𝐓𝐫𝐚𝐣𝐞𝐜𝐭𝐨𝐫𝐢𝐞𝐬:   𝝋 𝒕𝒊𝒋  =  𝑼𝒊𝟏 +  𝑼𝒊𝟐 ∗ 𝒕𝒊𝒋 +  𝜶 ∗ 𝑨𝒈𝒆𝒊 𝐒𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐌𝐨𝐝𝐞𝐥:   𝒉(𝒕) =  𝝀 𝒕 𝒆𝒙𝒑 𝜶𝟏𝑨𝒈𝒆 +  𝜶𝟐𝑺𝒆𝒙 +  𝜸𝝋 𝒕  
𝐒𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐓𝐢𝐦𝐞 (𝐄𝐱𝐩𝐨𝐧𝐞𝐧𝐭𝐢𝐚𝐥):  𝑻 =  𝟏( 𝜸 ∗ 𝑼𝒊𝟐) 𝑳 −𝜸(𝑼𝒊𝟐) 𝒍𝒐𝒈 𝑴𝝀𝒆𝒙𝒑 𝑿!𝜷 +  𝜸 𝑼𝒊𝟏  
𝐒𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐓𝐢𝐦𝐞 (𝐖𝐞𝐢𝐛𝐮𝐥𝐥):  𝑻 =  𝟏𝜸 𝑼𝒊𝟐 ∗ 𝟏𝝂 𝑳 𝜸 𝑼𝒊𝟐 ∗ 𝟏𝝂 ∗ − 𝒍𝒐𝒈 𝑴𝝀𝒆𝒙𝒑 𝑿!𝜷 +  𝜸(𝑼𝒊𝟏)
𝟏𝝂
 
 
Table 2.2: Distribution of Survival Data 
Characteristics Exponential Weibull 
Parameter λ (Scalar) > 0 λ (Scalar) > 0; ν (Shape) > 0 
Hazard Function h! t = λ h! t = λνt!!! 
Cumulative Hazard H! t = λt H! t = λt! 
Density Function f! t = λexp (−λt) λνt!!!exp (−λt!) 
Survival Function S! t = exp (−λt) exp (−λt!) 
Mean E(T)  =  1λ 1λ! Γ 1v + 1  
Variance Var(T)  =  1λ! 1λ!! Γ 2v + 1 − Γ! 1v + 1  
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Figure 2.1: Distribution of Longitudinal Measures by Exam 
 
 
Figure 2.2: Distribution of Survival, Censoring and Time-to-event 
 
 
Distribution	of	the	simulated	Log	of	triglycerides	by	exam	when	the	measures	were	recorded 
Distribution	of	the	survival,	censoring	and	time-to-event	data	using	two	different	simulation	schemes;	(1)	
Uniform	Censoring	(0,	30	years),	(2)	Censoring	at	tail	end	of	study	(25,	30	years) 
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Table 2.3: Type I Error (N = 100, Replicates = 10,000, Link = 0.000) 
Type I Error (Exponential Distribution) 
Censoring PLR CSP TDCM TSA MLA BSJM 
10% 0.052 0.056 0.056 0.057 0.052 0.050 
50% 0.048 0.050 0.050 0.052 0.046 0.040 
90% 0.049 0.050 0.050 0.054 0.078 0.010 
 
Type I Error (Weibull Distribution) 
Censoring PLR CSP TDCM TSA MLA BSJM 
10% 0.057 0.053 0.053 0.054 0.054 0.090 
50% 0.058 0.059 0.059 0.057 0.050 0.070 
90% 0.048 0.053 0.053 0.051 0.064 0.030 
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Figure 2.3: Estimate and Confidence Intervals (Link = 0.000, Type I Error Scenario, N = 100) 
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Figure 2.4: Estimates and Confidence Intervals For Link (Dist. =  Weibull, N = 100) 
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Figure 2.5: Estimates and Confidence Intervals For Age (Dist. = Weibull, N = 100) 
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Figure 2.6: Estimates and Confidence Intervals For Sex (Dist. = Weibull, N = 100)
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Table 2.4a: Comparison of Longitudinal Effect on Survival (Distribution = Weibull, N = 100, Link = 𝜸) 
Scenarios PLR CSP TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.005 0.232 0.933 -0.005 0.117 -0.001 0.188 0.938 -0.001 0.073 -0.001 0.188 0.938 -0.001 0.073 
0.500 0.444 0.261 0.925 -0.056 0.150 0.336 0.191 0.845 -0.164 0.103 0.336 0.191 0.845 -0.164 0.103 
1.000 0.865 0.303 0.911 -0.135 0.209 0.666 0.200 0.595 -0.334 0.191 0.666 0.200 0.595 -0.334 0.191 
50% 
0.000 0.015 0.265 0.941 0.015 0.147 0.013 0.244 0.949 0.013 0.124 0.013 0.244 0.949 0.013 0.124 
0.500 0.403 0.288 0.933 -0.097 0.183 0.354 0.252 0.913 -0.146 0.154 0.354 0.252 0.913 -0.146 0.154 
1.000 0.815 0.309 0.891 -0.185 0.235 0.688 0.238 0.712 -0.312 0.214 0.688 0.238 0.712 -0.312 0.214 
90% 
0.000 -0.004 0.498 0.948 -0.004 0.509 -0.002 0.494 0.943 -0.002 0.502 -0.002 0.494 0.943 -0.002 0.502 
0.500 0.387 0.524 0.927 -0.113 0.619 0.373 0.510 0.919 -0.127 0.590 0.373 0.510 0.919 -0.127 0.590 
1.000 0.794 0.601 0.914 -0.206 0.864 0.758 0.577 0.907 -0.242 0.838 0.758 0.577 0.907 -0.242 0.838 
 TSA MLA BSJM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.000 0.247 0.952 0.000 0.125 0.006 0.074 0.955 0.006 0.011 0.019 0.073 0.910 0.019 0.014 
0.500 0.512 0.251 0.950 0.012 0.128 0.609 0.103 0.848 0.109 0.033 0.592 0.099 0.920 0.092 0.025 
1.000 1.041 0.266 0.954 0.041 0.142 1.141 0.152 0.904 0.141 0.066 1.127 0.145 0.900 0.127 0.053 
50% 
0.000 0.009 0.319 0.950 0.009 0.208 0.006 0.096 0.945 0.006 0.020 -0.004 0.094 0.930 -0.004 0.021 
0.500 0.509 0.323 0.954 0.009 0.166 0.572 0.134 0.938 0.072 0.041 0.610 0.127 0.930 0.110 0.039 
1.000 1.049 0.315 0.945 0.049 0.211 1.190 0.170 0.804 0.190 0.100 1.107 0.156 0.930 0.107 0.059 
90% 
0.000 -0.005 0.644 0.948 -0.005 0.868 -0.041 0.188 0.909 -0.041 0.054 0.027 0.191 0.970 0.027 0.076 
0.500 0.556 0.666 0.947 0.056 0.970 0.588 0.251 0.878 0.088 0.112 0.778 0.242 0.933 0.278 0.161 
1.000 1.098 0.759 0.940 0.098 1.403 1.243 0.409 0.844 0.276 0.234 1.009 0.269 0.990 0.009 0.116 
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Table 2.4b: Comparison of Longitudinal Effect on Survival (Distribution = Weibull, N = 1000, Link = 𝜸) 
Scenarios PLR CSP TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.002 0.071 0.934 -0.001 0.011 -0.001 0.057 0.945 -0.001 0.007 -0.001 0.057 0.945 -0.001 0.007 
0.500 0.453 0.080 0.910 -0.047 0.015 0.339 0.058 0.201 -0.161 0.032 0.339 0.058 0.201 -0.161 0.032 
1.000 0.827 0.092 0.532 -0.173 0.048 0.646 0.061 0.000 -0.354 0.133 0.646 0.061 0.000 -0.354 0.133 
50% 
0.000 0.000 0.082 0.944 0.000 0.014 0.000 0.075 0.949 0.000 0.012 0.000 0.075 0.949 0.000 0.012 
0.500 0.401 0.088 0.788 -0.099 0.026 0.354 0.077 0.511 -0.146 0.033 0.354 0.077 0.511 -0.146 0.033 
1.000 0.784 0.093 0.363 -0.216 0.064 0.671 0.071 0.000 -0.329 0.118 0.671 0.071 0.000 -0.329 0.118 
90% 
0.000 0.005 0.150 0.956 0.005 0.045 0.004 0.148 0.954 0.004 0.044 0.004 0.148 0.954 0.004 0.044 
0.500 0.362 0.155 0.863 -0.138 0.067 0.353 0.151 0.842 -0.147 0.067 0.353 0.151 0.842 -0.147 0.067 
1.000 0.749 0.171 0.701 -0.251 0.122 0.727 0.160 0.601 -0.273 0.127 0.727 0.160 0.601 -0.273 0.127 
 TSA MLA BSJM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.000 0.074 0.942 0.000 0.011 -0.002 0.023 0.940 -0.002 0.001 0.001 0.023 0.948 0.001 0.001 
0.500 0.506 0.075 0.952 0.006 0.011 0.583 0.031 0.235 0.083 0.009 0.581 0.031 0.192 0.081 0.008 
1.000 1.009 0.080 0.945 0.009 0.013 1.120 0.047 0.258 0.120 0.019 1.111 0.045 0.016 0.111 0.016 
50% 
0.000 0.000 0.097 0.947 0.000 0.019 -0.006 0.030 0.942 -0.006 0.002 0.005 0.030 0.939 0.005 0.003 
0.500 0.514 0.099 0.952 0.014 0.020 0.563 0.041 0.675 0.063 0.007 0.556 0.040 0.701 0.056 0.006 
1.000 1.016 0.093 0.953 0.016 0.017 1.117 0.050 0.345 0.117 0.019 1.085 0.048 0.100 0.085 0.012 
90% 
0.000 0.002 0.191 0.951 0.002 0.074 -0.004 0.060 0.957 -0.004 0.007 0.035 0.064 0.914 0.035 0.017 
0.500 0.507 0.194 0.948 0.007 0.077 0.545 0.080 0.910 0.045 0.016 0.546 0.076 0.943 0.046 0.012 
1.000 1.041 0.207 0.945 0.041 0.089 1.136 0.102 0.738 0.136 0.042 1.007 0.091 0.929 0.007 0.015 
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Table 2.5a: Comparison of Longitudinal Effect on Survival (Varying Residual Error) 
Simulations (Censoring = 90%, N = 1000, Replicates = 1000, Link = 0.500,  σ = 0.1161) 
VARIABLES PARAMETERS PLR CSP TDCM TSA MLA 
LOGTG 
(𝜸 = 𝟎.𝟓𝟎𝟎) 
Estimate 0.530 0.494 0.494 0.523 0.663 
SE 0.220 0.204 0.204 0.209 0.174 
CP 0.942 0.941 0.941 0.940 0.720 
Bias 0.030 -0.005 -0.005 0.023 0.163 
MSE 0.103 0.086 0.086 0.091 0.071 
 
AGE (𝜶𝟏 = 𝟎.𝟎𝟓) 
Estimate 0.028 0.026 0.026 0.051 0.004 
SE 0.024 0.022 0.022 0.020 0.022 
CP 0.851 0.826 0.826 0.947 0.413 
Bias -0.022 -0.024 -0.024 0.001 -0.046 
MSE 0.002 0.002 0.002 0.001 0.003 
 
SEX (𝜶𝟐 = −𝟎.𝟓𝟎) 
Estimate -0.547 -0.503 -0.503 -0.504 -0.562 
SE 0.220 0.204 0.204 0.204 0.202 
CP 0.943 0.958 0.958 0.958 0.931 
Bias -0.047 -0.003 -0.003 -0.004 -0.052 
MSE 0.101 0.082 0.082 0.082 0.086 
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Table 2.5b: Comparison of Longitudinal Effect on Survival (Varying Residual Error) 
Simulations: (Censoring = 90%, N = 1000, Replicates = 1000, Link = 0.500, σ = .0011) 
 Parameters PLR CSP TDCM TSA MLA 
LOGTG 
(𝜸 = 𝟎.𝟓𝟎𝟎) 
Estimate 0.565 0.528 0.528 0.528 0.725 
SE 0.228 0.211 0.211 0.208 0.171 
CP 0.938 0.946 0.946 0.946 0.665 
Bias 0.065 0.028 0.028 0.028 0.225 
MSE 0.113 0.092 0.092 0.089 0.087 
 
AGE (𝜶𝟏 = 𝟎.𝟎𝟓) 
Estimate 0.027 0.025 0.025 0.051 0.001 
SE 0.025 0.022 0.022 0.021 0.022 
CP 0.823 0.792 0.792 0.943 0.397 
Bias -0.023 -0.025 -0.025 0.001 -0.049 
MSE 0.002 0.002 0.002 0.001 0.004 
 
SEX (𝜶𝟐 = −𝟎.𝟓𝟎) 
Estimate -0.546 -0.505 -0.505 -0.505 -0.536 
SE 0.222 0.205 0.205 0.205 0.204 
CP 0.938 0.948 0.948 0.945 0.923 
Bias -0.046 -0.005 -0.005 -0.005 -0.036 
MSE 0.106 0.086 0.086 0.086 0.093 
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Table 2.5c: Comparison of Longitudinal Effect on Survival (Varying Residual Error) 
Simulations: (Censoring = 90%, N = 1000, Replicates = 1000, Link = 0.500, σ = 0.5805) 
 Parameters PLR CSP TDCM TSA MLA 
LOGTG 
(𝜸 = 𝟎.𝟓𝟎𝟎) 
Estimate 0.231 0.217 0.217 0.502 0.608 
SE 0.145 0.135 0.135 0.242 0.218 
CP 0.549 0.458 0.458 0.934 0.963 
Bias -0.269 -0.283 -0.283 0.002 0.108 
MSE 0.116 0.117 0.117 0.125 0.093 
 
AGE (𝜶𝟏 = 𝟎.𝟎𝟓) 
Estimate 0.042 0.039 0.039 0.050 0.022 
SE 0.023 0.021 0.021 0.020 0.022 
CP 0.939 0.914 0.914 0.952 0.848 
Bias -0.008 -0.011 -0.011 0.000 -0.028 
MSE 0.001 0.001 0.001 0.001 0.001 
 
SEX (𝜶𝟐 = −𝟎.𝟓𝟎) 
Estimate -0.549 -0.509 -0.509 -0.511 -0.545 
SE 0.221 0.205 0.205 0.205 0.227 
CP 0.944 0.957 0.957 0.958 0.982 
Bias -0.049 -0.009 -0.009 -0.011 -0.045 
MSE 0.102 0.084 0.084 0.084 0.202 
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Table 2.6: Framingham Heart Study Data (N = 2262) 
Characteristics  Exam 2 Exam 3 Exam 4  Exam 5 Exam 6 Exam 7 
Sample Size – N* 2262 2211 2173 2118 2056 1995 
Years of Longitudinal Measures 1979 – 1983 1983 – 1987 1987 – 1991 1991 – 1995 1995 – 1998 1998 – 2001 
Age (Years) 43.32 (9.58) 47.69 (9.60) 51.15 (9.60) 54.80 (9.60) 58.87 (9.54)  61.78 (9.45) 
Triglycerides (mg/dL) 100.49 (88.77) 118.80 (123.59) 124.15 (110.18) 154.47 (133.08) 153.08 (114.92) 158.70 (112.49) 
Survival Time (Years) 4.33 (0.60) 3.43 (0.46) 3.61 (0.46) 4.01 (0.60) 2.87 (0.86) 6.00 (1.62) 
Cumulative Event Rate (%) 0.44% 0.88% 1.46% 2.08% 2.39% 3.71% 
Sex (% Female)  51.19% 
* Sample sizes reduce at each exam as subjects have events and are censored 
 
Table 2.7: Covariance Parameter Estimates (FHS Data) 
Covariance Parameters Estimate 
UN (1,1) – Intercept 0.2912 
UN (2,1) – Intercept and Slope -0.00465 
UN (2,2) - Slope 0.000320 
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Table 2.8: Maximum Likelihood Estimates – Mean Random Effects (FHS Data) 
Effect Estimate Error DF t Value Pr > |t| 
Intercept 4.2528 0.01247 2262 341.01 <.0001 
Slope 0.02518 0.000483 2265 52.13 <.0001 
 
 
Table 2.9: Bayesian (MCMC) Empirical Means and Std. Dev. (FHS Data) 
Variables Mean SD Naive SE Time-series SE 
Intercept 4.253 0.01229 0.000275 0.0003146 
Time 0.02516 0.000532 1.19E-05 1.272E-05 
UN (1,1) – Intercept 0.2937 0.01077 0.000241 0.0002437 
UN (2,1) – Intercept and Slope -0.0051 0.000355 7.94E-06 8.485E-06 
UN (2,2) – Slope 0.000418 1.73E-05 3.87E-07 3.776E-07 
 
 
Table 2.10: Quantiles (FHS Data) – Bayesian Approach (MCMC) 
Variables 2.5% 25% 50% 75% 97.5% 
Intercept 4.228 4.244 4.253 4.261 4.276 
Time Interval 0.02415 0.0248 0.02514 0.02551 0.02621 
UN (1,1) – Intercept 0.2735 0.2861 0.2937 0.301 0.3152 
UN (2,1) – Intercept and Slope -0.00578 -0.00533 -0.0051 -0.004849 -0.00441 
UN (2,2) – Slope 0.000384 0.000406 0.000417 0.000429 0.000453 
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Figure 2.7: Survival Distribution by Event Occurrence 
 
 
Table 2.11: Jointly Modeling Longitudinal and Survival Data (FHS Data) 
 𝐀𝐆𝐄 (𝜶𝟏) 𝐒𝐄𝐗 (𝜶𝟐) 𝐋𝐨𝐠𝐓𝐆 (𝜸) 
Methods Estimate SE P Estimate SE P Estimate SE P 
PLR 0.0520 0.0119 <.0001 -1.0154 0.2444 <.0001 0.6107 0.1755 0.0005 
CSP 0.0560 0.0119 <.0001 -1.0254 0.2435 <.0001 0.6181 0.1741 0.0004 
TDCM 0.0560 0.0119 <.0001 -1.0254 0.2435 <.0001 0.6181 0.1741 0.0004 
AG 0.0560 0.0119 <.0001 -1.0254 0.2435 <.0001 0.6181 0.1741 0.0004 
TSA 0.0650 0.0120 <.0001 -1.0008 0.2437 <.0001 0.9404 0.2111 <0.0001 
MLA 0.0494 0.0119 <.0001 -0.9992 0.2444 <.0001 0.9764 0.2191 <0.0001 
BSJM 0.0503 0.0121 <.0001 -1.0021 0.2468 <.0001 1.0263 0.1813 <0.0001 
 
Distribution of the time to myocardial infarction among participants with events and 
censored subjects in the Framingham Heart Study 
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CHAPTER 3: ADJUSTING FOR TIME IN TDCM, PLR AND CSP SURVIVAL 
ANALYSIS OF TIME DEPENDENT COVARIATES 
 
3.1 INTRODUCTION 
In many survival studies, individuals are monitored during the study, and explanatory 
variables are recorded. These explanatory variables may change in value over the course of 
observation. The Cox proportional-hazard model has been widely used in the analyses of 
time-to-event data with time dependent variables. The interrelationships between the 
survival outcome and time dependent variables can lead to bias unless the relationships are 
well understood (Fisher and Lin, 1999). The most common type of time dependent covariate 
is a repeated measurement on a subject or a change in the subject’s treatment arm. Therneau 
and Grambsch (2000) considered a well-known example of TDCM using the Stanford Heart 
Transplant Program. Data for subjects are presented as multiple observations, each of which 
applies to an interval of observation. The time interval is considered to be the time period 
between the exams when the longitudinal measures were recorded.  
The Cox proportional hazard regression model is often used to analyze covariate 
information that changes over time. The hazard may be thought of as being proportional to 
the instantaneous probability of an event at a particular time. This approach is more 
complicated than the fixed covariate approach as the covariate information changes over 
time. Typical settings with time dependent covariates include HIV studies in which baseline 
characteristics are recorded and immunological measures such as CD4+ lymphocyte counts 
or viral load are measured repeatedly to assess patients’ health until HIV conversion.  
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There is an extensive literature and a wide range of statistical packages for modeling 
time dependent covariate data. Some previous work includes those of Fisher and Lin (1999); 
Cupples et al. (1988); D’Agostino et al. (1990); Pepe and Cai (1993); Prentice and Gloeckler 
(1978); Abbott (1985); Green and Symons (1983); Ingram and Kleinman (1989); Kalbfleisch 
and Prentice (2002); Wu and Ware (1979); Anderson and Gill (1982). 
For an example we consider data from the Framingham Heart Study (FHS) in which 
lipid measurements and myocardial infarction (MI) data were collected over a period of 26 
years (1979–2005). FHS is a widely known longitudinal study that examines potential risk 
factors for the development of cardiovascular disease. In this study high-density lipoprotein 
(HDL), low density lipoprotein (LDL) and triglycerides (TG) were measured at generally 
comparable time intervals over 26 years. Time to myocardial infarction was also recorded for 
each participant, although some subjects were censored during and at the end of the study 
period. In this thesis we assess time dependent covariate methods which characterize the 
association (link) between the longitudinal lipid measures and time to myocardial infarction  
Our main objective in this Chapter is to (i) Evaluate the adjusted (adjusting for time) 
and unadjusted time dependent covariate models which examine the association of the 
longitudinal measures to survival; (ii) Compare the Time dependent covariate model 
(TDCM) to adjusted and unadjusted Pooled Logistic Regression (PLR), adjusted and 
unadjusted Cross Sectional Pooling (CSP); (iii) Use simulation studies to access the 
performance of these methods in a number of scenarios. These methods to analyze time 
dependent covariate data consider the observed longitudinal measures as covariates in the 
survival model. The TDCM approach is able to capture the appropriate covariate values of 
the subject in each risk set at the time of event. The Cross Sectional Pooling (CSP) and the 
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Pooled Logistic Regression (PLR) are both implemented in the context of repeated 
observation intervals. In the PLR the outcome is an event indicator that records whether an 
event occurs in an interval and does not account for the time to event in each interval. In 
contrast the CSP incorporates the length of time to event in the interval between exams as 
well as whether or not the event occurs. The PLR is applied in the context of logistic 
regression and the CSP is applied in the context of proportional hazards. We consider 
instances where risk factors are measured at regular equally spaced intervals and consider 
models for PLR and CSP that do account for the time of the interval and do not. In this 
Chapter we compare these methods for modeling time dependent covariate data and offer 
some recommendations on their use. 
 
3.2 TIME DEPENDENT COVARIATE METHODS 
In this section, we revisit the methods described in Chapter 1 for modeling time 
dependent covariates in the context of longitudinal and survival data (TDCM, PLR and 
CSP). As we mentioned in Chapter 1 the longitudinal measures in these models are 
considered to be time dependent covariates. Our goal is to conduct a series of simulations to 
compare these time dependent covariate methods in models that adjust for the time intervals 
and those that do not.  
In Chapter 1 we defined a time dependent explanatory variable as one whose value 
for any given subject may change over the period of time that the subject is observed. The 
most common type of time dependent covariates are repeated measures on a subject or a 
change in the subject’s treatment arm. For PLR and CSP, data for subjects are presented as 
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multiple observations, each of which applies to an interval of observation. A proportional 
hazard model is often used to analyze covariate information that changes over time. The 
hazard may be thought of as being proportional to the instantaneous probability of an event 
at a particular time. The longitudinal measures are recorded at the beginning of each interval 
and are considered as potential predictors of the time-to-event outcome in the interval of 
interest. In the PLR and CSP each observation interval is considered a mini-follow up study 
in which the current risk factors are updated to predict events in the interval. The intervals 
represent the different time periods in which longitudinal measures are recorded. The data 
setup for the PLR and the CSP are similar to the Andersen and Gill (1982) approach in 
which multiple follow-up intervals are created for each subject. This approach pools 
observations over the intervals into a single sample in order to predict the short term risk of 
the event. In the PRO implementation once an individual has an event or is censored in a 
particular interval all subsequent intervals are excluded from the analysis. The proportional 
hazard model (Cross sectional pooling – CSP) and the logistic regression (Pooled logistic 
regression – PLR) can both be implemented in the context of the PRO. 
 
3.3 UNJUSTED AND ADJUSTED MODELS 
In Chapter 1 we described the adjusted and unadjusted models for CSP and PLR. In 
the PLR adjusted models we consider the time periods in which the longitudinal 
measurements are recorded (0, 5, 10, 15, 20, and 25) as an ordinal covariate in the model. 
From equation (1.13), 𝜃 = 0 is an unadjusted model in which we do not adjust for the time 
intervals between the longitudinal measures. In the PLR, we can also consider the time 
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interval as the increase in Age of each participant from one exam to the next. In the adjusted 
CSP a stratified Cox model is implemented and the strata are defined by the time intervals 
(𝑗), in equation (1.14), when the longitudinal measurements were recorded. The adjusted 
CSP can also be referred to as a stratified Cox analysis. The adjusted CSP is expected to 
provide identical results as the TDCM. In the unadjusted model, the hazard is assumed to be 
the same across all the time intervals. 
 
3.4 SIMULATION STUDY 
In this section, we conduct a series of simulations to evaluate the time dependent 
covariate methods for modeling longitudinal and survival data described in section 3.2 and 
3.3. We assess the performance of these methods with Type I error, bias, accuracy (MSE) 
and coverage probabilities. We simulate longitudinal and survival data to resemble data from 
the Framingham Heart Study. In Table 2.1 (Chapter 2), we highlight the parameters for 
simulating the longitudinal and survival data. The longitudinal trajectories were generated 
from a linear model adjusting for the age of the participants. The survival time was generated 
to depend on the longitudinal measures and a set of covariates. The survival times were 
generated for each time period during which the longitudinal measures were recorded. In 
each time period if the survival time is less than or equal to the total time period of the mini 
follow-up then the event is considered to be observed and the time-to-event in that interval 
equals the survival time; otherwise the time-to-event time equals the time period for the 
interval of interest (Burton et al., 2006). We employ a Weibull model in generating the 
survival data.  
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We simulated 1000 independent multivariate datasets consisting of longitudinal 
measures and time-to-event outcomes. Below we describe an algorithm used to generate the 
longitudinal and survival data. We generated the longitudinal data using Steps 1 to 5 and the 
survival data using in Step 6 and 7 in the following sequence: 
3.4.1 Simulating Longitudinal Data 
1. Parameter estimates of the mean and variance-covariance matrix 𝐺  of the random 
effects, covariance matrix and residual errors are obtained by fitting a random effects 
model to the FHS data. The residual variance σ! is obtained from the model (See 
Table 2.1). 
2. Generate random effects (𝑈!! ,𝑈!!) from a bivariate normal distribution with mean 
and variance-covariance 𝐺  obtained in step 1. The random effects (𝑈!! ,𝑈!!) 
represent the intercept and slope. 
3. Generate baseline covariates similar to FHS.  
Age at baseline ~ 𝑁(35, 5)  and Sex ~ 𝑟𝑏𝑒𝑟𝑛(𝑛, 0.54) 
4. Generate the longitudinal trajectories 𝜑! 𝑡!"  for each subject 𝑖 = 1, 2,… ,𝑛  
and for each time point 𝑗 = 1, 2,… ,𝑚!  using a linear model:  𝜑! 𝑡!"  =  𝑈!! +  𝑈!! ∗ 𝑡!" + 𝜏 ∗ 𝐴𝑔𝑒 
5. Generate the observed longitudinal measures 𝑌  from a multivariate normal 
distribution with mean 𝜑! 𝑡!"  and variance 𝑉 :  
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𝑉 = 𝑍!𝐺𝑍!! + 𝑅! ,   𝑤ℎ𝑒𝑟𝑒 𝑍! =  
1 01 51111
10152025
 𝑎𝑛𝑑 𝑅!  ~ 𝑑𝑖𝑎𝑔𝑚𝑎𝑡𝑟𝑖𝑥 σ!  
3.4.2 Simulating Survival Data: 
6. Specify the estimates for Age at baseline (0.050), Sex (-0.500) and the association 
parameter (0.000, 0.500, 1.000) which measures the strength of the association 
between the longitudinal measures 𝑌 𝑡  and the time-to-event. 
7. Generate the time-to-event (𝑇), for each time period in which the longitudinal 
measures were recorded, from the inverse of the cumulative hazard distribution, 
assuming constant baseline hazard:     ℎ(𝑡) =  𝜆 𝑡 𝑒𝑥𝑝 𝜶𝟏𝐴𝑔𝑒 +  𝜶𝟐𝑆𝑒𝑥 +  𝜸𝑌!"(𝑡)  
Survival times are generated for each interval to depend on the longitudinal measures at the 
beginning of the interval and a set of covariates (Age and Sex). We consider two different 
simulation schemes. In the first scheme the baseline Age is associated with the survival time 
between the exams in which the longitudinal measures were recorded. In this case the 
baseline Age is associated with the survival times between exams. In the second scheme a 
time dependent Age is implemented. In this case the survival time between exams is 
associated with the Age at the beginning of the exam. If an individual has an event in a 
particular interval, all subsequent intervals are excluded from the analysis. The survival time 
for each participant can be computed by considering the cumulative survival time across 
intervals until event occurs. 
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We fit the methods described in section 3.2 and 3.3 to analyze each of 1,000 
replicates for bias, MSE and coverage; 10,000 replicates for Type I error: (1) Un-stratified 
Cross-sectional pooling (CSP_UN); (2) Stratified Cross-sectional pooling (CSP_AD); (3) 
Time dependent covariate model (TDCM); (4) Un-adjusted Pooled logistic regression 
(PLR_UN); (5) Adjusted Pooled logistic regression (adjusting for time intervals in which the 
longitudinal measures were recorded – PLR_AD); (6) Andersen and Gill (AG). 
 
3.5 SIMULATION RESULTS 
In this section we present results from the simulation studies for the methods 
described in section 3.2 and 3.3. Type I errors were computed for the null case (γ = 0), to 
assess all six methods (Table 3.1) in 10,000 replicates using sample sizes of 100 and 1000.  
In all simulation schemes using baseline Age in generating the data, the stratified 
CSP (CSP_AD), TDCM and the AG provided identical results, as expected. For a sample of 
1000 all adjusted time dependent covariate methods provided Type I error rates close to the 
nominal level of 0.050. The unadjusted PLR and the un-stratified CSP showed elevated Type 
I errors with reduced rates, when censoring is low (high event rate). For example, with a 
sample size of 1000 and the censoring rate of 10% the unadjusted PLR had a Type I error of 
0.212 and un-stratified CSP had an error of 0.218 (Table 3.8). With higher censoring rates of 
90% the unadjusted PLR and the un-stratified CSP had an error of 0.072. Figure 3.1 shows 
the bias and the coverage of the association parameter for γ = 0 scenario. The adjusted 
models provide estimates that are on target with better coverage compared to the unadjusted 
models.  
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In Table 3.2a we present the estimates, standard errors, coverage probability, bias 
and MSE for the comparison of the longitudinal effect on survival using the Weibull 
distribution (N = 100 and baseline Age simulation scheme). We varied the censoring rates 
(10%, 50% and 90%) and the association parameter (γ = 0.00, 0.50, and 1.00) in the 
simulation scenarios. The TDCM, AG and the CSP – stratified (identical results) show low 
bias and high coverage probability compared to the other methods. The PLR methods 
provided upwardly biased estimates compared to the other methods with a higher bias in the 
unadjusted models. The bias was attenuated when the longitudinal effect on survival was 
smaller.  This is also depicted in Figures 3.2 and 3.3. The PLR methods had larger standard 
errors compared to the Cox models in all simulation scenarios considered. In models with 
high censoring rates the standard errors were larger, as expected.  
Table 3.3a presents the results for the comparison of the longitudinal effect on 
survival when N = 1000. The pattern of results in the estimates were similar those in Table 
3.2a (N = 100). The standard errors were smaller with a larger sample, as expected. The 
results suggest that the adjusted time dependent covariate methods performed best at 
estimating the association parameter compared to the unadjusted methods using the first 
scheme (baseline Age). 
In the second simulation scheme (Time dependent Age simulation) we considered 
the same set of scenarios as the first scheme. Both the adjusted and the unadjusted methods 
provided Type I error rates close to the nominal level of 0.05 in all scenarios considered 
(Table 3.4). In Table 3.4a we show the results when N = 100. The estimates for the 
unadjusted and the adjusted CSP methods provide similar results in instances when the 
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longitudinal effect on survival is small. The standard errors were slightly higher in the 
adjusted analyses compared to the unadjusted analyses. The PLR methods provided higher 
estimates compared to the adjusted and unadjusted CSP, TDCM and the AG methods. The 
adjusted PLR had higher standard errors, thus better coverage probabilities, compared to the 
unadjusted PLR. In an instance when the censoring was low (10%) and the longitudinal 
association parameter on survival was high (Link = 1.000) the unadjusted PLR showed a 
high bias (0.388) compared to all other methods. The bias, though still high, was attenuated 
in the adjusted PLR method (0.307). Also the unadjusted CSP showed a bias of 0.110 
compared to the adjusted CSP bias of 0.030.  
For a sample size of 1000 (Table 3.5a) the bias was attenuated. The unadjusted PLR 
showed a bias of 0.342 and the adjusted PLR had a bias of 0.255. The unadjusted CSP also 
showed a bias of 0.082 compared to the adjusted CSP bias of 0.002. In another instance 
when the censoring was high (90%) and the longitudinal effect of survival was large (Link = 
1.000) the unadjusted analyses provided more reliable estimates (less bias) compared to the 
adjusted analysis. The results suggest that when the data is generated using time dependent 
Age the adjusted time dependent covariate methods provide more reliable estimates 
compared to the unadjusted methods in instances when longitudinal effect on survival was 
high with extreme censoring (10% and 90%). The estimates are similar in instances when the 
longitudinal effect is attenuated. 
The performance of these methods in estimating the time independent covariate 
effects of Age (𝛼! = 0.050) and Sex (𝛼! = −0.500) was also assessed. When we applied 
the first simulation scheme the Age effect was attenuated in the unadjusted models in all the 
scenarios (Table 3.2b). The standard errors were also smaller in the unadjusted models 
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compared to the adjusted models. The results showed that the adjusted PLR had a positive 
bias in the Age effect with the bias reduced when the censoring rate is high. We saw similar 
patterns in the estimation of the Age effect with a larger sample size (Table 3.3b). The PLR 
methods showed a negative bias (larger magnitude) in the Sex effect compared to the other 
methods with the bias attenuated when the sample size was increased (Table 3.2c and 3.3c). 
The Cox models yield fairly good estimates for the Sex effect in all scenarios considered. The 
standard errors and confidence intervals become larger with higher censoring rates, as 
expected.  
In the second simulation scheme the Age effect was similar in both the adjusted and 
the unadjusted models with the exception in scenarios with extreme censoring (10% or 
90%). From Table 3.4b and 3.5b we see that the estimates for Age effect in the different 
simulation scenarios are close to the true estimate (0.050) with the exception of the 10% and 
90% censoring scenarios. As seen earlier, the PLR methods provide upwardly biased 
estimates of the Age effect compared to the CSP, AG and the TDCM. The bias in the PLR 
methods may not be related to odds ratio vs. relative risk as this was seen in instances with 
rare events (10%) and high event rates (90%). The PLR had higher bias for the Sex effect 
compared to the other methods. The bias was attenuated when the longitudinal effect on 
survival was smaller and also when the censoring rate was higher (Tables 3.4c and 3.5c). For 
example from Table 3.4c we see that the PLR adjusted and the unadjusted models provided 
higher estimates of the Sex effect compared to the other methods. The estimate and bias 
were higher in instances when the longitudinal effect on survival was larger. When the 
longitudinal effect is 1.000 and the censoring is 10% the unadjusted PLR provided an 
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estimate of -0.671 with a bias of -0.171. In this scenario the adjusted PLR provided an 
estimate of -0.666 with a bias of -0.166. Though the adjusted PLR in this case provided a 
lower bias, the estimate is still far from the truth. The unadjusted CSP showed an estimate of 
-0.537 compared to the adjusted CSP which had an estimate of -0.524. When we considered 
the same scenario with a larger size of 1000 (Table 3.5c) the adjusted CSP showed a small 
bias (-0.001) compared to the unadjusted model (-0.015), the unadjusted PLR (-0.139) and 
the adjusted PLR (-0.127). As expected the adjusted CSP, AG and TDCM methods provided 
identical results for the Age, longitudinal and Sex effects. Overall these results suggest that 
the adjusted Cox models provide more reliable estimates compared to the unadjusted Cox 
and logistic models. 
 
3.6 APPLICATION TO FRAMINGHAM HEART STUDY (FHS) 
In this section we considered FHS data in which lipid measurements and myocardial 
infarction (MI) data were collected over a period of 26 years. Using the time dependent 
methods described in section 3.2 and 3.3 we characterize the association between the 
longitudinal measures and time-to-event response. We use log TG at each exam for the 
longitudinal part of the model and survival time measured from exam 1 to MI or loss to 
follow up. We adjust for Sex and Age in all the models. For the TDCM we adjusted for the 
baseline Age of each subject; for the PLR and CSP we adjusted for the Age at exam. In 
Table 3.6 we present the estimates for Age, Sex and the association parameters. The results 
suggest a higher estimate of the association parameter for log TG in the stratified CSP, 
TDCM and the AG methods (γ = 0.6182). The association parameter describes the strength 
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of the relationship between log triglycerides and survival in the interval. The PLR and the 
CSP show a lower association estimates in the unadjusted analyses (γ = 0.6023 and γ = 
0.6068) compared to the other methods. The Age effect and standard errors were similar 
among the methods with estimates ranging from 0.048 to 0.056 with the unadjusted analyses 
yielding lower estimates compared to the adjusted analysis. The Sex effect was fairly 
consistent among the different methods (-1.018 to -1.030). Using a 0.05 level of significance 
the Age, Sex and Log of the triglyceride measures were significantly association with the 
time-to-myocardial infarction. These results suggest that repeated measures of triglycerides 
are significantly associated with the time-to-event myocardial infarction in the Framingham 
Heart Study Cohort. The results for the stratified CSP, TDCM and the AG were identical 
for both the time dependent and the time independent covariates. 
 
3.7 CONCLUSION AND DISCUSSION 
In this Chapter we explored time dependent covariate methods that link longitudinal 
and survival data for intervals of observation. These methods quantify the association 
between the longitudinal process and survival outcome on the hazard at the same time point 
as the time-to-event. We analyzed data from FHS in which lipid measurements and 
myocardial infarction (MI) data were collected over a period of 26 years (1979 – 2005). We 
conducted a series of simulations to assess the performance of these methods through bias, 
coverage probabilities and Type I error rates. To our knowledge this is the first paper that 
compares adjusted and unadjusted models for modeling time dependent covariate data with 
simulations. 
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From the simulations we see that adjusted time dependent covariate methods 
perform best at estimating the association parameter compared to the unadjusted Cox and 
logistic models. Our results indicate that in some instances the PLR provides upwardly 
biased estimates and larger standard errors compared to the Cox models. The PLR and the 
time dependent covariate methods provide similar results when the event is rare. This is 
consistent with the results presented by Green and Symons (1983). In addition the Cox 
models provide estimates which are relatively stable compared to the PLR. In unadjusted 
models the Age effect was attenuated depending on the association of the longitudinal 
measures on survival. D’Agostino et al. (1990) indicated that the analyst must consider the 
nature of variables such as Age, which may be highly correlated with the follow-up time. 
In general, we recommend the use of a stratified Cox model when the time-to-event 
is available. When the time of the response is not available, a PLR may be applied adjusting 
for the time intervals at which the time dependent covariate measures were recorded. The 
Cox model provides greater use of the available data compared to the PLR.  
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3.8 TABLES AND FIGURES 
Table 3.1: Type I Error (Link = 0.000) 
Scenarios Baseline Age Simulation 
N Censoring CSP_UN CSP_AD TDCM AG PLR_UN PLR_AD 
100 10% 0.077 0.055 0.055 0.055 0.073 0.053 
100 50% 0.070 0.057 0.057 0.057 0.068 0.056 
100 90% 0.052 0.048 0.048 0.048 0.050 0.048 
1000 10% 0.218 0.050 0.050 0.050 0.212 0.051 
1000 50% 0.146 0.050 0.050 0.050 0.147 0.050 
1000 90% 0.072 0.050 0.050 0.050 0.072 0.050 
Scenarios Time Dependent Age Simulation 
100 10% 0.052 0.052 0.052 0.052 0.049 0.051 
100 50% 0.049 0.053 0.053 0.053 0.050 0.053 
100 90% 0.047 0.046 0.046 0.046 0.046 0.045 
1000 10% 0.052 0.052 0.052 0.052 0.049 0.051 
1000 50% 0.049 0.053 0.053 0.053 0.050 0.053 
1000 90% 0.047 0.046 0.046 0.046 0.046 0.045 
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Figure 3.1: Confidence Intervals For Association Parameter – Baseline Age (Type I Error Scenario) 
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Figure 3.2: Estimates and Confidence Intervals For Association Parameter – Baseline Age (N = 100) 
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Figure 3.3: Estimates and Confidence Intervals For Association Parameter – Baseline Age (N = 1000) 
 
 
 
 
 
77 
Table 3.2a: Comparison of Longitudinal Effect on Survival – Baseline Age Simulation (N = 100, Link = 𝜸) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.062 0.175 0.920 0.062 0.071 0.000 0.179 0.935 0.000 0.066 0.000 0.179 0.935 0.000 0.066 
0.500 0.578 0.179 0.929 0.078 0.071 0.504 0.185 0.953 0.004 0.068 0.504 0.185 0.953 0.004 0.068 
1.000 1.101 0.189 0.921 0.101 0.086 1.020 0.196 0.945 0.020 0.078 1.020 0.196 0.945 0.020 0.078 
50% 
0.000 0.075 0.229 0.935 0.075 0.112 0.010 0.234 0.946 0.010 0.110 0.010 0.234 0.946 0.010 0.110 
0.500 0.564 0.230 0.931 0.064 0.117 0.494 0.235 0.944 -0.006 0.118 0.494 0.235 0.944 -0.006 0.118 
1.000 1.083 0.242 0.931 0.083 0.127 1.016 0.249 0.948 0.016 0.127 1.016 0.249 0.948 0.016 0.127 
90% 
0.000 0.070 0.483 0.934 0.070 0.512 0.009 0.495 0.940 0.009 0.528 0.009 0.495 0.940 0.009 0.528 
0.500 0.553 0.630 0.952 0.03 0.643 0.491 0.650 0.958 -0.009 0.683 0.491 0.650 0.958 -0.009 0.683 
1.000 1.092 0.480 0.951 0.092 0.487 1.036 0.497 0.960 0.036 0.510 1.036 0.497 0.960 0.036 0.510 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.076 0.215 0.917 0.076 0.107 0.000 0.221 0.936 0.000 0.102 0.000 0.179 0.935 0.000 0.066 
0.500 0.704 0.227 0.863 0.204 0.146 0.623 0.233 0.935 0.123 0.123 0.504 0.185 0.953 0.004 0.068 
1.000 1.370 0.261 0.739 0.370 0.275 1.289 0.267 0.842 0.289 0.223 1.020 0.196 0.945 0.020 0.078 
50% 
0.000 0.081 0.246 0.939 0.081 0.130 0.015 0.252 0.946 0.011 0.127 0.010 0.234 0.946 0.010 0.110 
0.500 0.612 0.252 0.924 0.112 0.149 0.542 0.258 0.944 0.042 0.144 0.494 0.235 0.944 -0.006 0.118 
1.000 1.188 0.276 0.913 0.188 0.191 1.121 0.281 0.936 0.121 0.176 1.016 0.249 0.948 0.016 0.127 
90% 
0.000 0.071 0.491 0.937 0.071 0.531 0.010 0.503 0.941 0.010 0.549 0.009 0.495 0.940 0.009 0.528 
0.500 0.560 0.639 0.952 0.060 0.657 0.505 0.658 0.955 0.005 0.706 0.491 0.650 0.958 -0.009 0.683 
1.000 1.125 0.499 0.952 0.125 0.533 1.071 0.512 0.956 0.071 0.553 1.036 0.497 0.960 0.036 0.510 
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Table 3.2b: Comparison of Age Effect on Survival – Baseline Age Simulation (N = 100, Age = 0.050) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.013 0.014 0.248 -0.037 0.002 0.051 0.024 0.941 0.001 0.001 0.051 0.024 0.941 0.001 0.001 
0.500 0.013 0.014 0.215 -0.037 0.002 0.051 0.024 0.941 0.001 0.001 0.051 0.024 0.941 0.001 0.001 
1.000 0.012 0.014 0.203 -0.038 0.002 0.053 0.025 0.929 0.003 0.001 0.053 0.025 0.929 0.003 0.001 
50% 
0.000 0.011 0.016 0.329 -0.039 0.002 0.052 0.031 0.952 0.002 0.002 0.052 0.031 0.952 0.002 0.002 
0.500 0.011 0.016 0.325 -0.039 0.002 0.053 0.031 0.942 0.003 0.002 0.053 0.031 0.942 0.003 0.002 
1.000 0.010 0.016 0.283 -0.040 0.002 0.052 0.032 0.947 0.002 0.002 0.052 0.032 0.947 0.002 0.002 
90% 
0.000 0.011 0.034 0.778 -0.039 0.004 0.049 0.065 0.961 -0.001 0.009 0.049 0.065 0.961 -0.001 0.009 
0.500 0.015 0.044 0.871 -0.035 0.006 0.055 0.086 0.950 0.005 0.012 0.055 0.086 0.950 0.005 0.012 
1.000 0.012 0.032 0.765 -0.038 0.004 0.052 0.064 0.946 0.002 0.009 0.052 0.064 0.946 0.002 0.009 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.016 0.017 0.465 -0.034 0.002 0.063 0.031 0.932 0.013 0.002 0.051 0.024 0.941 0.001 0.001 
0.500 0.016 0.017 0.485 -0.034 0.002 0.064 0.031 0.927 0.014 0.002 0.051 0.024 0.941 0.001 0.001 
1.000 0.015 0.018 0.478 -0.035 0.002 0.067 0.032 0.911 0.017 0.002 0.053 0.025 0.929 0.003 0.001 
50% 
0.000 0.012 0.017 0.414 -0.038 0.002 0.056 0.034 0.954 0.006 0.002 0.052 0.031 0.952 0.002 0.002 
0.500 0.012 0.017 0.411 -0.038 0.002 0.058 0.034 0.941 0.008 0.002 0.053 0.031 0.942 0.003 0.002 
1.000 0.010 0.018 0.381 -0.040 0.002 0.057 0.035 0.942 0.007 0.003 0.052 0.032 0.947 0.002 0.002 
90% 
0.000 0.011 0.034 0.784 -0.039 0.004 0.050 0.066 0.962 0.000 0.009 0.049 0.065 0.961 -0.001 0.009 
0.500 0.010 0.052 0.875 -0.040 0.033 0.056 0.100 0.956 0.006 0.064 0.055 0.086 0.950 0.005 0.012 
1.000 0.012 0.034 0.777 -0.038 0.004 0.054 0.066 0.945 0.004 0.010 0.052 0.064 0.946 0.002 0.009 
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Table 3.2c: Comparison of Sex Effect on Survival – Baseline Age Simulation (N = 100, Sex = -0.500) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.533 0.219 0.926 -0.033 0.107 -0.511 0.221 0.945 -0.011 0.102 -0.511 0.221 0.945 -0.011 0.102 
0.500 -0.525 0.220 0.934 -0.025 0.103 -0.503 0.222 0.943 -0.003 0.099 -0.503 0.222 0.943 -0.003 0.943 
1.000 -0.522 0.220 0.947 -0.022 0.101 -0.510 0.223 0.954 -0.010 0.099 -0.510 0.223 0.954 -0.010 0.099 
50% 
0.000 -0.510 0.283 0.948 -0.010 0.164 -0.503 0.285 0.952 -0.003 0.162 -0.503 0.285 0.952 -0.003 0.162 
0.500 -0.522 0.281 0.938 -0.022 0.167 -0.520 0.283 0.946 -0.020 0.166 -0.520 0.283 0.946 -0.020 0.166 
1.000 -0.510 0.286 0.946 -0.010 0.172 -0.510 0.289 0.952 -0.010 0.173 -0.510 0.289 0.952 -0.010 0.173 
90% 
0.000 -0.514 0.602 0.967 -0.014 0.575 -0.509 0.605 0.966 -0.009 0.583 -0.509 0.605 0.966 -0.009 0.583 
0.500 -0.453 0.841 0.992 0.047 1.352 -0.461 0.821 0.990 -0.039 1.016 -0.461 0.821 0.990 -0.039 1.016 
1.000 -0.517 0.601 0.965 -0.017 0.785 -0.516 0.608 0.960 -0.016 0.801 -0.516 0.608 0.960 -0.016 0.801 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.650 0.271 0.901 -0.150 0.186 -0.635 0.275 0.921 -0.135 0.177 -0.511 0.221 0.945 -0.011 0.102 
0.500 -0.642 0.274 0.916 -0.142 0.180 -0.627 0.279 0.933 -0.127 0.172 -0.503 0.222 0.943 -0.003 0.943 
1.000 -0.648 0.287 0.922 -0.148 0.191 -0.643 0.292 0.933 -0.143 0.186 -0.510 0.223 0.954 -0.010 0.099 
50% 
0.000 -0.546 0.303 0.952 -0.046 0.190 -0.544 0.306 0.952 -0.044 0.189 -0.503 0.285 0.952 -0.003 0.162 
0.500 -0.564 0.304 0.937 -0.064 0.198 -0.567 0.307 0.942 -0.067 0.200 -0.520 0.283 0.946 -0.020 0.166 
1.000 -0.559 0.315 0.937 -0.059 0.212 -0.563 0.319 0.940 -0.063 0.215 -0.510 0.289 0.952 -0.010 0.173 
90% 
0.000 -0.525 0.609 0.965 -0.025 0.587 -0.520 0.613 0.964 -0.020 0.601 -0.509 0.605 0.966 -0.009 0.583 
0.500 -0.458 0.849 0.992 0.041 1.378 -0.463 0.860 0.989 0.037 1.437 -0.461 0.821 0.990 -0.039 1.016 
1.000 0.527 0.614 0.967 -0.027 0.818 -0.530 0.622 0.962 -0.030 0.942 -0.516 0.608 0.960 -0.016 0.801 
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Table 3.3a: Comparison of Longitudinal Effect on Survival – Baseline Age Simulation (N = 1000, Link = 𝜸) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.062 0.054 0.796 0.062 0.010 -0.001 0.055 0.955 -0.001 0.006 -0.001 0.055 0.955 -0.001 0.006 
0.500 0.574 0.055 0.720 0.074 0.012 0.500 0.056 0.958 0.000 0.006 0.500 0.056 0.958 0.000 0.006 
1.000 1.079 0.058 0.720 0.079 0.013 0.999 0.059 0.943 -0.001 0.007 0.999 0.059 0.943 -0.001 0.007 
50% 
0.000 0.065 0.071 0.859 0.065 0.014 0.001 0.072 0.966 0.001 0.010 0.001 0.072 0.966 0.001 0.010 
0.500 0.565 0.071 0.851 0.065 0.014 0.498 0.072 0.949 -0.002 0.010 0.498 0.072 0.949 -0.002 0.010 
1.000 1.068 0.075 0.844 0.068 0.016 1.001 0.076 0.939 0.001 0.012 1.001 0.076 0.939 0.001 0.012 
90% 
0.000 0.055 0.146 0.914 0.055 0.049 -0.007 0.148 0.929 -0.007 0.047 -0.007 0.148 0.929 -0.007 0.047 
0.500 0.576 0.195 0.940 0.076 0.080 0.511 0.199 0.955 0.011 0.077 0.511 0.199 0.955 0.011 0.077 
1.000 1.071 0.142 0.908 0.072 0.047 1.009 0.144 0.940 0.009 0.044 1.009 0.144 0.940 0.009 0.044 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.074 0.066 0.811 0.074 0.014 -0.002 0.068 0.952 -0.002 0.009 -0.001 0.055 0.955 -0.001 0.006 
0.500 0.696 0.070 0.204 0.196 0.048 0.612 0.071 0.653 0.112 0.023 0.500 0.056 0.958 0.000 0.006 
1.000 1.336 0.080 0.012 0.336 0.126 1.249 0.081 0.124 0.249 0.075 0.999 0.059 0.943 -0.001 0.007 
50% 
0.000 0.069 0.076 0.858 0.069 0.016 0.001 0.078 0.967 0.001 0.011 0.001 0.072 0.966 0.001 0.010 
0.500 0.609 0.078 0.717 0.109 0.024 0.539 0.079 0.910 0.039 0.014 0.498 0.072 0.949 -0.002 0.010 
1.000 1.165 0.085 0.524 0.165 0.042 1.096 0.086 0.794 0.096 0.024 1.001 0.076 0.939 0.001 0.012 
90% 
0.000 0.056 0.147 0.915 0.056 0.050 -0.007 0.150 0.930 -0.007 0.048 -0.007 0.148 0.929 -0.007 0.047 
0.500 0.5811 0.197 0.939 0.081 0.082 0.515 0.200 0.957 0.155 0.079 0.511 0.199 0.955 0.011 0.077 
1.000 1.095 0.147 0.892 0.095 0.054 1.033 0.149 0.935 0.033 0.048 1.009 0.144 0.940 0.009 0.044 
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Table 3.3b: Comparison of Age Effect on Survival – Baseline Age Simulation (N = 1000, Age = 0.050) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.012 0.004 0.000 -0.038 0.001 0.050 0.007 0.952 0.000 0.000 0.050 0.007 0.952 0.000 0.000 
0.500 0.010 0.004 0.000 -0.040 0.002 0.050 0.007 0.956 0.000 0.000 0.050 0.007 0.956 0.000 0.000 
1.000 0.010 0.004 0.000 -0.040 0.002 0.050 0.007 0.944 0.000 0.000 0.050 0.007 0.944 0.000 0.000 
50% 
0.000 0.010 0.005 0.000 -0.040 0.002 0.050 0.009 0.950 0.000 0.000 0.050 0.009 0.950 0.000 0.000 
0.500 0.010 0.005 0.000 -0.040 0.002 0.050 0.009 0.927 0.000 0.000 0.050 0.009 0.927 0.000 0.000 
1.000 0.009 0.005 0.000 -0.041 0.002 0.050 0.010 0.945 0.000 0.000 0.050 0.010 0.945 0.000 0.000 
90% 
0.000 0.010 0.010 0.032 -0.039 0.002 0.050 0.019 0.937 0.000 0.000 0.050 0.019 0.937 0.000 0.000 
0.500 0.011 0.014 0.171 -0.039 0.002 0.051 0.026 0.953 0.001 0.001 0.051 0.026 0.953 0.001 0.001 
1.000 0.011 0.009 0.026 -0.039 0.002 0.050 0.019 0.942 0.000 0.001 0.050 0.019 0.942 0.000 0.001 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.014 0.005 0.000 -0.036 0.001 0.061 0.009 0.767 0.011 0.000 0.050 0.007 0.952 0.000 0.000 
0.500 0.013 0.005 0.000 -0.037 0.001 0.061 0.009 0.785 0.011 0.000 0.050 0.007 0.956 0.000 0.000 
1.000 0.012 0.005 0.000 -0.038 0.001 0.062 0.010 0.779 0.012 0.000 0.050 0.007 0.944 0.000 0.000 
50% 
0.000 0.011 0.005 0.000 -0.039 0.001 0.054 0.010 0.938 0.004 0.000 0.050 0.009 0.950 0.000 0.000 
0.500 0.011 0.005 0.000 -0.039 0.002 0.055 0.010 0.913 0.004 0.000 0.050 0.009 0.927 0.000 0.000 
1.000 0.010 0.005 0.000 -0.040 0.002 0.055 0.011 0.920 0.005 0.000 0.050 0.010 0.945 0.000 0.000 
90% 
0.000 0.011 0.010 0.050 -0.039 0.002 0.050 0.020 0.937 0.000 0.000 0.050 0.019 0.937 0.000 0.000 
0.500 0.011 0.014 0.181 -0.039 0.002 0.052 0.026 0.951 0.002 0.001 0.051 0.026 0.953 0.001 0.001 
1.000 0.011 0.010 0.032 -0.039 0.002 0.051 0.019 0.941 0.001 0.001 0.050 0.019 0.942 0.000 0.001 
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Table 3.3c: Comparison of Sex Effect on Survival – Baseline Age Simulation (N = 1000, Sex = -0.500) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.520 0.068 0.925 -0.020 0.010 -0.501 0.068 0.946 -0.001 0.009 -0.501 0.068 0.946 -0.001 0.009 
0.500 -0.515 0.068 0.932 -0.015 0.010 -0.500 0.068 0.951 0.000 0.009 -0.500 0.068 0.951 0.000 0.009 
1.000 -0.516 0.068 0.924 -0.016 0.010 -0.501 0.068 0.948 -0.001 0.009 -0.501 0.068 0.948 -0.001 0.009 
50% 
0.000 -0.505 0.088 0.939 -0.005 0.016 -0.501 0.088 0.943 -0.001 0.016 -0.501 0.088 0.943 -0.001 0.016 
0.500 -0.507 0.087 0.935 -0.007 0.016 -0.503 0.087 0.941 -0.003 0.016 -0.503 0.087 0.941 -0.003 0.016 
1.000 -0.499 0.089 0.949 0.001 0.016 -0.499 0.089 0.954 0.001 0.015 -0.499 0.089 0.954 0.001 0.015 
90% 
0.000 -0.499 0.181 0.962 0.001 0.063 -0.499 0.181 0.959 0.001 0.063 -0.499 0.181 0.959 0.001 0.063 
0.500 -0.498 0.243 0.949 0.002 0.120 -0.498 0.243 0.944 0.002 0.121 -0.498 0.243 0.944 0.002 0.121 
1.000 -0.503 0.174 0.946 -0.003 0.063 -0.503 0.174 0.944 -0.003 0.063 -0.503 0.174 0.944 -0.003 0.063 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.630 0.084 0.656 -0.130 0.032 -0.611 0.084 0.744 -0.111 0.027 -0.501 0.068 0.946 -0.001 0.009 
0.500 -0.626 0.085 0.679 -0.126 0.031 -0.612 0.086 0.753 -0.112 0.027 -0.500 0.068 0.951 0.000 0.009 
1.000 -0.638 0.089 0.657 -0.138 0.036 -0.626 0.090 0.716 -0.126 0.032 -0.501 0.068 0.948 -0.001 0.009 
50% 
0.000 -0.538 0.094 0.909 -0.038 0.020 -0.536 0.094 0.922 -0.036 0.020 -0.501 0.088 0.943 -0.001 0.016 
0.500 -0.546 0.094 0.908 -0.046 0.021 -0.544 0.094 0.915 -0.044 0.020 -0.503 0.087 0.941 -0.003 0.016 
1.000 -0.543 0.097 0.925 -0.043 0.021 -0.545 0.098 0.931 -0.045 0.021 -0.499 0.089 0.954 0.001 0.015 
90% 
0.000 -0.505 0.183 0.962 -0.005 0.065 -0.505 0.183 0.962 -0.005 0.065 -0.499 0.181 0.959 0.001 0.063 
0.500 -0.502 0.245 0.947 -0.002 0.122 -0.502 0.245 0.945 -0.002 0.123 -0.498 0.243 0.944 0.002 0.121 
1.000 -0.514 0.178 0.943 -0.014 0.066 -0.515 0.178 0.943 -0.015 0.066 -0.503 0.174 0.944 -0.003 0.063 
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Figure 3.4: Confidence Intervals For Association Parameter – Time Dependent Age (Type I Error Scenario) 
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Figure 3.5: Estimates and Confidence Intervals For Association Parameter – Time Dependent Age (N = 100) 
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Figure 3.6: Estimates and Confidence Intervals For Association Parameter – Time Dependent Age (N = 1000) 
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Table 3.4a: Comparison of Longitudinal Effect on Survival – Time Dependent Age Simulation (N = 100, Link = 𝜸) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.013 0.175 0.939 -0.013 0.062 -0.013 0.180 0.947 -0.013 0.066 -0.013 0.180 0.947 -0.013 0.066 
0.500 0.510 0.177 0.940 0.010 0.066 0.511 0.184 0.938 0.011 0.071 0.511 0.184 0.938 0.011 0.071 
1.000 1.110 0.188 0.913 0.110 0.085 1.030 0.195 0.956 0.030 0.076 1.030 0.195 0.956 0.030 0.076 
50% 
0.000 -0.016 0.242 0.953 -0.016 0.120 -0.016 0.247 0.939 -0.016 0.126 -0.016 0.247 0.939 -0.016 0.126 
0.500 0.512 0.226 0.930 0.012 0.109 0.507 0.232 0.933 0.007 0.113 0.507 0.232 0.933 0.007 0.113 
1.000 1.035 0.236 0.951 0.035 0.116 1.036 0.244 0.950 0.036 0.121 1.036 0.244 0.950 0.036 0.121 
90% 
0.000 0.002 0.556 0.949 0.002 0.634 0.005 0.572 0.948 0.005 0.666 0.005 0.572 0.948 0.005 0.666 
0.500 0.513 0.534 0.953 0.013 0.608 0.518 0.549 0.956 0.018 0.643 0.518 0.549 0.956 0.018 0.643 
1.000 1.097 0.484 0.947 0.097 0.511 1.042 0.501 0.950 0.042 0.541 1.042 0.501 0.950 0.042 0.541 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.017 0.213 0.942 -0.017 0.092 -0.016 0.217 0.946 -0.016 0.097 -0.013 0.180 0.947 -0.013 0.066 
0.500 0.615 0.223 0.923 0.115 0.117 0.622 0.229 0.921 0.122 0.126 0.511 0.184 0.938 0.011 0.071 
1.000 1.388 0.261 0.709 0.388 0.289 1.307 0.267 0.827 0.307 0.236 1.030 0.195 0.956 0.030 0.076 
50% 
0.000 -0.017 0.259 0.953 -0.017 0.139 -0.017 0.265 0.940 -0.017 0.145 -0.016 0.247 0.939 -0.016 0.126 
0.500 0.561 0.251 0.932 0.061 0.137 0.559 0.257 0.935 0.059 0.142 0.507 0.232 0.933 0.007 0.113 
1.000 1.148 0.273 0.932 0.148 0.174 1.155 0.280 0.924 0.155 0.182 1.036 0.244 0.950 0.036 0.121 
90% 
0.000 0.002 0.565 0.951 0.002 0.658 0.007 0.578 0.950 0.007 0.683 0.005 0.572 0.948 0.005 0.666 
0.500 0.527 0.546 0.954 0.027 0.640 0.531 0.559 0.954 0.031 0.673 0.518 0.549 0.956 0.018 0.643 
1.000 1.129 0.503 0.948 0.129 0.560 1.075 0.515 0.946 0.075 0.580 1.042 0.501 0.950 0.042 0.541 
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Table 3.4b: Comparison of Age Effect on Survival – Time Dependent Age Simulation (N = 100, Age = 0.050) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.053 0.014 0.937 0.003 0.000 0.052 0.024 0.944 0.002 0.001 0.052 0.024 0.944 0.002 0.001 
0.500 0.053 0.014 0.950 0.003 0.000 0.052 0.024 0.931 0.002 0.001 0.052 0.024 0.931 0.002 0.001 
1.000 0.011 0.014 0.185 -0.039 0.002 0.052 0.025 0.930 0.002 0.001 0.052 0.025 0.930 0.002 0.001 
50% 
0.000 0.052 0.017 0.950 0.002 0.001 0.052 0.033 0.948 0.002 0.002 0.052 0.033 0.948 0.002 0.002 
0.500 0.052 0.016 0.946 0.002 0.001 0.055 0.030 0.940 0.005 0.002 0.055 0.030 0.940 0.005 0.002 
1.000 0.051 0.016 0.964 0.001 0.001 0.050 0.031 0.957 0.000 0.002 0.050 0.031 0.957 0.000 0.002 
90% 
0.000 0.053 0.040 0.956 0.003 0.004 0.052 0.075 0.958 0.002 0.012 0.052 0.075 0.958 0.002 0.012 
0.500 0.055 0.039 0.957 0.005 0.003 0.054 0.072 0.942 0.004 0.011 0.054 0.072 0.942 0.004 0.011 
1.000 0.012 0.033 0.771 -0.038 0.004 0.051 0.065 0.952 0.001 0.009 0.051 0.065 0.952 0.001 0.009 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.064 0.017 0.877 0.014 0.001 0.063 0.029 0.926 0.013 0.002 0.052 0.024 0.944 0.002 0.001 
0.500 0.064 0.017 0.886 0.014 0.001 0.063 0.030 0.919 0.013 0.002 0.052 0.024 0.931 0.002 0.001 
1.000 0.014 0.018 0.453 -0.036 0.002 0.065 0.032 0.926 0.015 0.002 0.052 0.025 0.930 0.002 0.001 
50% 
0.000 0.056 0.019 0.945 0.006 0.001 0.056 0.035 0.951 0.005 0.003 0.052 0.033 0.948 0.002 0.002 
0.500 0.057 0.018 0.940 0.007 0.001 0.061 0.034 0.935 0.011 0.002 0.055 0.030 0.940 0.005 0.002 
1.000 0.056 0.018 0.950 0.006 0.001 0.055 0.035 0.962 0.005 0.002 0.050 0.031 0.957 0.000 0.002 
90% 
0.000 0.054 0.041 0.956 0.004 0.004 0.054 0.077 0.958 0.004 0.013 0.052 0.075 0.958 0.002 0.012 
0.500 0.056 0.040 0.957 0.006 0.003 0.056 0.073 0.940 0.006 0.012 0.054 0.072 0.942 0.004 0.011 
1.000 0.012 0.034 0.781 -0.038 0.004 0.053 0.067 0.951 0.003 0.009 0.051 0.065 0.952 0.001 0.009 
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Table 3.4c: Comparison of Sex Effect on Survival – Time Dependent Age Simulation (N = 100, Sex = -0.500) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.512 0.216 0.945 -0.012 0.096 -0.514 0.219 0.947 -0.014 0.098 -0.514 0.219 0.947 -0.014 0.098 
0.500 -0.519 0.217 0.933 -0.019 0.098 -0.519 0.220 0.936 -0.019 0.101 -0.519 0.220 0.936 -0.019 0.101 
1.000 -0.537 0.221 0.936 -0.037 0.107 -0.524 0.224 0.950 -0.024 0.103 -0.524 0.224 0.950 -0.024 0.103 
50% 
0.000 -0.505 0.296 0.945 -0.005 0.179 -0.504 0.298 0.950 -0.004 0.181 -0.504 0.298 0.950 -0.004 0.181 
0.500 -0.518 0.274 0.946 -0.018 0.152 -0.516 0.277 0.944 -0.016 0.155 -0.516 0.277 0.944 -0.016 0.155 
1.000 -0.517 0.277 0.951 -0.017 0.156 -0.518 0.280 0.954 -0.018 0.159 -0.518 0.280 0.954 -0.018 0.159 
90% 
0.000 -0.491 0.720 0.974 0.009 1.067 -0.493 0.725 0.973 0.007 1.084 -0.493 0.725 0.973 0.007 1.084 
0.500 -0.530 0.681 0.983 -0.030 0.929 -0.533 0.686 0.986 -0.033 0.940 -0.533 0.686 0.986 -0.033 0.940 
1.000 -0.529 0.608 0.962 -0.029 0.805 -0.534 0.615 0.960 -0.034 0.818 -0.534 0.615 0.960 -0.034 0.818 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.615 0.265 0.939 -0.115 0.155 -0.622 0.268 0.937 -0.122 0.161 -0.514 0.219 0.947 -0.014 0.098 
0.500 -0.625 0.271 0.918 -0.125 0.166 -0.632 0.273 0.912 -0.132 0.173 -0.519 0.220 0.936 -0.019 0.101 
1.000 -0.671 0.289 0.911 -0.171 0.207 -0.666 0.293 0.927 -0.166 0.204 -0.524 0.224 0.950 -0.024 0.103 
50% 
0.000 -0.540 0.317 0.942 -0.040 0.206 -0.542 0.319 0.940 -0.042 0.210 -0.504 0.298 0.950 -0.004 0.181 
0.500 -0.566 0.302 0.939 -0.066 0.189 -0.569 0.304 0.934 -0.069 0.194 -0.516 0.277 0.944 -0.016 0.155 
1.000 -0.572 0.312 0.949 -0.072 0.201 -0.576 0.314 0.945 -0.076 0.207 -0.518 0.280 0.954 -0.018 0.159 
90% 
0.000 -0.498 0.728 0.973 0.002 1.093 -0.503 0.734 0.973 -0.003 1.118 -0.493 0.725 0.973 0.007 1.084 
0.500 -0.539 0.692 0.983 -0.039 0.961 -0.546 0.698 0.984 -0.046 0.981 -0.533 0.686 0.986 -0.033 0.940 
1.000 -0.542 0.621 0.962 -0.042 0.840 -0.550 0.628 0.960 -0.050 0.861 -0.534 0.615 0.960 -0.034 0.818 
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Table 3.5a: Comparison of Longitudinal Effect on Survival – Time Dependent Age Simulation (N = 1000, Link = 𝜸) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.003 0.054 0.957 0.003 0.006 0.003 0.055 0.954 0.003 0.006 0.003 0.055 0.954 0.003 0.006 
0.500 0.498 0.055 0.954 -0.002 0.006 0.498 0.056 0.952 -0.002 0.006 0.498 0.056 0.952 -0.002 0.006 
1.000 1.083 0.058 0.720 0.082 0.014 1.002 0.059 0.958 0.002 0.007 1.002 0.059 0.958 0.002 0.007 
50% 
0.000 -0.001 0.075 0.953 -0.001 0.011 -0.002 0.076 0.944 -0.002 0.012 -0.002 0.076 0.944 -0.002 0.012 
0.500 0.499 0.070 0.947 -0.001 0.010 0.499 0.071 0.944 -0.001 0.010 0.499 0.071 0.944 -0.001 0.010 
1.000 1.001 0.073 0.946 0.001 0.011 1.002 0.074 0.948 0.002 0.011 1.002 0.074 0.948 0.002 0.011 
90% 
0.000 0.007 0.168 0.944 0.007 0.058 0.007 0.171 0.938 0.007 0.060 0.007 0.171 0.938 0.007 0.060 
0.500 0.501 0.158 0.947 0.001 0.051 0.501 0.161 0.946 0.001 0.053 0.501 0.161 0.946 0.001 0.053 
1.000 1.067 0.145 0.906 0.067 0.048 1.003 0.147 0.937 0.003 0.045 1.003 0.147 0.937 0.003 0.045 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.003 0.066 0.957 0.003 0.008 0.003 0.067 0.957 0.003 0.009 0.003 0.055 0.954 0.003 0.006 
0.500 0.599 0.069 0.709 0.099 0.019 0.601 0.070 0.711 0.101 0.020 0.498 0.056 0.952 -0.002 0.006 
1.000 1.342 0.080 0.005 0.342 0.130 1.255 0.082 0.111 0.255 0.078 1.002 0.059 0.958 0.002 0.007 
50% 
0.000 -0.001 0.080 0.950 -0.001 0.013 -0.002 0.081 0.945 -0.002 0.013 -0.002 0.076 0.944 -0.002 0.012 
0.500 0.545 0.077 0.909 0.045 0.014 0.545 0.079 0.912 0.045 0.014 0.499 0.071 0.944 -0.001 0.010 
1.000 1.109 0.084 0.746 0.109 0.026 1.109 0.086 0.744 0.109 0.027 1.002 0.074 0.948 0.002 0.011 
90% 
0.000 0.007 0.170 0.945 0.007 0.059 0.007 0.173 0.937 0.007 0.061 0.007 0.171 0.938 0.007 0.060 
0.500 0.510 0.161 0.947 0.010 0.053 0.509 0.164 0.941 0.009 0.055 0.501 0.161 0.946 0.001 0.053 
1.000 1.091 0.150 0.888 0.091 0.055 1.027 0.152 0.926 0.027 0.049 1.003 0.147 0.937 0.003 0.045 
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Table 3.5b: Comparison of Age Effect on Survival – Time Dependent Age Simulation (N = 1000, Age = 0.050) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.050 0.004 0.941 0.000 0.000 0.050 0.007 0.937 0.000 0.000 0.050 0.007 0.937 0.000 0.000 
0.500 0.050 0.004 0.956 0.000 0.000 0.050 0.007 0.957 0.000 0.000 0.050 0.007 0.957 0.000 0.000 
1.000 0.010 0.004 0.000 -0.040 0.002 0.050 0.008 0.939 0.000 0.000 0.050 0.008 0.939 0.000 0.000 
50% 
0.000 0.050 0.005 0.949 0.000 0.000 0.051 0.010 0.961 0.000 0.000 0.051 0.010 0.961 0.000 0.000 
0.500 0.050 0.005 0.955 0.000 0.000 0.050 0.009 0.957 0.000 0.000 0.050 0.009 0.957 0.000 0.000 
1.000 0.051 0.005 0.949 0.001 0.000 0.050 0.009 0.949 0.000 0.000 0.050 0.009 0.949 0.000 0.000 
90% 
0.000 0.049 0.012 0.950 -0.001 0.000 0.049 0.022 0.960 -0.001 0.001 0.049 0.022 0.960 -0.001 0.001 
0.500 0.050 0.012 0.959 0.000 0.000 0.050 0.021 0.947 0.000 0.001 0.050 0.021 0.947 0.000 0.001 
1.000 0.011 0.010 0.027 -0.039 0.002 0.051 0.019 0.946 0.001 0.001 0.051 0.019 0.946 0.001 0.001 
  PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 0.061 0.005 0.475 0.011 0.000 0.061 0.009 0.796 0.011 0.000 0.050 0.007 0.937 0.000 0.000 
0.500 0.061 0.005 0.488 0.011 0.000 0.060 0.009 0.805 0.010 0.000 0.050 0.007 0.937 0.000 0.000 
1.000 0.012 0.005 0.000 -0.038 0.002 0.062 0.010 0.759 0.012 0.000 0.050 0.008 0.939 0.000 0.000 
50% 
0.000 0.054 0.006 0.906 0.004 0.000 0.054 0.011 0.938 0.004 0.000 0.051 0.010 0.961 0.000 0.000 
0.500 0.055 0.006 0.875 0.005 0.000 0.054 0.010 0.937 0.004 0.000 0.050 0.009 0.957 0.000 0.000 
1.000 0.056 0.006 0.832 0.006 0.000 0.055 0.011 0.924 0.005 0.000 0.050 0.009 0.957 0.000 0.000 
90% 
0.000 0.050 0.012 0.950 0.000 0.000 0.050 0.023 0.959 0.000 0.001 0.049 0.022 0.960 -0.001 0.001 
0.500 0.051 0.012 0.957 0.001 0.000 0.051 0.021 0.943 0.001 0.001 0.050 0.021 0.947 0.000 0.001 
1.000 0.011 0.010 0.034 -0.039 0.002 0.052 0.020 0.947 0.002 0.001 0.051 0.019 0.946 0.001 0.001 
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Table 3.5c: Comparison of Sex Effect on Survival – Time Dependent Age Simulation (N = 1000, Sex = -0.500) 
Scenarios CSP_UNSTRATIFIED CSP_STRATIFIED TDCM 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.500 0.067 0.966 0.000 0.009 -0.500 0.067 0.965 0.000 0.009 -0.500 0.067 0.965 0.000 0.009 
0.500 -0.500 0.067 0.958 0.000 0.009 -0.500 0.068 0.958 0.000 0.009 -0.500 0.068 0.958 0.000 0.009 
1.000 -0.515 0.068 0.933 -0.015 0.010 -0.501 0.069 0.944 -0.001 0.009 -0.501 0.069 0.944 -0.001 0.009 
50% 
0.000 -0.500 0.092 0.954 0.000 0.017 -0.500 0.092 0.949 0.000 0.017 -0.500 0.092 0.949 0.000 0.017 
0.500 -0.503 0.085 0.956 -0.003 0.014 -0.503 0.085 0.957 -0.003 0.014 -0.503 0.085 0.957 -0.003 0.014 
1.000 -0.506 0.086 0.952 -0.006 0.014 -0.506 0.086 0.949 -0.006 0.015 -0.506 0.086 0.949 -0.006 0.015 
90% 
0.000 -0.503 0.208 0.944 -0.003 0.089 -0.503 0.208 0.944 -0.003 0.089 -0.503 0.208 0.944 -0.003 0.089 
0.500 -0.500 0.196 0.951 0.000 0.075 -0.500 0.196 0.953 0.000 0.075 -0.500 0.196 0.953 0.000 0.075 
1.000 -0.506 0.178 0.956 -0.006 0.063 -0.505 0.178 0.958 -0.005 0.063 -0.505 0.178 0.958 -0.005 0.063 
 PLR_UNADJUSTED PLR_ADJUSTED AG 
Censoring 𝜸 Estimate SE CP Bias MSE Estimate SE CP Bias MSE Estimate SE CP Bias MSE 
10% 
0.000 -0.599 0.082 0.798 -0.099 0.023 -0.599 0.083 0.795 -0.099 0.023 -0.500 0.067 0.965 0.000 0.009 
0.500 -0.602 0.084 0.782 -0.102 0.024 -0.602 0.084 0.780 -0.102 0.024 -0.500 0.068 0.958 0.000 0.009 
1.000 -0.639 0.089 0.655 -0.139 0.036 -0.627 0.090 0.720 -0.127 0.032 -0.501 0.069 0.944 -0.001 0.009 
50% 
0.000 -0.532 0.098 0.942 -0.032 0.020 -0.532 0.098 0.943 -0.032 0.020 -0.500 0.092 0.949 0.000 0.017 
0.500 -0.549 0.093 0.919 -0.049 0.019 -0.549 0.093 0.919 -0.049 0.019 -0.503 0.085 0.957 -0.003 0.014 
1.000 -0.559 0.096 0.910 -0.059 0.021 -0.559 0.097 0.911 -0.059 0.022 -0.506 0.086 0.949 -0.006 0.015 
90% 
0.000 -0.509 0.211 0.945 -0.009 0.091 -0.509 0.211 0.944 -0.009 0.091 -0.503 0.208 0.944 -0.003 0.089 
0.500 -0.508 0.199 0.955 -0.008 0.077 -0.508 0.199 0.955 -0.008 0.078 -0.500 0.196 0.953 0.000 0.075 
1.000 -0.516 0.181 0.950 -0.016 0.066 -0.517 0.182 0.945 -0.017 0.066 -0.505 0.178 0.958 -0.005 0.063 
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Table 3.6: Modeling Longitudinal and Survival Data (Framingham Heart Study) 
 𝐀𝐆𝐄 (𝜶𝟏) 𝐒𝐄𝐗 (𝜶𝟐) 𝐋𝐨𝐠𝐓𝐆 (𝜸) 
Methods Estimate SE P Estimate SE P Estimate SE P 
PLR Unadjusted 0.0480 0.0101 <.0001 -1.0179 0.2444 <.0001 0.6023 0.1754 0.0006 
PLR Adjusted 0.0520 0.0119 <.0001 -1.0154 0.2444 <.0001 0.6107 0.1755 0.0005 
CSP Un-stratified 0.0528 0.0103 <.0001 -1.0305 0.2434 <.0001 0.6068 0.1732 0.0005 
CSP Stratified 0.0561 0.0119 <.0001 -1.0254 0.2435 <.0001 0.6182 0.1741 0.0004 
TDCM 0.0561 0.0119 <.0001 -1.0254 0.2435 <.0001 0.6182 0.1741 0.0004 
AG 0.0561 0.0119 <.0001 -1.0254 0.2435 <.0001 0.6182 0.1741 0.0004 
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CHAPTER 4: MEDIATION ANALYSIS WITH LONGITUDINAL AND 
SURVIVAL DATA 
 
4.1 INTRODUCTION 
Mediation analysis is commonly used in epidemiologic and social science research to 
help identify variables in the causal pathway between an exposure and an outcome. A 
common objective in mediation analysis is to explore how a third variable affects the 
relationship between the exposure and outcome variables. These intermediate variables are 
often hypothesized to be linked in the causal chain between the independent and the 
dependent variables (James & Brett, 1984). Baron and Kenny (1986) define a mediator as a 
variable that accounts for all or part of the relationship between a predictor and an outcome. 
More formally, mediation occurs when the relationship between an exposure and an 
outcome can be partially or totally accounted for by an intermediate variable.  
An effect of an exposure that acts through a mediator is called an indirect effect. An 
effect that is not mediated this way is called a direct effect (See Figure 4.1). The intermediate 
variable is often added in the analysis in order to improve the understanding of the 
relationship. Mackinnon and Dwyer (1980) provide a good example in which they evaluate 
programs to reduce drug use and considered target mediators such as resistance skills. They 
hypothesize that a program that increases resistance skills will decrease drug use. In another 
example one may be interested in the effect of a genetic variant on lung cancer and explore 
how the relationship is mediated by nicotine dependence. Although this framework may 
appear simple, the exposure-outcome-mediator system can be complicated as there may be 
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other associations that exist in the system other than mediation. These statistical challenges 
in the system have made the methodology for assessing mediation an active research area. 
The purpose of this study is to conduct a series of simulations to compare the 
accelerated failure time regression using the joint maximum likelihood approach (AFT–joint) 
for modeling longitudinal and survival data to the accelerated failure time regression model 
using the observed longitudinal measures (AFT–observed) in estimating the point and 
variance estimators of the mediated effect measures. The AFT–joint model is implemented 
in a joint framework in modeling the longitudinal measures, genetic variants and the time to 
event occurrence. A linear mixed effects model is used to estimate random effects from the 
longitudinal measures which are then used to obtain predicted values of the mediator. A 
Weibull model under the accelerated failure time formulation is then implemented to obtain 
parameter estimates for the exposure and the mediator. In the AFT–observed model a 
parametric baseline hazard survival regression is performed in which the longitudinal 
measures are considered as time dependent covariate measures.  
We assess the performance of these methods in estimating the mediated effect 
calculated by the product of coefficients method and by difference in coefficients method. 
We consider data from the Framingham Heart Study in which lipid measurements and 
myocardial infarction (MI) data were collected over a period of 26 years (1979–2005). High-
density lipoprotein (HDL), low density lipoprotein (LDL) and triglycerides (TG) were 
measured at generally comparable time intervals over the 26 year period. Time to myocardial 
infarction was also recorded for each participant, although some subjects were censored by 
the end of the study period. We assess the two methods which characterize the extent to 
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which the effect of a genetic variant on myocardial infarction is mediated by the longitudinal 
lipid measures or whether there is also a direct effect of the genetic variant on myocardial 
infarction.  
Mediation analysis has been studied extensively in situations where the outcome is 
quantitative (MacKinnon et al., 1995). In this Chapter, we compare methods which 
characterize the relationship between an exposure (genetic variant) on an outcome (time to 
event occurrence) mediated through an intermediate set of variable (longitudinal measures). 
In Section 4.2 and 4.3 we present an overview of mediation analysis and describe the 
methods for estimating the mediated effect in the context of longitudinal and survival data. 
We describe the standard formulation of these methods. In section 4.4 we apply these 
methods to FHS Data. In Section 4.5, we evaluate these methods using simulation studies 
considering varying scenarios. In Section 4.6 we conclude with some discussion on the 
results from the simulation study and the Framingham Heart Study. 
 
4.2 MEDIATION ANALYSIS IN LONGITUDINAL AND SURVIVAL DATA 
 In this section we consider methods that characterize the relationship between an 
exposure (genetic variant) and an outcome (time to event occurrence) mediated by an 
intermediate variable measured repeatedly (longitudinal measures). We present a framework 
for considering mediation analysis with longitudinal and survival data (Figure 4.2). The 
exposure variable is a SNP (coded as the number of minor alleles); the outcome is the time 
to occurrence of myocardial infarction and the mediator is the set of time dependent 
96 
 
 
 
96 
longitudinal lipid measures. We consider the longitudinal measures to be time dependent 
covariates whose values change at the beginning of each interval when the longitudinal 
measures were taken. We implement the accelerated failure time model, with Y = LogT, as 
there is nonequivalence in the product and difference estimators of the mediated effect when 
the Cox model is applied (Tein and Mackinnon, 2003). We consider two approaches: (1) 
parameter estimation through a joint maximum likelihood of exposure, longitudinal and 
survival data and (2) a time dependent survival model. 
4.2.1 Accelerated Failure Time using Joint Model (AFT–joint) 
The first approach we use is the joint modeling of longitudinal and survival data to 
estimate the mediated effect in the context of accelerated failure time regression with Y = 
Log T. We implement a likelihood model similar to that of Brown and Ibrahim (2003), 
which associates the longitudinal trajectories (mediator) and the genetic variant (exposure) of 
each subject to survival (outcome) data. The longitudinal responses are linked to the time-to-
event model using the random effects in the accelerated failure time regression model. We 
implement a random effect, likelihood model for the longitudinal measurements by 
constructing trajectories for each patient. For the longitudinal measures we consider a time 
dependent covariate with possible measurement error in the observed data. We implement 
the random effects approach presented in equations 1.1 and 1.2. 
We apply a linear mixed effects model (LME), which allows individual or subject-
specific inference by Laird and Ware, to fit data from longitudinal response processes. 
 𝑌!"∗ = 𝑈!! +  𝑈!! ∗ 𝑡!" + 𝛼!! ∗ 𝐴𝑔𝑒! + 𝛽!𝑆𝑁𝑃! (4.1) 
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Here 𝑈!! and 𝑈!! represent the subject-specific intercepts and slopes, assumed to be 
normally distributed. The 𝑡!"  represent the times when the longitudinal measures were taken 
during the follow-up period. The SNP, codes as the number of minor allele frequency (0, 1, 
2), measures the genetic variation at a specific locus for each subject and is time invariant. 
The parameter 𝛽! is a measure of the effect of the SNP on the longitudinal measures. The 
parameter estimate 𝛼!! is a measure of the baseline Age effect on the longitudinal measures.  
For the survival part we consider a parametric accelerated failure time survival 
regression model which associates the survival times to the predicted values of the 
longitudinal measures, the SNP and the covariates of interest. One can describe this 
relationship by using the Weibull model, expressed as a log linear model. The accelerated 
failure model is considered multiplicative in terms of T and additive in terms of Log T. 
𝑙𝑜𝑔 𝑡! =  𝜇 + 𝛼!" ∗ 𝐴𝑔𝑒! + 𝛼!! ∗ 𝑆𝑒𝑥! + 𝛽! ∗ 𝑆𝑁𝑃! + 𝛾𝑌!∗ 𝑡! + 𝜎𝜀!! (4.2) 
The parameter 𝛾 is the association parameter which links the estimated longitudinal 
trajectories 𝑌!∗ at times 𝑡! to the survival times. The regression parameters 𝛼!" and 𝛼!! are 
the regression coefficients of the Age and Sex effects on the survival times. The 
parameter 𝜇 is the intercept and σ is the scalar parameter for a Weibull model. The 
parameter 𝛽! is the adjusted effect of the SNP on the survival times. This parameter is also 
known as the direct effect. Equation (4.2) is analogous to (1.16) as these equations measure 
the direct effect of the exposure on the outcome.  
𝑙𝑜𝑔 𝑡! =  𝜇 + 𝛼!" ∗ Age! + 𝛼!" ∗ Sex! + 𝛽! ∗ SNP! + σε!! (4.3) 
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In equation 4.6 the parameter 𝛽! is the unadjusted effect of the SNP on the survival times. 
This is analogous to (1.15) as it estimates the total effect of the exposure on the outcome. If 
we let 𝑌 = 𝑙𝑜𝑔 𝑡!  then the underlying probability distribution for 𝑌 can written as: 
𝑓! 𝑦! =  1/𝜎 ∗ exp 𝑦! − 𝑍!𝜎 − e !!!!!!    (4.4) 
 
𝑆! 𝑦! =  exp −e !!!!!!    𝑤ℎ𝑒𝑟𝑒  𝑍! = 𝜇 + 𝛼!" ∗ 𝐴𝑔𝑒! + 𝛼!" ∗ 𝑆𝑒𝑥! + 𝛽! ∗ 𝑆𝑁𝑃! . 
(4.5) 
 
The likelihood function for the survival data assuming right censored data can be written as: 
𝐿 =  𝑓! 𝑦! !! ∗ 𝑆! 𝑦! !!!!!!!!  (4.6)  
We implement Rizopoulos’ joint maximum likelihood approach (Rizopoulos, 2010) 
in an accelerated failure time framework, using a Weibull model, to estimate the likelihood 
specified in (4.6). This approach implements a Weibull accelerated failure time regression 
model and uses the Gauss-Hermite integration rule to approximate the integral. In the 
estimation process a hybrid optimization approach is employed, starting with the EM 
Algorithm and then continues with direct maximization. The accelerated failure time models 
within the joint modeling framework are also discussed extensively by Tseng, Hsieh, and 
Wang (2005). They implement a procedure based on maximizing the joint likelihood 
function where random effects are treated as missing data. They applied a Monte Carlo EM 
algorithm to estimate all the unknown parameters in (4.6), including the unknown baseline 
hazard function. 
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4.2.2 Accelerated Failure Time with time dependent measures (AFT–observed) 
The second approach we use is the accelerated failure time regression model with 
time dependent covariates implemented in R (eha package) by Broström. This model 
assumes a parametric baseline hazard and allows for stratification with different scale and 
shape parameters in each stratum. The model specification is similar to equations (4.1), (4.2) 
and (4.3). The main difference is that instead of using the joint estimation with predicted 
longitudinal measures 𝑌!∗ 𝑡!  in equation (4.2), we use the observed longitudinal measures at 
each exam 𝑌!" 𝑡!" . Equation (4.2) can be written in the context of AFT with time 
dependent covariate measures as: 
𝑙𝑜𝑔 𝑡!" =  𝜇 + 𝛼!" ∗ Age! + 𝛼!! ∗ Sex! + 𝛽! ∗ SNP! + 𝜸𝑌!" 𝑡!" + σε!! (4.7) 
The variable 𝑡!"  represents the survival time of the 𝑖!! subject at each interval 𝑗. The 
variable 𝑌!"  represents the longitudinal measure of the  𝑖!! subject at the beginning of 
the 𝑗!! interval. The data setup is similar to the Andersen and Gill approach (1982).  The 
model is formulated as a counting process in which events for subjects are observed as time 
marches onwards. In this approach multiple records are created for each subject, one record 
for each distinct interval of the time dependent measurements. Each record contains a start 
value and a stop value representing the time interval during which the values of the 
explanatory variables remain unchanged. Each record also contains the event status at the 
stop time. The event is the time dependent version of the event indicator variable, which 
equals 1 only in the time period during which the event occurs.  
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We compare the AFT–joint and AFT–observed models in estimating of the 
mediated effect. The framework for considering mediation analysis in longitudinal and 
survival is presented in Figure 4.2. Using equations (4.1), (4.2) and (4.3) the mediated effect 
for the AFT–joint model can be computed with the product (𝛽! ∗ 𝛾) and the difference (𝛽! 
– 𝛽!). The mediated effect for the AFT–observed model can be computed using equations 
(4.1), (4.2) and (4.7). We assess the performance of these methods in estimating the point 
and stand error estimates of the mediated effect measures. 
 
4.3 SIMULATION STUDY 
In this section, we conduct a series of simulations to evaluate and assess the 
performance of the methods described in Section 4.3. We assess the performance of these 
methods in terms of bias using point and variance estimates of the mediated effect. We 
simulate longitudinal and survival data to resemble data from the FHS. The longitudinal 
trajectories were generated from a linear model adjusting for the age of the participants at 
baseline. The log survival time was generated to depend on the longitudinal measures and a 
set of covariates (Age and Sex). We simulated 1000 independent multivariate datasets 
consisting of SNPs, longitudinal measures, log survival times and covariates. Below we 
describe an algorithm used to generate the longitudinal and survival data. We generated the 
longitudinal data using Steps 1 to 6 and the survival data using Step 7 to 8 in the following 
sequence: 
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4.3.1 Longitudinal Data Generation 
1. Parameter estimates of the mean and variance-covariance matrix 𝐺  of the random 
effects, covariance matrix and residual errors are obtained by fitting a random effects 
model to the FHS data. The residual variance σ! is obtained from the model (See 
Table 2.1). 
2. Generate random effects (𝑈!! ,𝑈!!) from a bivariate normal distribution with mean 
and variance-covariance 𝐺  obtained in step 1. The random effects (𝑈!! ,𝑈!!) 
represent the intercept and slope. 
3. Generate baseline covariates similar to FHS: Age~N(35, 5) and Sex~rbern(0.54)  
4. Generate SNP data using the Hardy Weinberg equilibrium (HWE) equation: 𝑝! + 2𝑝𝑞 + 𝑞! = 1 (4.11) 
The variable 𝑝 is the frequency of a minor allele and 𝑞 as the frequency of the major 
allele for a given SNP. If we consider A to be a major allele and a to be a minor allele 
then genotype AA refers to homozygous major and Aa heterozygous. Under HWE, 𝑝! is the predicted frequency of the homozygous major (AA) proportion in the 
population, 2𝑝𝑞 is the predicted frequency of heterozygous (Aa) proportion and 𝑞! 
is the frequency of homozygous minor allele proportion. By specifying 𝑝 and 𝑞 one 
can determine the predicted frequency of all three genotypes for a given trait within a 
population. Using a uniform distribution we assign at random the number of minor 
alleles of each individual in the population. We considered two scenarios for the 
minor allele frequency in the population (5% and 50%).  
102 
 
 
 
102 
5. Generate the longitudinal trajectories 𝜑! 𝑡!"  for each subject 𝑖 = 1, 2,… ,𝑛  
and for each time point 𝑗 = 1, 2,… ,𝑚!  using the linear model: 𝜑! 𝑡!"  =  𝑈!! +  𝑈!! ∗ 𝑡!" + 𝛼!! ∗ 𝐴𝑔𝑒! + 𝛽!𝑆𝑁𝑃! 
6. Generate the observed longitudinal measures 𝑌  from a multivariate normal with 
mean 𝜑! 𝑡!"  and variance 𝑉 : 𝑉 = 𝑍!𝐺𝑍!! + 𝑅!  𝑎𝑛𝑑 𝑅!  ~ 𝑑𝑖𝑎𝑔𝑚𝑎𝑡𝑟𝑖𝑥 σ!  
 
4.3.2 Survival Data Generation 
7. Choose values for the parameter estimates for Age (0.050), Sex (-0.500), SNP (0.050, 
0.500) and the association parameter (0.000, 0.500, 1.000) which measures the 
strength of the association between the longitudinal measures and the time-to-event. 
8. Generate the log of the survival time log(T) from an accelerated failure time Weibull 
for each time period in which the longitudinal measures were taken. 𝑙𝑜𝑔 𝑡!" =  𝜇 + 𝛼!" ∗ Age! + 𝛼!! ∗ Sex! + 𝛽! ∗ SNP! + 𝜸𝑌!" 𝑡!" + σε!! 
The survival times are generated at each interval to depend on the observed longitudinal 
measures at the beginning of the interval and a set of covariates. If an individual has an event 
in a particular interval all subsequent intervals for the individual are excluded from the 
analysis. The overall survival time for each participant can be computed by summing the 
survival times across the intervals until the event occurs. We considered two different event 
rates in the simulation analysis (10% and 90%). We fit the following methods to each of the 
1000 replicates: (1) Accelerated failure time regression model using the observed time 
dependent longitudinal measures (AFT–observed) and (2) Accelerated failure time regression 
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using the joint maximum likelihood approach (AFT–joint). As mentioned earlier, the Age 
variable is considered a time varying covariate in the AFT–observed method. A time 
variable, coded as the log of the times (0, 5, 10, 15, 20, 25), is also included in the AFT–
observed model to adjust for the time intervals in which the longitudinal measures were 
recorded. In the AFT–joint approach the baseline Age variable is included in the model. We 
assess the performance of these methods in estimating the mediated effect calculated by the 
product and by difference in coefficients method. 
 
4.4 SIMULATION RESULTS 
In this section we present results from the simulation studies for the methods 
described in section 4.2, focusing on the mediated effect estimates. We varied the event rate 
(10%, 90%), SNP effect on the longitudinal measures (0.050, 0.500), SNP effect on survival 
(0.500, 1.000), association parameter (0.000, 0.500, 1.000), minor allele frequency (MAF = 
5%, 50%) and sample size (N = 100, 1000). The Age effect in the longitudinal and survival 
model (0.050) was fixed in all simulations considered. The Sex effect in the survival model (-
0.500) was also fixed in all the simulations considered.  
In Table 4.1 we present the results for N = 100, event rate of 10% and a MAF of 
50%. For 1000 replicates, we compared the average point estimate of the mediated effect 
and the standard errors for the AFT–observed model and the AFT–joint models and 
evaluated their bias. The mediated effect for the product and the difference were estimated 
in both models. All estimates for the mediated effect are biased downwards. We see that 
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when there is mediation the product method provides higher (less biased) estimates 
compared to the difference method. For example, in Table 4.1, we consider the case when N 
= 100, event rate = 10% and minor allele frequency (MAF) is 50%. When the SNP effect on 
the longitudinal is 0.500 (β1) and the SNP effect on the survival is 1.000 (β2) the true 
mediated effect is 0.500; using the product method for the AFT–observed model the 
mediated effect is 0.345 (SE = 0.172) and the difference method is 0.288 (SE = 0.188). The 
standard errors for the difference method are generally higher compared to the product 
method. When we applied the AFT–joint model for this scenario we obtained a product 
mediated effect of 0.357 (SE = 0.182) and a difference mediated effect of 0.186 (SE = 
0.177). The AFT–joint model product approach provided the largest mediated effect with 
less bias compared to the difference in this scenario. The absolute difference between the 
product and the difference methods in the AFT–joint model was larger compared to the 
AFT–observed model.  
In Table 4.2 we examined the scenario with MAF to 5%; both the AFT–joint and 
the AFT–observed model underestimate the mediated effect. For the AFT–observed model 
the standard errors for the difference are higher compared to the product method, as seen 
earlier. The AFT–joint product provides higher estimates for the mediated effect compared 
to the other three methods (AFT–observed difference, AFT–observed product and AFT–
joint difference). In both models the product method provides better estimates (closer to the 
truth) compared to the difference. When there is no mediated effect (𝛽! ∗ 𝛾 = 0), the AFT–
observed models for the product and difference provide similar results. 
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In Table 4.3 we varied the event rate to 90% and consider the different scenarios 
specified earlier. The bias in the mediated effect is higher compared to the case when the 
event rate is 10%. With a MAF of 50% the product method for the AFT–joint product 
model provides more reliable estimates with less bias compared to the other methods. For 
example when the SNP effect on the longitudinal is 0.500, SNP effect on survival is 0.500 
and the mediated effect is 0.500 the AFT–joint model using the product provides a mediated 
effect of 0.271 (SE = 0.072). The mediated effect for the difference using the AFT–joint 
model is 0.179 (SE = 0.058); the AFT–observed product mediated effect is 0.123 (SE = 
0.036) and the AFT–observed difference mediated effect is 0.094 (SE = 0.032). As seen 
earlier the mediated effect is underestimated in all these models. 
In Table 4.4 we present results when the event rate is 90% and the MAF is 5%. We 
see that the AFT–joint product provides more reliable estimates compared to the other 
methods. Also the AFT–observed product yields larger mediated effects compared to the 
AFT–observed difference method. When there is no mediated effect the AFT–observed 
product and difference methods provide similar results. With higher event rates (90%) the 
absolute bias in the mediated effect is higher compared to the case when the event rate is 
lower (10%). For example, when SNP effect on the longitudinal is 0.500 and the effect on 
survival is 1.000, the estimated mediated effect for the AFT–joint product is 0.268 (SE = 
0.116) compared to the estimate 0.133 for the difference method. The mediated effect for 
the product method of the AFT–observed model is 0.112 (SE = 0.052) compared to AFT 
difference of 0.082 (SE = 0.050). We see that the mediated effect is more attenuated with 
higher event rate in all the models considered. 
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When we increased the sample to 1000 we see similar patterns in the results for the 
different scenarios (Appendix Table A4 – A7). All four models underestimated the mediated 
effect, as seen earlier. The AFT–joint product model provided the highest (least biased) 
estimate in the mediated effect. In some scenarios the AFT–joint difference provided a 
negative value for the mediated effect. This occurred in instances when the SNP effect on 
the mediator (longitudinal measures) was small. The AFT–observed product and difference 
methods show similar results in all scenarios considered. With a larger sample size (N = 
1000) the standard errors for the AFT–observed product and difference were almost 
identical. The standard errors for the mediated effect were smaller with larger sample size, as 
expected.  
 
4.5 APPLICATION TO FRAMINGHAM HEART STUDY (FHS) 
We considered FHS data in which lipid measurements and myocardial infarction 
(MI) data were collected over a period of 26 years (1979 – 2005). Among the offspring 
participants, high-density lipoprotein (HDL), low density lipoprotein (LDL) and triglycerides 
(TG) were measured at fairly similar time intervals over a period of 26 years. The time to 
myocardial infarction was recorded for each participant, although some subjects were 
censored by the end of the study period and some individuals dropped out due to death. We 
log transformed the TG measures in our analysis to reduce skewness in TG measures. A 
total of 2262 subjects with complete data were followed from 1979 to 2005 and data were 
collected at the start of each exam (Table 2.6). We also log transformed the time to MI in 
order to implement the accelerated failure time parametric model. We considered 32 distinct 
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SNPs, published by Kathiresan et al. in Nature Genetics (2009), as the exposure variables in 
the mediation model. These 32 SNPs were common SNPs (minor allele frequency > 1%) 
associated with blood lipoprotein concentrations. In their paper they conducted a meta-
analysis of seven genome-wide association studies (GWAS) of lipid phenotypes. FHS 
represented the largest GWAS sample. The minor allele of each SNP was modeled as 
additive; thus the effect size 𝛽! represents the difference in the lipid levels per copy of the 
minor allele. 
Using the methods described in section 4.2 we characterize the mediated effect of 
TG measures on the relationship between the 32 SNPs and time to myocardial infarction in 
FHS Data. We used the longitudinal log TG as the mediator in the model and assume a 
linear trend. We adjusted for Sex and Age in all the models. The variable Sex is considered to 
be a fixed covariate at each exam in the AFT–joint and AFT–observed models. In the AFT–
observed approach the Age variable is included in the model as a time varying covariate; the 
data structure in the model is multiple rows per subject where each row is considered a mini-
follow up study in which the current risk factors are updated to predict events in the interval. 
A time variable, coded as log of the times when the potential mediated longitudinal measures 
were recorded, was included in the model to adjust for the time intervals in which the 
longitudinal measures were recorded. In the AFT–joint approach the baseline Age variable is 
included in the model; the data structure is a single row per subject where the overall 
survival/censoring time is specified for each subject. We assess the results of these methods 
in estimating the mediated effect calculated by the product of coefficients method and by the 
difference in coefficients method. 
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We analyzed the 32 SNPs associated with lipid measures and present a plot of 
mediated effect using the product and difference methods (Figure 4.3). The AFT–observed 
product and AFT–joint product show strong correlation as the plots lie close to a line, 
noting the scale differences for the methods. The AFT–joint methods overall provide higher 
estimates for the mediated effect compared to the AFT-observed. The AFT–joint difference 
approach seems to provide results different from the three other methods. In Table 4.5 we 
present the results for the AFT models for all 32 SNPs, implementing the Sobel method to 
determine the standard error for the mediated effect. The AFT–observed model seems to 
provide similar results in magnitude and direction, for the product and the difference, for 
most of the SNPs. SNP rs12678919 also showed a product mediated effect of -0.026 and a 
difference mediated effect of -0.035 (SE = 0.007, P = 0.000). The largest product effect is 
seen in SNP rs964184 which has a product effect of 0.046 and a difference effect of 0.056 
(SE = 0.004 and P = 0.000). SNP rs714052 showed a product effect of -0.020 and a 
difference of -0.027 (SE = 0.006 and P = 0.001). For several SNPs the difference method 
had higher estimates compared to the product method (AFT–observed models).  The effect 
of the longitudinal measures (γ) on the time to MI was fairly consistent across the 32 SNPs 
with effect sizes ranging from 0.213 – 0.225. For some SNPs the magnitude of the direct 
effect (𝛽!) was higher than the magnitude of the total effect (𝛽!) thus yielding a negative 
value in the mediated effect.  
We present the results for the mediated effect using the AFT–joint model in Table 
4.6. As we saw in Chapter 2 the parameter estimate for the link, a measure of the association 
between the longitudinal and survival data, was higher in the AFT–joint model compared to 
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the model which uses the observed longitudinal measures. The magnitude and direction of 
the mediated effect seems to be different for the product and the difference methods. SNP 
rs964184, which had the highest mediated effect in the AFT–observed model, showed a 
mediated product effect of 0.131 and a difference of 0.176 (SE = 0.039, P < 0.001). The 
AFT–joint model also showed negative mediated effects with the direct effect larger than the 
total effect. Overall the AFT–joint model provided larger mediated effects and Sobel 
standard errors compared to the AFT–observed model. 
 
4.6 CONCLUSION AND DISCUSSION 
In this Chapter we explored the concept of mediation analysis in the context of 
longitudinal and survival data. In this framework the exposure variable is a genetic marker; 
the mediator is considered to be a set of time dependent longitudinal measures; the outcome 
is survival times of subjects in the study. We employed an accelerated failure time model as 
there is nonequivalence in the product and difference of the mediated effect when the Cox 
model is applied. We examined the accelerated failure time model using a joint maximum 
likelihood approach (AFT–joint) and an accelerated failure time regression model using the 
observed longitudinal measures (AFT–observed) to obtain the point and variance estimates 
of the mediated effect. We applied these methods to real data (FHS) to estimate the point 
and standard error estimates of the mediated effect.  
A series of simulations were conducted to compare estimates of mediation from the 
joint maximum likelihood approach (AFT–joint) to those from the accelerated failure time 
regression model using the observed longitudinal measures (AFT–observed). The AFT–joint 
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model was implemented in a joint framework in modeling the longitudinal measures, genetic 
variants and the time to event occurrence. A linear mixed effect model was used to estimate 
random effects from the longitudinal measures which are then used to obtain predicted 
values of the potential mediator. A Weibull model under the accelerated failure time 
formulation was then implemented to obtain parameter estimates for the exposure and the 
mediator. In the AFT–observed a parametric baseline hazard survival regression was 
performed in which the longitudinal measures were considered as time dependent covariate 
measures. We applied the product and difference methods in estimating the mediated effects 
in both models. 
Based on the simulation results all four estimators (AFT–observed product, AFT–
observed difference, AFT–joint product and AFT–joint difference) underestimated the 
mediated effect. The AFT–joint product model had the least biased estimate of the mediated 
effect compared to the other three models when the event rate was high. The AFT–
observed product and difference methods showed similar estimates of the mediated effect in 
most of the models, especially when a large sample was employed. The mediated effect 
estimates for the AFT–joint difference were more biased compared to the AFT–joint 
product. When we used a large sample size (N = 1000) several AFT–joint difference models 
had a negative mediated effect especially in models when the SNP effect on the mediator 
was small. The real data (FHS) showed similar pattern in the results for all four models. 
Tein and Mackinnon (2003) showed that in survival analysis under the condition of 
no censored data and no time dependent mediators, the difference between the product and 
the difference methods were negligible using the AFT in SAS. We examined the bias of the 
mediated effect in longitudinal and survival data setting under the condition of censored data 
111 
 
 
 
111 
and a time dependent mediator. The results suggest that the AFT–joint model implemented 
in a joint Weibull accelerated failure time fashion shows nonequivalence in the product and 
difference estimators of the mediated effect. The AFT–observed model provides similar 
estimates in the product and the difference especially in instances with larger sample sizes. 
We see that all four models underestimate the mediated effect. In the future we plan to 
examine models that may yield unbiased estimates in the mediated effect in longitudinal and 
survival data with time dependent mediated variables.  
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4.7 TABLES AND FIGURES 
Figure 4.1: Statistical Mediation Model 
 
 
 
 
Figure 4.2: Mediation in Longitudinal and Survival Data 
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Table 4.1: Mediated Effect in Longitudinal and Survival Data (N = 100, Event Rate = 10%, MAF = 50%) 
Scenarios True Estimates 
AFT–observed  Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 50% 0.050 0.500 0.000 0.026 -0.006 0.051 -0.002 0.024 0.017 0.080 
0.000 0.000 0.050 -0.500 50% 0.050 1.000 0.001 0.027 -0.008 0.051 -0.001 0.026 0.029 0.122 
0.000 0.000 0.050 -0.500 50% 0.500 0.500 0.002 0.126 -0.003 0.128 -0.010 0.123 0.000 0.077 
0.000 0.000 0.050 -0.500 50% 0.500 1.000 -0.009 0.157 -0.021 0.177 -0.018 0.142 0.015 0.097 
0.025 0.500 0.050 -0.500 50% 0.050 0.500 0.018 0.042 0.002 0.095 0.018 0.042 -0.055 0.094 
0.025 0.500 0.050 -0.500 50% 0.050 1.000 0.019 0.039 0.000 0.094 0.020 0.041 -0.088 0.126 
0.250 0.500 0.050 -0.500 50% 0.500 0.500 0.206 0.148 0.189 0.137 0.210 0.153 0.119 0.103 
0.250 0.500 0.050 -0.500 50% 0.500 1.000 0.206 0.169 0.171 0.162 0.210 0.177 0.080 0.121 
0.050 1.000 0.050 -0.500 50% 0.050 0.500 0.035 0.057 0.007 0.099 0.037 0.062 -0.057 0.106 
0.050 1.000 0.050 -0.500 50% 0.050 1.000 0.030 0.053 -0.012 0.124 0.032 0.056 -0.122 0.377 
0.500 1.000 0.050 -0.500 50% 0.500 0.500 0.319 0.124 0.281 0.125 0.351 0.153 0.204 0.129 
0.500 1.000 0.050 -0.500 50% 0.500 1.000 0.345 0.172 0.288 0.188 0.357 0.182 0.186 0.177 
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Table 4.2: Mediated Effect in Longitudinal and Survival Data (N = 100, Event Rate = 10%, MAF = 5%) 
Scenarios True Estimates 
AFT–observed  Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 5% 0.050 0.500 -0.003 0.049 -0.003 0.077 -0.006 0.042 0.022 0.075 
0.000 0.000 0.050 -0.500 5% 0.050 1.000 0.005 0.037 -0.006 0.060 -0.001 0.036 0.013 0.063 
0.000 0.000 0.050 -0.500 5% 0.500 0.500 -0.001 0.131 0.005 0.141 -0.010 0.129 0.016 0.130 
0.000 0.000 0.050 -0.500 5% 0.500 1.000 -0.023 0.134 -0.029 0.145 -0.018 0.165 -0.006 0.119 
0.025 0.500 0.050 -0.500 5% 0.050 0.500 0.020 0.091 0.005 0.129 0.007 0.100 0.013 0.141 
0.025 0.500 0.050 -0.500 5% 0.050 1.000 0.005 0.101 0.008 0.142 0.016 0.106 0.007 0.163 
0.250 0.500 0.050 -0.500 5% 0.500 0.500 0.209 0.145 0.192 0.157 0.202 0.140 0.202 0.158 
0.250 0.500 0.050 -0.500 5% 0.500 1.000 0.212 0.128 0.176 0.181 0.195 0.137 0.168 0.143 
0.050 1.000 0.050 -0.500 5% 0.050 0.500 0.037 0.148 -0.017 0.213 0.002 0.144 -0.002 0.196 
0.050 1.000 0.050 -0.500 5% 0.050 1.000 0.040 0.139 -0.046 0.231 -0.008 0.149 -0.051 0.226 
0.500 1.000 0.050 -0.500 5% 0.500 0.500 0.371 0.222 0.253 0.251 0.330 0.197 0.261 0.232 
0.500 1.000 0.050 -0.500 5% 0.500 1.000 0.345 0.188 0.265 0.290 0.337 0.202 0.269 0.261 
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Table 4.3: Mediated Effect in Longitudinal and Survival Data (N = 100, Event Rate = 90%, MAF = 50%) 
Scenarios True Estimates 
AFT–observed Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 50% 0.050 0.500 0.000 0.005 -0.001 0.006 0.000 0.009 -0.001 0.011 
0.000 0.000 0.050 -0.500 50% 0.050 1.000 0.000 0.005 -0.002 0.008 0.000 0.009 0.001 0.019 
0.000 0.000 0.050 -0.500 50% 0.500 0.500 -0.001 0.028 -0.002 0.029 -0.003 0.047 -0.002 0.037 
0.000 0.000 0.050 -0.500 50% 0.500 1.000 0.000 0.032 -0.002 0.033 -0.004 0.051 -0.004 0.032 
0.025 0.500 0.050 -0.500 50% 0.050 0.500 0.006 0.011 0.001 0.013 0.015 0.024 -0.016 0.033 
0.025 0.500 0.050 -0.500 50% 0.050 1.000 0.007 0.012 -0.005 0.016 0.015 0.024 -0.037 0.034 
0.250 0.500 0.050 -0.500 50% 0.500 0.500 0.068 0.030 0.059 0.026 0.145 0.058 0.100 0.044 
0.250 0.500 0.050 -0.500 50% 0.500 1.000 0.072 0.034 0.058 0.027 0.139 0.059 0.075 0.037 
0.050 1.000 0.050 -0.500 50% 0.050 0.500 0.012 0.019 -0.005 0.021 0.027 0.042 -0.028 0.045 
0.050 1.000 0.050 -0.500 50% 0.050 1.000 0.013 0.020 -0.018 0.026 0.028 0.043 -0.070 0.054 
0.500 1.000 0.050 -0.500 50% 0.500 0.500 0.123 0.036 0.094 0.032 0.271 0.072 0.179 0.058 
0.500 1.000 0.050 -0.500 50% 0.500 1.000 0.127 0.036 0.088 0.031 0.267 0.066 0.142 0.125 
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Table 4.4: Mediated Effect in Longitudinal and Survival Data (N = 100, Event Rate = 90%, MAF = 5%) 
Scenarios True Estimates 
AFT–observed Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 5% 0.050 0.500 0.000 0.009 0.000 0.011 0.001 0.017 0.007 0.025 
0.000 0.000 0.050 -0.500 5% 0.050 1.000 0.000 0.010 -0.001 0.011 -0.001 0.018 0.015 0.036 
0.000 0.000 0.050 -0.500 5% 0.500 0.500 -0.001 0.029 -0.002 0.030 -0.003 0.049 0.004 0.042 
0.000 0.000 0.050 -0.500 5% 0.500 1.000 0.000 0.027 -0.001 0.029 -0.002 0.050 0.013 0.038 
0.025 0.500 0.050 -0.500 5% 0.050 0.500 0.006 0.025 0.003 0.030 0.013 0.056 -0.007 0.069 
0.025 0.500 0.050 -0.500 5% 0.050 1.000 0.005 0.023 -0.003 0.026 0.011 0.052 -0.040 0.063 
0.250 0.500 0.050 -0.500 5% 0.500 0.500 0.061 0.035 0.055 0.035 0.142 0.074 0.108 0.071 
0.250 0.500 0.050 -0.500 5% 0.500 1.000 0.058 0.034 0.047 0.033 0.136 0.077 0.064 0.285 
0.050 1.000 0.050 -0.500 5% 0.050 0.500 0.012 0.042 -0.001 0.047 0.029 0.101 -0.023 0.102 
0.050 1.000 0.050 -0.500 5% 0.050 1.000 0.010 0.043 -0.014 0.046 0.022 0.100 -0.074 0.104 
0.500 1.000 0.050 -0.500 5% 0.500 0.500 0.114 0.050 0.093 0.051 0.268 0.118 0.178 0.110 
0.500 1.000 0.050 -0.500 5% 0.500 1.000 0.112 0.052 0.082 0.050 0.268 0.116 0.133 0.106 
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Table 4.5: Mediated Effect in FHS Data (AFT–observed Regression Model)  
SNP MAF 𝜷𝟑 𝜷𝟐 𝜷𝟏 𝜸 𝜷𝟏 ∗ 𝜸 𝜷𝟑 − 𝜷𝟐 Sobel SE P (Prod.) P (Diff.) 
rs10889353 0.300 0.018 0.022 -0.035 0.220 -0.008 -0.004 0.004 0.037 0.315 
rs11206510 0.162 -0.070 -0.062 -0.018 0.218 -0.004 -0.008 0.005 0.422 0.113 
rs12740374 0.244 -0.011 -0.009 -0.028 0.219 -0.006 -0.001 0.004 0.167 0.739 
rs4846914 0.405 -0.018 -0.025 0.033 0.220 0.007 0.008 0.004 0.047 0.037 
rs1260326 0.442 -0.050 -0.065 0.066 0.225 0.015 0.014 0.004 0.000 0.000 
rs515135 0.184 0.078 0.071 -0.007 0.216 -0.002 0.007 0.004 0.706 0.087 
rs6544713 0.317 -0.020 -0.023 0.007 0.220 0.002 0.003 0.004 0.683 0.408 
rs7557067 0.207 0.060 0.062 -0.030 0.218 -0.006 -0.001 0.004 0.125 0.726 
rs1501908 0.355 -0.001 0.001 0.003 0.219 0.001 -0.002 0.003 0.844 0.510 
rs3846663 0.354 -0.035 -0.036 0.003 0.219 0.001 0.001 0.003 0.847 0.711 
rs714052 0.114 0.026 0.053 -0.089 0.223 -0.020 -0.027 0.006 0.001 0.000 
rs12678919 0.062 -0.044 -0.009 -0.121 0.218 -0.026 -0.035 0.007 0.000 0.000 
rs2954029 0.435 0.021 0.032 -0.051 0.222 -0.011 -0.011 0.004 0.003 0.004 
rs7819412 0.471 0.125 0.131 -0.009 0.226 -0.002 -0.005 0.003 0.570 0.136 
rs1883025 0.259 0.011 0.007 0.003 0.219 0.001 0.005 0.004 0.869 0.250 
rs471364 0.150 -0.264 -0.261 -0.033 0.220 -0.007 -0.003 0.005 0.160 0.537 
rs174547 0.339 -0.083 -0.087 0.027 0.222 0.006 0.004 0.004 0.108 0.255 
rs964184 0.149 -0.003 -0.060 0.199 0.233 0.046 0.056 0.009 0.000 0.000 
rs2338104 0.529 0.097 0.095 0.008 0.219 0.002 0.003 0.003 0.594 0.410 
rs2650000 0.374 0.020 0.021 0.007 0.219 0.002 -0.001 0.003 0.640 0.803 
rs10468017 0.349 0.093 0.089 0.027 0.218 0.006 0.004 0.004 0.126 0.291 
rs173539 0.312 0.021 0.033 -0.030 0.222 -0.007 -0.012 0.004 0.098 0.002 
rs2271293 0.104 0.137 0.142 -0.027 0.221 -0.006 -0.005 0.006 0.285 0.384 
rs4939883 0.224 -0.019 -0.009 -0.026 0.219 -0.006 -0.010 0.005 0.219 0.034 
rs10401969 0.057 -0.058 -0.027 -0.074 0.219 -0.016 -0.031 0.008 0.041 0.000 
rs17216525 0.069 -0.052 -0.029 -0.065 0.218 -0.014 -0.023 0.007 0.034 0.000 
rs2967605 0.164 0.243 0.231 0.068 0.213 0.015 0.013 0.007 0.038 0.074 
rs4420638 0.162 -0.132 -0.158 0.064 0.222 0.014 0.026 0.012 0.224 0.024 
rs6511720 0.091 0.041 0.069 -0.091 0.222 -0.020 -0.029 0.009 0.027 0.002 
rs1800961 0.056 0.242 0.226 0.001 0.217 0.000 0.017 0.017 0.988 0.327 
rs6102059 0.292 -0.133 -0.124 -0.023 0.214 -0.005 -0.010 0.004 0.175 0.008 
rs7679 0.160 -0.175 -0.177 0.011 0.218 0.002 0.002 0.004 0.592 0.729 
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Table 4.6: Mediated Effect in FHS Data (AFT–joint Model) 
SNP MAF 𝜷𝟑 𝜷𝟐 𝜷𝟏 𝜸 𝜷𝟏 ∗ 𝜸 𝜷𝟑 − 𝜷𝟐 Sobel SE P (Prod.) P (Diff.) 
rs10889353 0.300 -0.044 -0.027 -0.035 0.560 -0.020 -0.016 0.011 0.062 0.125 
rs11206510 0.162 0.062 0.079 -0.018 0.565 -0.010 -0.017 0.013 0.430 0.187 
rs12740374 0.244 -0.049 -0.039 -0.028 0.574 -0.016 -0.010 0.012 0.188 0.404 
rs4846914 0.405 -0.031 -0.054 0.033 0.581 0.019 0.023 0.011 0.071 0.026 
rs1260326 0.442 -0.056 -0.106 0.066 0.580 0.038 0.050 0.014 0.006 0.000 
rs515135 0.184 0.133 0.125 -0.007 0.570 -0.004 0.008 0.011 0.707 0.461 
rs6544713 0.317 -0.048 -0.060 0.007 0.576 0.004 0.012 0.010 0.684 0.216 
rs7557067 0.207 0.082 0.092 -0.030 0.573 -0.017 -0.010 0.012 0.149 0.398 
rs1501908 0.355 -0.010 -0.015 0.003 0.554 0.002 0.005 0.009 0.844 0.594 
rs3846663 0.354 -0.029 -0.041 0.003 0.563 0.002 0.012 0.009 0.847 0.193 
rs714052 0.114 0.096 0.175 -0.089 0.577 -0.051 -0.079 0.020 0.010 0.000 
rs12678919 0.062 -0.099 -0.012 -0.121 0.572 -0.069 -0.087 0.025 0.005 0.000 
rs2954029 0.435 -0.005 0.025 -0.051 0.575 -0.029 -0.031 0.012 0.016 0.011 
rs7819412 0.471 0.188 0.226 -0.009 0.612 -0.005 -0.038 0.009 0.573 0.000 
rs1883025 0.259 -0.032 -0.052 0.003 0.582 0.002 0.020 0.011 0.869 0.060 
rs471364 0.150 -0.357 -0.385 -0.033 0.586 -0.020 0.028 0.015 0.182 0.054 
rs174547 0.339 -0.176 -0.212 0.027 0.607 0.016 0.036 0.011 0.131 0.001 
rs964184 0.149 -0.051 -0.227 0.199 0.657 0.131 0.176 0.039 0.001 0.000 
rs2338104 0.529 0.169 0.182 0.008 0.550 0.004 -0.013 0.008 0.597 0.120 
rs2650000 0.374 0.056 0.061 0.007 0.562 0.004 -0.005 0.009 0.642 0.591 
rs10468017 0.349 0.172 0.175 0.027 0.545 0.015 -0.003 0.010 0.151 0.765 
rs173539 0.312 0.040 0.071 -0.030 0.571 -0.017 -0.031 0.011 0.123 0.005 
rs2271293 0.104 0.161 0.186 -0.027 0.581 -0.016 -0.025 0.015 0.299 0.092 
rs4939883 0.224 -0.006 0.027 -0.026 0.564 -0.015 -0.033 0.012 0.238 0.008 
rs10401969 0.057 -0.093 -0.029 -0.074 0.570 -0.042 -0.065 0.023 0.066 0.005 
rs17216525 0.069 -0.123 -0.079 -0.065 0.571 -0.037 -0.044 0.020 0.058 0.025 
rs2967605 0.164 0.220 0.207 0.068 0.566 0.039 0.012 0.021 0.062 0.550 
rs4420638 0.162 -0.016 -0.112 0.064 0.567 0.036 0.096 0.031 0.243 0.002 
rs6511720 0.091 0.029 0.108 -0.091 0.593 -0.054 -0.079 0.027 0.049 0.004 
rs1800961 0.056 0.089 0.065 0.001 0.567 0.001 0.024 0.045 0.988 0.584 
rs6102059 0.292 -0.187 -0.187 -0.023 0.561 -0.013 0.000 0.010 0.196 0.995 
rs7679 0.160 -0.232 -0.259 0.011 0.568 0.006 0.028 0.012 0.595 0.017 
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Figure 4.3: Mediated Effect in FHS Data (AFT–joint and AFT–observed Models) 
 
 
 
  
Plot	of	the	mediated	effect	using	the	product	and	difference	methods	among	32	SNP	associated	with	blood	lipid	
concentrations	(FHS	Data);	32	SNPs	obtained	from	Kathiresan	et	al.	in	Nature	Genetics	(2009). 
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CHAPTER 5: CONCLUSION AND DISCUSSION 
 
5.1 SUMMARY AND CONCLUSION 
 Modeling of longitudinal and survival data has received much attention in statistical 
research and is becoming increasingly useful. In this thesis, we examined several methods for 
modeling longitudinal and survival data. Our main focus was addressing three main research 
objectives: 1) Comparing methods for modeling longitudinal and survival data; 2) Evaluating 
time dependent covariate methods for modeling longitudinal and survival data; 3) Mediation 
analysis in longitudinal and survival data.  
In the first part of the thesis, we presented several methods which link the 
longitudinal data to survival data. These methods quantify the link parameter as the 
association between the longitudinal process and survival using the hazard at the same time 
point as the time-to-event. We analyzed data from FHS in which lipid measurements and 
myocardial infarction (MI) data were collected over a period of 26 years. We conducted 
simulation studies to explore and access the performance of these methods, using Type I 
errors, bias, MSE and coverage probabilities. To our knowledge this is the first paper that 
compares the BSJM to the TSA, MLA, TDCM, PRO, CSP methods  
We found that the TSA performed best at estimating the link parameter. The main 
advantage of this approach is that it is simple and can be implemented using existing 
statistical packages. The BSJM and the MLA provided estimates that were biased upwards, in 
the link parameter, similar to the findings by Wulfsohn and Tsiatis (1997). One main 
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shortcoming of the BSJM is the computing time involved in estimating the parameters and 
its slow convergence in some of the MCMC runs. The TDCM, stratified CSP and the PLR 
that used the observed longitudinal measures as time dependent covariate measures in the 
survival analysis resulted in underestimation of the true estimates. These results were similar 
to the findings by Sweeting and Thompson (2011), where they recommended the use of a 
shared random effects model. The TDCM, stratified CSP and the AG provided identical 
results in all scenarios considered, as expected. Comparison of the methods in Framingham 
Heart Study revealed similar patterns. We explored a number of other scenarios where we 
varied the residual error in the longitudinal measures. The results showed that with low 
residual errors in the longitudinal measures the TSA provides similar results as time 
dependent covariate methods that use the observed longitudinal measures. Higher residual 
error resulted in severe underestimation of the true association parameter by the time 
dependent covariate methods. 
In the second part of the thesis, we focused on four time dependent models (time 
dependent covariate models, Anderson and Gill counting method, pooled logistic regression 
and cross-sectional pooling), considering models that are unadjusted and adjusted for time. 
We simulated a number of scenarios and evaluated the effect of accounting for the time 
intervals at which the longitudinal measures are recorded on these models. From the 
simulations we found that the adjusted time dependent covariate methods performed best at 
estimating the association parameter compared to the unadjusted Cox and logistic models. 
Our results indicated that in some instances the PLR provided upwardly biased estimates 
and larger standard errors compared to the Cox models. The PLR and the time dependent 
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covariate methods showed similar results when the event is rare. This is consistent with the 
results presented by Green and Symons (1983). In addition the Cox models provided 
relatively stable estimates compared to the PLR. 
In the third part of the thesis, we applied the concept of jointly modeling 
longitudinal and survival data in the context of mediation analysis. Mediation analysis was 
introduced and applied in a research framework based on genetic variants, longitudinal 
measures and disease risk. The direct, indirect and mediated effects of longitudinal measures 
on time-to-event outcome were assessed using a series of regression equations. In this 
setting the genetic variant (coded as the number of minor alleles for a SNP) was the 
exposure variable, the longitudinal measure was the potential mediator and the time to 
myocardial infarction was the survival outcome. We implemented the accelerated failure time 
regression model using joint maximum likelihood approach (AFT–joint) and an accelerated 
failure time regression model using the observed longitudinal measures as time dependent 
covariates (AFT–observed) to assess the point and variance estimates of the mediated effect. 
From the simulation results all four estimators underestimated the mediated effect. The 
AFT–joint product model had the least biased estimate of the mediated effect compared to 
the other three models. The AFT–observed product and difference methods showed similar 
estimates of the mediated effect in most of the models, especially when a large sample was 
employed. The mediated effect estimates for the AFT–joint difference were smaller than the 
AFT–joint product estimates. When we used a large sample size several AFT–joint 
difference models had a negative mediated effect especially in models when the SNP effect 
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on the mediator was small. The real data (FHS) showed similar pattern in the results for all 
four models. 
 
5.2 FUTURE CONSIDERATIONS 
In Chapter 2, we explored a number of scenarios where we varied the residual error 
in the longitudinal measures. The results showed that with low residual errors in the 
longitudinal measures the TSA provided similar results as time dependent covariate methods 
that use the observed longitudinal measures. Higher residual error resulted in severe 
underestimation of the true association parameter by the time dependent covariate methods. 
In future work, we plan to explore more scenarios on the residual errors and provide some 
recommendations on appropriate residual error for the TSA to provide similar results as the 
time dependent covariate methods.  
In Chapter 3, we considered time dependent covariate models for modeling 
longitudinal and survival data. In all our models data was available at the beginning of each 
time interval, during the follow-up period of each subject. Dropouts in a longitudinal study 
may lead to missing data in the longitudinal time dependent measures. Since missing data are 
very common, we plan to extend our simulation studies to address missing data problems. In 
the future, we would consider situations in which there is missing data in the time dependent 
longitudinal measures. Such missingness may be assumed to be ignorable or missing at 
random when the missingness may not be related to the missing values. The last-value-
carried-forward (LOCF) method has been widely used to impute missing longitudinal 
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measures, but this may lead to bias in the estimates. We plan to explore methods for 
modeling longitudinal and survival data in the presence of missing data. 
In Chapter 4, we implemented the accelerated failure time regression model using 
the joint maximum likelihood approach (AFT–joint) and an accelerated failure time 
regression model using the observed longitudinal measures (AFT–observed) to assess the 
point and variance estimates of the mediated effect. We employed the accelerated failure 
time model as there was nonequivalence in the product and difference of the mediated effect 
when the Cox model is applied. In the future, we plan to consider the Cox model and 
determine whether appropriate multiplying factors or transformation may be feasible for the 
two mediated effect to yield similar results. We also examined the bias of mediated effect in 
longitudinal and survival data setting under the condition of censored data and a time 
dependent mediator. The results suggest that the AFT–joint and the AFT–observed models 
underestimated the mediated effect using the product and difference methods. Exploring 
models that provide unbiased estimates for the mediated effect of the product and difference 
may be essential.  
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APPENDIX 
Figure A.1: Estimates and Confidence Intervals For Link (Dist. = Exponential, N = 100) 
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Figure A.2: Estimates and Confidence Intervals For Age (Dist. = Exponential, N = 100) 
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Figure A.3: Estimates and Confidence Intervals For Sex (Dist. = Exponential, N = 100)
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Table A.4: Mediated Effect in Longitudinal and Survival Data (N = 1000, Event Rate = 10%, MAF = 50%) 
Scenarios True Estimates 
AFT–observed Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 50% 0.050 0.500 0.000 0.004 0.000 0.005 -0.001 0.004 0.007 0.015 
0.000 0.000 0.050 -0.500 50% 0.050 1.000 0.000 0.004 0.000 0.005 -0.001 0.004 0.015 0.032 
0.000 0.000 0.050 -0.500 50% 0.500 0.500 -0.001 0.023 -0.001 0.055 -0.010 0.023 -0.004 0.060 
0.000 0.000 0.050 -0.500 50% 0.500 1.000 -0.001 0.031 -0.001 0.031 -0.010 0.032 -0.004 0.018 
0.025 0.500 0.050 -0.500 50% 0.050 0.500 0.020 0.010 0.018 0.016 0.022 0.011 -0.061 0.067 
0.025 0.500 0.050 -0.500 50% 0.050 1.000 0.017 0.009 0.015 0.017 0.020 0.011 -0.118 0.039 
0.250 0.500 0.050 -0.500 50% 0.500 0.500 0.187 0.037 0.183 0.036 0.212 0.048 0.102 0.093 
0.250 0.500 0.050 -0.500 50% 0.500 1.000 0.168 0.038 0.166 0.039 0.195 0.049 0.043 0.134 
0.050 1.000 0.050 -0.500 50% 0.050 0.500 0.032 0.016 0.024 0.026 0.041 0.020 -0.078 0.049 
0.050 1.000 0.050 -0.500 50% 0.050 1.000 0.030 0.014 0.019 0.028 0.038 0.018 -0.157 0.073 
0.500 1.000 0.050 -0.500 50% 0.500 0.500 0.291 0.032 0.278 0.033 0.371 0.054 0.189 0.036 
0.500 1.000 0.050 -0.500 50% 0.500 1.000 0.287 0.040 0.280 0.041 0.358 0.061 0.123 0.171 
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Table A.5: Mediated Effect in Longitudinal and Survival Data (N = 1000, Event Rate = 10%, MAF = 5%) 
Scenarios True Estimates 
AFT–observed Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 5% 0.050 0.500 0.000 0.006 0.000 0.006 -0.002 0.006 0.041 0.041 
0.000 0.000 0.050 -0.500 5% 0.050 1.000 0.000 0.005 -0.001 0.018 -0.001 0.005 0.102 0.065 
0.000 0.000 0.050 -0.500 5% 0.500 0.500 0.001 0.034 0.001 0.036 -0.013 0.033 0.030 0.043 
0.000 0.000 0.050 -0.500 5% 0.500 1.000 0.000 0.037 0.001 0.044 -0.014 0.037 0.094 0.062 
0.025 0.500 0.050 -0.500 5% 0.050 0.500 0.019 0.021 0.019 0.032 0.021 0.023 -0.038 0.043 
0.025 0.500 0.050 -0.500 5% 0.050 1.000 0.020 0.022 0.021 0.046 0.021 0.024 -0.053 0.063 
0.250 0.500 0.050 -0.500 5% 0.500 0.500 0.197 0.039 0.199 0.047 0.216 0.048 0.152 0.055 
0.250 0.500 0.050 -0.500 5% 0.500 1.000 0.188 0.035 0.188 0.051 0.212 0.047 0.125 0.061 
0.050 1.000 0.050 -0.500 5% 0.050 0.500 0.035 0.036 0.036 0.062 0.042 0.043 -0.044 0.072 
0.050 1.000 0.050 -0.500 5% 0.050 1.000 0.034 0.038 0.035 0.071 0.041 0.046 -0.096 0.096 
0.500 1.000 0.050 -0.500 5% 0.500 0.500 0.346 0.051 0.348 0.074 0.404 0.069 0.285 0.089 
0.500 1.000 0.050 -0.500 5% 0.500 1.000 0.339 0.049 0.333 0.078 0.399 0.072 0.245 0.107 
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Table A.6: Mediated Effect in Longitudinal and Survival Data (N = 1000, Event Rate = 90%, MAF = 50%) 
Scenarios True Estimates 
AFT–observed Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 50% 0.050 0.500 0.000 0.001 0.000 0.001 0.000 0.002 0.000 0.002 
0.000 0.000 0.050 -0.500 50% 0.050 1.000 0.000 0.001 0.000 0.001 0.000 0.002 0.001 0.004 
0.000 0.000 0.050 -0.500 50% 0.500 0.500 0.000 0.008 0.000 0.008 -0.001 0.014 -0.001 0.011 
0.000 0.000 0.050 -0.500 50% 0.500 1.000 0.000 0.009 0.000 0.009 -0.004 0.015 -0.003 0.009 
0.025 0.500 0.050 -0.500 50% 0.050 0.500 0.006 0.003 0.001 0.004 0.014 0.007 -0.015 0.009 
0.025 0.500 0.050 -0.500 50% 0.050 1.000 0.006 0.003 -0.003 0.004 0.014 0.007 -0.035 0.010 
0.250 0.500 0.050 -0.500 50% 0.500 0.500 0.065 0.009 0.058 0.008 0.140 0.016 0.099 0.013 
0.250 0.500 0.050 -0.500 50% 0.500 1.000 0.069 0.010 0.058 0.008 0.137 0.018 0.075 0.011 
0.050 1.000 0.050 -0.500 50% 0.050 0.500 0.011 0.006 -0.004 0.006 0.026 0.013 -0.028 0.015 
0.050 1.000 0.050 -0.500 50% 0.050 1.000 0.012 0.006 -0.018 0.008 0.027 0.013 -0.070 0.017 
0.500 1.000 0.050 -0.500 50% 0.500 0.500 0.118 0.010 0.090 0.009 0.267 0.021 0.175 0.016 
0.500 1.000 0.050 -0.500 50% 0.500 1.000 0.124 0.011 0.086 0.009 0.267 0.023 0.144 0.017 
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Table A.7: Mediated Effect in Longitudinal and Survival Data (N = 1000, Event Rate = 90%, MAF = 5%) 
Scenarios True Estimates 
AFT–observed Model AFT–joint Model 
Product Difference Product Difference 𝜷𝟏 ∗ 𝜸 𝛾 Age Sex MAF 𝛽! 𝛽! 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 𝛽! ∗ 𝛾 SE 𝛽! − 𝛽! SE 
0.000 0.000 0.050 -0.500 5% 0.050 0.500 0.000 0.001 0.000 0.001 0.000 0.002 0.001 0.003 
0.000 0.000 0.050 -0.500 5% 0.050 1.000 0.000 0.001 0.000 0.001 0.000 0.002 0.001 0.007 
0.000 0.000 0.050 -0.500 5% 0.500 0.500 0.000 0.008 0.000 0.008 0.000 0.013 0.001 0.010 
0.000 0.000 0.050 -0.500 5% 0.500 1.000 0.000 0.007 0.000 0.007 0.000 0.013 0.001 0.007 
0.025 0.500 0.050 -0.500 5% 0.050 0.500 0.006 0.007 0.002 0.008 0.014 0.015 -0.018 0.018 
0.025 0.500 0.050 -0.500 5% 0.050 1.000 0.006 0.006 -0.001 0.007 0.014 0.015 -0.046 0.018 
0.250 0.500 0.050 -0.500 5% 0.500 0.500 0.058 0.010 0.052 0.009 0.139 0.021 0.095 0.019 
0.250 0.500 0.050 -0.500 5% 0.500 1.000 0.055 0.010 0.047 0.009 0.136 0.021 0.064 0.018 
0.050 1.000 0.050 -0.500 5% 0.050 0.500 0.011 0.012 -0.002 0.013 0.026 0.029 -0.028 0.030 
0.050 1.000 0.050 -0.500 5% 0.050 1.000 0.011 0.012 -0.012 0.013 0.027 0.029 -0.078 0.035 
0.500 1.000 0.050 -0.500 5% 0.500 0.500 0.113 0.015 0.092 0.015 0.266 0.041 0.166 0.032 
0.500 1.000 0.050 -0.500 5% 0.500 1.000 0.109 0.015 0.080 0.014 0.264 0.033 0.118 0.030 
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